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SUMMARY 
Introduction 
Cerebral autoregulation (CA) refers to the physiological mechanisms in the brain to maintain constant blood flow 
despite changes in cerebral perfusion pressure (CPP). It plays an important protective role against the danger of 
ischaemia at low perfusion pressure, and the risk of brain oedema at higher CPP. Over the years, various methods 
for CA assessment have been proposed, including both static and dynamic CA. Whereas ‘static’ CA is assessed by 
analysing the cerebral blood flow (CBF) response to slow manipulations of arterial blood pressure (ABP) or cerebral 
perfusion pressure (CPP), the dynamic CA is assessed from analysing the CBF velocity (CBFV) response to 
transient changes in ABP, either externally induced or occurring spontaneously. One dynamic method known as the 
leg-cuff test uses a sudden drop in ABP produced by a rapid deflation of thigh cuffs to grade the ensuing CBFV 
response with a parametric, second order-model, Tiecks’ model.  The resulting CA index, the autoregulation index 
(ARI), grades CA into ten levels (from 0 - 9), while ARI = 0 represents absent autoregulation and ARI = 9 indicates 
hyperactive autoregulation.  However, direct calculation of ARI in such a manner requires substantial 
decreases/increases in ABP, which, for traumatic brain injury (TBI) patients, should be avoided in some cases.  
One attractive method that takes advantage of spontaneous fluctuations in ABP and CBFV is transfer function (TF) 
analysis, an approach that sheds light on the dynamic properties of CA from the perspective of linear response 
theory. This type of analysis assumes that functional CA can be described as a high pass filter that readily transmits 
rapid (high frequency) changes in ABP to CBFV, but attenuates the transmission of slower (low frequency, usually 
lower than 0.05 Hz) ABP perturbations to CBFV. Parameters derived from TF include phase shift, gain and 
coherence.  In 1998, Panerai and colleagues combined the Tiecks’ model with TF analysis in low frequency range to 
yield the impulse response (IR)-based ARI, defined as the best match between the IR estimated from patients’ real 
data with IR of Tiecks’ model.  
Another commonly used measure, the mean flow index (Mx), estimates CA through the correlation coefficient 
between slow fluctuations (20 sec to 3 minutes) of mean CBFV and CPP. It is a purely time domain measurement, 
based on the concept that if CA is intact, there will be no correlation between changes in CPP and changes in CBFV 
(Mx = zero or negative), whereas when CA is exhausted changes in CPP will be directly correlated with changes in 
CBFV (Mx ≈ +1). In traumatic brain injury, where frequent, repeated assessment of CA is highly desirable, a 
technique based on analysis of the relationship between two routinely monitored modalities, ABP and intracranial 
pressure (ICP) has gained wide popularity.  Given that changes in ICP may be interpreted as surrogates for changes 
in cerebral blood volume, pressure reactivity index (PRx), calculated as a moving correlation coefficient between 
mean ABP and ICP, is well suited for real-time, continuous monitoring of CA and is by now routinely used in many 
head trauma centres.   
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These methods mentioned above, all describe CA, but perhaps reflect its slightly different aspects. Until now, how 
these parameters are related with each other is still not clear. Especially that in reality, their properties will be 
affected by issues related to their estimation from the measurement data, as well as by the degree of misfit of the 
models used to describe the underlying physiology. A comprehensive investigation of the relationship between all 
these parameters using measurements taken from a particular patient population is therefore needed. In addition, the 
methods mentioned above mostly assume the system being analysed is linear and the signals are stationary, the 
assumption has been shown not to reflect the reality very well. A more robust method, in particular suitable for non-
stationary signal analysis, needs therefore to be explored.  
The clinical benefit of PRx monitoring lies in the fact that plotting PRx against CPP will often generate a ‘U’-shape 
curve, the minimum of which represents the CPP corresponding to the smallest value of PRx, where the CA 
response is most active, and the point is termed optimal CPP (CPPopt). Observational studies have confirmed that 
patients whose median CPP is closer to their determined CPPopt seem to have better clinical outcomes. The problem 
with the current algorithm of CPPopt is the fact that CPPopt can only be generated during approximately 55% of the 
monitoring time. An improved method which can create more stable and continuous CPPopt is needed, to make 
CPPopt-guided management more likely to be accepted into clinical practice. 
Objectives, Methods and Results  
This thesis addresses three primary questions: 
1. What are the relationships between currently widely used CA parameters, i.e. Mx, ARI, TF parameters, from 
theoretical and practical point of view? 
2. It there an effective method that can be introduced to assess CA, which is suitable for analyses of non-stationary 
signals? 
3. How can bedside monitoring of cerebral autoregulation be improved in traumatic brain injury patients ? 
These general aims have been translated into a series of experiments, retrospective analyses and background studies 
which are presented in different chapters of this thesis. As part of this project, all the methods used in this thesis 
have been implemented in ICM+ (http://www.neurosurg.cam.ac.uk/icmplus) using custom built plugins (written in 
C and complied into dll libraries) where necessary. Most of the chapters of this work have been also written up as 
manuscripts for peer-review journals and are either published already or are in currently under review (see list of 
publications). 
First, a validation study of the relationship between different established CA parameters, such as Mx, TF, ARI, was 
applied to a group of simulated data and a database of TBI patients. The result showed that the impulse-response-
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based ARI correlates significantly with the time-correlation-based index Mx and TF phase. Both Mx and ARI were 
significantly related to patients’ outcome, although Mx correlates more strongly than ARI.  
Second, a new time – frequency analytical method, the wavelet transform, is introduced to asses CA, which is 
suitable for non-stationary signals. The new method, termed wavelet transform pressure reactivity index (wPRx),  
was validated through two groups of experimental piglets’ data. Subsequently, the wPRx was applied to a big cohort 
of TBI patients. The results showed a significantly positive relationship between wPRx and the time-correlation-
based index, PRx, with wPRx demonstrating  more stable behaviour than PRx.  
Third, an improved approach for optimal CPP estimation for TBI patients is described. This mathematical approach 
was based on a multi-window algorithm and applying a weighting system which incorporates more characteristics of 
the PRx-CPP plot. The result showed significant improvement of CPPopt yield using the multi-window approach, 
with more stable results. This methodological improvement is essential for its clinical application in future CPPopt 
trials.    
Finally, the thesis tests whether the CA parameters used in this project also work in other clinical situations. The 
result showed that the CA parameters (i.e. ARI, Mx, PRx, wPRx) demonstrated deteriorated CA during high ICP, 
such as ICP plateau and refractory ICP.  
Conclusion 
This PhD project carefully scrutinised currently used CA assessment methodologies in TBI patients, demonstrating 
significant relationships between ARI, Mx and TF phase. The new introduced wavelet-transform-based method, 
wPRx was validated and showed more stable result for CA assessment than the well-established parameter, PRx. A 
multi-window approach with weighting system for optimal CPP estimation was described. The result showed a 
significant improvement in the continuity and stability of CPPopt estimation, which made it possible to be applied in 
the future clinical management of TBI patients. 
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CHAPTER 1 AIMS AND HYPOTHESES 
Survival after traumatic brain injury (TBI) depends on the control of intracranial hypertension and the provision of 
haemodynamic support to achieve an ‘adequate’ cerebral blood flow with cerebral perfusion pressure (CPP) being 
one of the main driving forces. Therefore to set an adequate CPP target for the individual TBI patient at the bedside 
is of great importance, which still remains challenging. Maintaining a CPP above 70 mmHg was proposed as a 
method for preventing secondary injuries [1], [2]. However, a large randomized controlled trial could not 
demonstrate a benefit of a fixed CPP-targeted therapy [3], [4].  The recent Brain Trauma Foundation guidelines 
advocated exploring the feasibility and impact on the outcome of strategies based on individualized autoregulation-
guided CPP management [2]. Over the years, a dynamic patient-targeted CPP protocol, based on the cerebral 
autoregulation (CA) ability of cerebral vasculature has been proposed. Many methodologies for CA assessment have 
been proposed, including static and dynamic methodologies. However, until now, there is still not a golden standard 
method for CA assessment in TBI patients. Better understanding and further standards in methodology are still 
needed.  
This thesis looked into details of currently available CA assessment methods and introduced a new time–frequency 
analytical method, suitable for non-stationary signals. This thesis addresses three primary questions: 
1. What are the relationships between currently widely used CA parameters, from theoretical and practical point of 
view? 
2. It there an effective method that can be introduced to assess CA, which is suitable for analyses of non-stationary 
signals? 
3. How can bedside monitoring of cerebral autoregulation be improved in traumatic brain injury patients ? 
The study used the structure described in Figure 1.1.  
 
 
Figure 1.1 Diagram of the framework of this research.CA: cerebral autoregulation; ABP: arterial blood pressure; 
ICP: intracranial pressure; FV: flow velocity; CPP: cerebral perfusion pressure. 
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1.1 The validation of relationships between currently widely used CA parameters  
CA is an important homeostatic mechanism that protects the brain against injury due to potential insufficient or 
excessive cerebral blood flow (CBF) caused by an increase or decrease in CPP or arterial blood pressure (ABP). In 
the last decades, various methods for CA assessment have been proposed, including static and dynamic methods.  
Initially, clinical studies mainly evaluated CA by analysing the CBF response to slow manipulations of ABP or CPP 
[5]–[8]. However, this process is not routinely applicable as it requires potentially harmful ABP manipulations [5]. 
Later on, transcranial Doppler (TCD) ultrasonography was introduced, which allowed dynamic CA assessment by 
analysing CBFV response to rapid changes in ABP, either externally induced or occurring spontaneously[9]–[11]. 
The most popular way of grading FV response to rapid changes in ABP, is the autoregulation index (ARI), which 
grades CA into 10 levels (from 0–9); ARI = 0 represents absence of autoregulation while ARI = 9 indicates 
hyperactive autoregulation [12], [13]. However, direct calculation of ARI in such a manner requires substantial 
decreases/increases in ABP, which, for traumatic brain injury (TBI) patients, should be avoided in some cases.  
One attractive method that takes advantage of spontaneous fluctuations in ABP and CBFV is transfer function (TF) 
analysis, an approach that sheds light on the dynamic properties of CA from the perspective of linear response 
theory [14]–[16]. This type of analysis assumes that functional CA can be described as a high pass filter that readily 
transmits rapid (high frequency) changes in ABP to CBFV, but attenuates the transmission of slower (low frequency, 
usually lower than 0.05 Hz) ABP perturbations to CBFV[17]. Parameters derived from TF include phase shift, gain 
and coherence.  In 1998, Panerai and colleagues combined the Tiecks’ model with TF analysis in low frequency 
range to yield the impulse response (IR)-based ARI, defined as the best match between the IR estimated from 
patients’ real data with IR of Tiecks’ model[18].  
 
Another commonly used measure, the mean flow index (Mx), estimates CA through the correlation coefficient 
between slow fluctuations (20 sec to 3 minutes) of mean CBFV and CPP[19]. It is a purely time domain 
measurement, based on the concept that if CA is intact, there will be no correlation between changes in CPP and 
changes in CBFV (Mx = zero or negative), whereas when CA is exhausted changes in CPP will be directly 
correlated with changes in CBFV (Mx ≈ +1)[20]. In traumatic brain injury, where frequent, repeated assessment of 
CA is highly desirable, a technique based on analysis of the relationship between two routinely monitored modalities, 
ABP and intracranial pressure (ICP) has gained wide popularity.  Given that changes in ICP may be interpreted as 
surrogates for changes in cerebral blood volume, pressure reactivity index (PRx), calculated as a moving correlation 
coefficient between mean ABP and ICP, is well suited for real-time, continuous monitoring of CA and is by now 
routinely used in many head trauma centres [21].  
 
Despite advances in the application of CA assessment, there remain many uncertainties about the theoretical and 
pragmatic relationships between the indices. Although a few comparisons have been published [22]–[29] they have 
been based on real measurements, which inevitably introduces confounding factors to the relationships such as poor 
fit of the assumed models or the presence of unknown extraneous ‘noise’ [30], i.e. components in ABP and CBFV  
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that are not related to each other.  The potential for differential sensitivity of the CA indices to these confounding 
factors makes meaningful comparisons between the different methods difficult. To cross validate the relationships 
between the CA indices in a more controlled environment, this study generated artificial FV signals according to 
Tiecks’ ARI model of CA [12] using real ABP signals from TBI patients as input.  
 
Hypothesis I: Theoretically, the relationships between the most commonly used indices of CA: ARI, Mx and TF 
phase and gain, are related to each other. The exogenous noise of signals will influence the accuracy of CA 
assessment.  
 
After the comparison of CA parameters through modelling data in theoretical level, a further investigation is needed 
to test how these commonly used parameters correlate with each other in real clinical scenario of TBI patients.  The 
effect of different inputs (ABP or 
CPP) for CA assessment should also be studied. 
 
Hypothesis II: In TBI patients, different available CA parameters still correlate significantly with each other, while 
different input (ABP or CPP) demonstrates influences in CA assessment. CA parameters are generally related to 
patients’ outcome.  
1.2 Introduction of a new time–frequency-based analysis method for CA assessment 
The methods for CA assessment described above are either simple correlation indices (such as PRx) or are assumed 
to be suitable for linear signal analysis, such as spectral decomposition and TF [31], [32].  With the clarification of 
the non-stationary nature of CA [28], many attempts are motivated to perform more sophisticated analyses to 
quantify the coupling mechanism of  ABP and ICP. The wavelet-transform (WT) method has been widely applied in 
analysing noisy, transient and non-stationary signals. One advantage of wavelet analysis is the ability to perform 
local analysis and reveal signal features with desired temporal–frequency resolution. Noting that CA is altered 
through low-frequency (LF) arteriole vessel diameter changes [33], wavelet analysis can provide desired resolution 
for each signal feature simultaneously, higher scale (frequency) resolution for lower frequency and higher temporal 
resolution for higher frequency [34], [35]. 
In this study, WT algorithm was introduced to assess CA and was implemented into software ICM+ 
®
(http://www.neurosurg.cam.ac.uk/icmplus). To validate the algorithm, a validation study was conducted on two 
cohorts of experimental hypotensive piglets’ data with continuous ABP and ICP monitoring.  
Hypothesis III: Wavelet phase shift can be used to assess CA and to distinguish good CA and bad CA. Low wavelet 
phase shift close to zero should be related with bad CA.  
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Hypothesis IV: Wavelet coherence might be used as a guarantee of reliable phase relationship between ABP and 
ICP. Different thresholds should be chosen for different central frequencies of mother wave used for wavelet 
analysis. 
After the wavelet method was validated through the experimental data, it was applied to a cohort of 515 TBI patients 
admitted to Addenbrooke’s Hospital between 2003 and 2015. The wavelet method phase shift between ABP and 
ICP was calculated in low frequency and was compared with the well-known CA parameter, PRx.  
 Hypothesis V: Wavelet phase shift is related to PRx and to patients’ outcome. Better CA demonstrated by higher 
phase shift, correlates with a better outcome.  
1.3 Calculation of optimal CPP for clinical TBI patients  
The final goal of this thesis was trying to find a better way to apply the CA parameters in clinical practise for TBI 
patients in the future. CA indices, such as PRx, performs in such a way that plotting PRx against CPP will often 
generate a ‘U’-shaped curve, the minimum of which represents the CPP corresponding to the smallest value of PRx, 
where the CA response is most active [36], [37], the point termed CPPopt. Steiner et al. introduced this concept in 
2002 looking at CPPopt calculated from the whole monitoring period [36]. In 2012, Aries et al. proposed and tested 
an automated CPPopt algorithm based on a moving four-hour calculation window in a different (retrospective) 
cohort of TBI patients by showing improved outcome in patients with CPP close to averaged automated CPPopt [38]. 
However, many challenges remain to improve the performance of CPPopt, such as low yield and discontinuity. The 
object of the present study was to investigate how the yield and continuity of CPPopt can be enhanced through a 
multi-window algorithm and a weighting system, that can maximally exploit and optimize the potential information 
about cerebral vascular pressure reactivity.  
 
Hypothesis VI: The multi-window approach can improve the estimation of optimal CPP and increase its potential to 
make the technique of pressure autoregulation controlled  management widely applicable in most ICUs. 
1.4 Outline of the thesis 
These general aims have been translated in a series of experiments, retrospective analyses and background studies 
which are presented in different chapters of this thesis.  
Chapter 2 provides a further description of the physiology of brain circulation relevant for the thesis starts with a 
short review of the basic mechanism responsible for ICP circulation with CBF to follow.  
Chapter 3 provides background information about methodologies currently used for CA assessment. This review 
also addresses the problems of current methods. 
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Chapter 4 describes methodological considerations regarding projects included in this thesis. It explained the 
materials, the methodologies and statistical analysis used in this PhD projects. 
Chapter 5 cross-validates the relationships between the current CA indices through artificial data generated 
according to Tiecks’ ARI model, and also through real data from 288 TBI patients. The parameters being compared 
includes ARI, Mx, TF phase and gain.  
Chapter 6 introduces a new method for CA assessment, which is suitable for non-stationary data analysis, the 
wavelet method. This chapter compared the new method with traditional PRx using data from 515 TBI patients to 
validate the new approach.  
Chapter 7 describes the development of a multi-window weighting approach for optimal CPP estimation for TBI 
patients. The association between outcome and the deviation of actual CPP from the calculated optimal CPP was 
studied. The yield and stability of the new multi-window approach was compared with traditional CPPopt estimation 
method.  
Chapter 8 describes whether the CA parameters studies in this project, could be replicated in other clinical situations, 
such as ICP plateau or refractory ICP.  
Chapter 9 provides a summary and future directions of the methodologies used in this thesis.  
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CHAPTER 2 BASIC OF CEREBRAL PHYSIOLOGY – REVIEW 
This thesis concentrates on the methodology for monitoring the autoregulation of CBF. 
Historically, autoregulation can be described as a static relationship between CBF and cerebral arterial blood 
pressure (ABP), the so-called Lassen curve [39]. The concept of CPP as a difference between ABP and ICP (or 
central venous pressure, CVP, if CVP > ICP), was introduced only in 1970s [40]. The Lassen curve illustrates the 
relationship between CBF and CPP [41], [42]. Therefore, this chapter describing the physiology of brain circulation 
relevant for the thesis starts with a short review of the basic mechanism responsible for ICP circulation with CBF to 
follow.  
2.1 Monro–Kellie hypothesis and pressure–volume curve 
The concept of ICP being a function of the volume and compliance of each component of the intracranial 
compartment was proposed by Monro (1783) and his student Kellie (1824) during the late 18th century [43], [44].
 
The interrelationship came to be known as the Monro–Kellie hypothesis, which states that the cranial compartment 
is encased in a non-expandable case of bone, and, thus, the volume inside the cranium is fixed [45]. The hypothesis 
further states that, as a rigid box, the human cranium encloses a fixed volume that is shared by the brain tissue, 
blood and cerebrospinal fluid (CSF) (Figure 2.1 A), such that an increase in the volume of one of the constituents 
must be compensated for by reduction in the others [46].  For example, the arterial blood entering the brain requires 
a continuous outflow of venous blood to make room for it [47], [48]. The intracranial flow of blood and CSF is thus 
pulsatile, as is the ICP [49]. 
 
Figure 2.1 (A) Anatomy of the intracranial compartment; (B) Intracranial pressure-volume curve [50] and the 
relationship between pulse amplitude of ICP and cerebral volume. Index: index of cerebrospinal compensatory 
reserve calculated as the moving correlation coefﬁcient between the amplitude of the fundamental harmonic of the 
ICP pulse wave and mean ICP.  ICP: intracranial pressure.  
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Kocher in 1901 described four stages of cerebral compression related to the expansion of intracranial brain tumours 
[51]. In 1951, Ryder et al. described the pressure–volume relationship as a hyperbolic function, which implies an 
increase in elastance as ICP increases [52]. The pressure–volume curve has three parts [50]: first, flat at lower 
intracerebral volumes, where good compensation is observed, therefore ICP remains low and constant even though 
there are changes in cerebral volume;  the second shows that with poor compensatory reserve, ICP rises 
exponentially with volume, that is, ICP increases considerably even with small increases in intracranial volume; 
finally, when the critical level of ICP is achieved and the cerebral arterial bed cannot dilate any more, the curve 
becomes flat again (Fig. 2.1B). The pulse waveform may conceptually be presented as a transformation of regular 
changes in pulsatile blood volume through the curve. Pulse amplitude is low for good compensatory reserve and 
does not depend on ICP, then starts to rise with mean ICP and above the ‘critical ICP’ secondarily decreases. 
2.2 Global model of CBF and circulation of CSF 
As a fragile organ, the brain is only able to withstand very short periods of lack of blood supply (ischaemia), and it 
has very high energy (ATP) requirement, which needs constant energetic substrate replenishment. The neurons 
produce energy almost entirely by oxidative metabolism of substrates, including glucose and ketone bodies, with 
very limited capacity for anaerobic metabolism. Without oxygen, energy-dependent processes cease leading to 
irreversible cellular injury if blood flow is not re-established rapidly (three to eight minutes under most 
circumstances) [53]. Therefore, adequate CBF must be maintained to ensure a constant delivery of oxygen and 
substrates and to remove the waste products of metabolism [54].  
In 1997, Czosnyka et al. introduced a mathematical model to interpret cerebrovascular circulation and 
autoregulation in the brain [55]. As described in Figure 2.2, the CBF pathway starts with the arterial blood inﬂow to 
the brain through the resistance of large intracranial arteries (Ra). Arterial blood is contained in a high-pressure 
arterial compliance Ca. Forward ﬂow through the cerebrovascular resistance vessels is inﬂuenced by CA. Capillary 
and venous blood are contained in a compliance of Cv. Finally, venous blood ﬂows out to the sagittal sinus through 
the bridging veins Rb. The CSF pathway encompasses CSF formation (If), storage in the distensible ﬂuid structures 
formed by the ventricles and basal cisterns (Ci) and reabsorption through the arachnoid granulations (Rcsf) to the 
sagittal sinus. 
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Figure 2.2 Hydrodynamic equivalent of the model, comprising pathways of CBF and the CSF circulation. A rigid 
skull is represented by the outer box, with a compensatory reserve Ci associated with the compliant dural sac within 
the lumbar channel [55]. 
2.3 Cerebral autoregulation 
It is estimated that the brain uses around 20% of total oxygen for normal function, making regulation of blood flow 
and oxygen delivery critical for survival [56], [57] . CA refers to the ability of the brain to keep stable CBF in spite 
of changes in CPP or if ICP is normal, ABP [10], [58]. It is present in many parts of the vascular bed, but is 
particularly well developed in the brain (to keep CBF at a constant level, matched to metabolism), probably due to 
the need for a constant blood supply and water homeostasis [59]. CA is a universal physiological mechanism, the 
relationship between CBF and CPP that is depicted by the Lassen curve (Figure 2.3), with ABP or CPP along the x-
axis and CBF along the y-axis[39], [60]. 
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Figure 2.3 The Lassen autoregulatory curve by plotting CBF vs perfusion pressure (in this case approximated by 
ABP) relationship. It has been obtained from 3.5 days recording of thermodilution CBF and radial artery blood 
pressure in a patient after a low-grade haemorrhagic stroke. Natural variations of ABP from 60 to 120 mmHg 
provoked changes in CBF that enabled plotting the curve and visualizing the upper (ULA) and lower (LLA) limits 
of autoregulation. Stability of blood flow is maintained through active changes in vascular diameter within a certain 
range of ABP. The changes in diameter lead to changes in cerebral vascular resistance (CVR) and modulate blood 
flow. Below the LLA, further vasodilation of vessels is impossible and in some cases passive collapse is noted, 
resulting in a decrease in CBF. Above the ULA, the increased transmural pressure exceeds the ability of vessels to 
constrict and leads to passive vasodilation, which leads to an increase in blood flow plus cross-capillary water leak 
and results in cerebral oedema [57].    
Classically, four components of CBF  regulation have been described: myogenic, metabolic, chemical and 
neurogenic.  
2.3.1 Myogenic CBF regulation (pressure autoregulation) 
In normotensive adults, CBF is maintained at around 50 ml per 100 g of brain tissue per minute, provided that the 
mean ABP calculated as diastolic pressure plus one-third of the pulse pressure ) is 60 to 150 mmHg[61]. Strictly 
speaking, it is the CPP ( ABP – ICP) that governs autoregulation. The main myogenic mechanism of CA is 
vasodilation and constriction guided by CPP-induced changes in CVR (CBF = CPP/CVR)[62]. With functioning 
autoregulation, CVR changes in proportion to the changes in CPP to keep CBF constant.  
Figure 2.3 shows that between CPP of around 70 to 130 mmHg, CBF remains constant. Above and below this limit, 
autoregulation is lost and CBF becomes dependent on mean arterial pressure in a linear fashion [63], [64]. At the 
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LLA, cerebral vasodilation is maximal, and below this level the vessels collapse and CBF falls passively with falls 
in ABP [58], [65]. At the upper limit (ULA), vasoconstriction is maximal and beyond this, the elevated intraluminal 
pressure may force the vessels to dilate, leading to an increase in CBF and damage to the blood–brain barrier [66], 
[67](Figure 2.4). It has been demonstrated that myogenic autoregulation is commonly depleted in many acute 
neurological patients, including brain tumour, subarachnoid haemorrhage, stroke or head injury [68].   
 
Figure 2.4 Effect of changes in ABP, and cerebral vascular resistance on cerebral blood ﬂow [69]. CPP, cerebral 
perfusion pressure. 
2.3.2 Metabolic regulation of CBF 
Changes in CBF and metabolism tend to follow each other, local and global increases in metabolic demand are met 
rapidly with increase in CBF [70]. These changes are thought to be controlled by several vasoactive metabolic 
mediators, including hydrogen and potassium ions, adenosine, glycolytic intermediates, phospholipid metabolites 
and nitric oxide. 
Potassium and potassium ions are produced by synaptic transmission, and it has been shown that elevation of these 
ions stimulates vasodilation [71], [72], thus providing a possible mechanism for neurovascular coupling. The action 
of H
+
 on cerebral arteries mediates the CO2 reactivity. Nitric oxide (NO) has been implicated as the vasodilatory 
response to hypercapnia and acidosis is attenuated by NO inhibitors [73].  Metabolites are an attractive option as 
messengers for flow-metabolism coupling, for obvious reasons [74]. Extracellular levels of adenosine rise sharply 
with neuronal activity and topical application of adenosine to cerebral microcirculation causes vasodilation [75].  
2.3.3 Chemical mechanism of regulation of CBF  
At normotension, the relationship between partial pressure of carbon dioxide in arterial blood (PaCO2) and CBF is 
almost linear [69]. At a PaCO2 of 10.6 kPa (80 mmHg), no further increase in flow is possible as the arterioles are 
maximally dilated. Conversely, at 2.7 kPa (20 mmHg), flow cannot fall further as the arterioles are maximally 
vasoconstricted (Figure 2.12). These  effects  are  regulated  by  a  complex  and  interrelated  system  of mediators.  
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The arteriolar tone has an important influence on how PaCO2 affects CBF, which can help manage patients with 
increased ICP. Hyperventilation reduces the PaCO2 and causes vasoconstriction of the cerebral vessels (reduces their 
radius) and, therefore, reduces cerebral blood volume resulting in decreasing ICP while the intracranial compliance 
is reduced. However, if the PaCO2 is reduced too much, the resulting vasoconstriction can reduce CBF to the point 
of causing or worsening cerebral ischaemia.  In contrast, in the situation of exhausted brain compliance, hypercapnia 
can result in vasodilation which will increase the ICP. Therefore, hyperventilation or hypercapnia to moderate levels 
is generally considered a short term temporizing measure to control ICP, and overly aggressive operation should be 
avoided. Results showed impaired cerebral CO2 vasoreactivity is associated with a poor outcome in patients with 
TBI [76].  
Oxygen has little effect on the radius of blood vessels at partial pressures used clinically. However, while the partial 
pressure of oxygen (PaO2) is below 50 mmHg, CBF will increase rapidly [69], [77]. Thus, hypoxia and hypercapnia 
may significantly increase ICP through increasing CBF. Hypocapnia, on the other hand, significantly decreases CBF 
and hence ICP.   
 
Figure 2.5 The effect of PaCO2, PaO2, ABP on CBF in a healthy population. Acute hypoxia triggers dilation of 
cerebral microcirculation and increase in CBF. Hypercapnia causes dilation of cerebral arterioles and CBF elevation, 
whereas hypocapnia causes vasoconstriction and decrease in CBF [78]. 
2.3.3 Neurogenic mechanism of CBF regulation 
The neurogenic mechanism of CA is still not known clearly, with current theory supporting that the sympathetic and 
parasympathetic nervous systems can modulate the autoregulatory curve, but do not themselves control 
autoregulation [79].  It is said the main action of the sympathetic nerves is vasoconstriction, which protects the brain 
by shifting the autoregulation curve to the right in hypertension [80]. The parasympathetic nerves contribute to 
vasodilation and may play a part in hypotension and reperfusion injury [57]. Moreover, a recent study suggested that 
intrinsic innervation may have a role in modulating CA [81].   
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2.4  Traumatic brain injury 
Traumatic brain injury, often referred to as TBI, is a worldwide public health problem typically caused by contact 
and inertial forces acting on the brain[82].  Every year, over 2,500,000 patients sustain a TBI in the EU, and 75,000 
of these die, with a further 100,000 being left handicapped. In the UK, head injury occurs in more than 500,000 
persons per year of which about 10% are diagnosed as severe, 15% moderate and the remainder as minor head 
injuries [83]. In the United States, TBI contributes to about 30% of all injury deaths [84],  and in 2013, 50,000 
people died due to TBI in USA. According to a survey conducted in 28 European Union countries and all 48 states 
in Europe, 1,375,974  hospital discharges and 33 415 deaths were related to TBI were identified in 2012 [85] .  
The annual costs of TBI are huge and exceed 70 billion dollars per year in the US. It is the leading cause of 
mortality and morbidity in young people, and in the past decade, the number of TBI seems to be increased in people 
aged 65 years and older- especially in high income countries [85], [86]. On a global scale, the number of life years 
lost due to TBI is four times that of diabetes-related loss. According to the report from the United States Centers for 
Disease Control and Prevention (CDC), there are approximately 1.5 million people in the U.S. who suffer from a 
TBI each year [84].  Recent statistics show a steep increase in the incidence of TBI, with an increase of 21% over 
the last five years – threefold greater than the rate of increase in population [87]. 
The leading causes of TBI vary by age: falls are the leading cause of TBI among persons aged 65 years and older; 
road traffic accident is the leading cause of TBI among younger patients [88]. The top four causes according to the 
CDC are: traffic accident (14.3%), strucks (15.5%), assaults (10.7%) and falls (40.5%) (Figure 2.6).  Scientists 
reported that the most common mechanism of injury appears to be shifting in Europe from road traffic incidents to 
falls [89]. Firearm injuries are often fatal: 9 out of 10 people die from their injuries. Along with a TBI, persons are 
also susceptible to spinal cord injuries, which are another type of traumatic injury that can result from vehicle 
crashes, firearms and falls. Prevention of TBI is the best approach because there is no cure. 
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Figure 2.6 Leading causes of traumatic brain injury. The leading causes of TBI vary by age: falls are the leading 
cause of TBI among persons aged 65 years and older; transportation is the leading cause of TBI among persons 
under the age of 65 years[88]. 
The severity of a TBI may range from ‘mild’ (i.e. a loss of consciousness from 20 minutes to 6 hours and a Glasgow 
Coma Scale of 9 to 12) to ‘severe’ (i.e. a loss of consciousness of greater than 6 hours and a Glasgow Coma Scale of 
3 to 8) [90]. The annual incidence of mild TBI is about 131 cases per 100,000 people, the incidence of moderate TBI 
is about 15 cases per 100,000 people, and the incidence of severe TBI is approximately 14 cases per 100,000 people 
[91]. 
Individuals with severe injuries can be left in long-term unresponsive states. For many people with severe TBI, long-
term rehabilitation is often necessary to maximize function and independence. Even with mild TBI, the 
consequences to a person’s life can be dramatic, and they may suffer several months of disabling symptoms. Jacobs 
reported long-term problems after TBI, including patients’ financial status, behavioural functioning, and 
psychosocial morbidity which can result in a heavy burden to the patients’ family [92]–[94]. Ghajar pointed out that 
patients with severe TBI have a big risk of  hypotension, hypoxaemia and brain swelling, which can exacerbate 
brain damage and increase the risk of death if not treated properly [90]. Change in brain function can have a 
dramatic impact on family, job, social and community interaction. 
2.5 Diturbance of cerebral autoregulation after TBI  
CA can be impaired in any degree of TBI, even mild, and with normal ICP and mean ABP (ABPm) [95][96] . Once 
the autoregulatory mechanisms have been completely abolished, CBF passively follows changes in ABP and CPP; 
sudden increases in mean ABP (ABPm) can be more easily transmitted into the microcirculation and can contribute 
to either areas of infarction or secondary haemorrhages and edema [97]–[100] [101]. Under these conditions, the 
brain becomes vulnerable to ischaemic or hyperaemic injuries if perfusion pressure does not remain coupled with 
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metabolic demands (Fig 2.7). Monitoring of CA in head-injured patients is considered useful for understanding the 
pathophysiology and effects of therapy, regarding its role as a causative agent and a factor in guiding therapy as well 
as the determinants of outcome in TBI,  although such monitoring has not yet become part of routine patient 
management in many centres [102][103] . 
 
Fig 2.7  Cerebrovascular autoregulation in health, chronic hypertension and during autoregulation loss. In chronic 
hypertension, values for lower and upper limits of pressure autoregulation are higher than those under normal 
conditions, resulting in a degree of resetting as high as 40 mmHg. Therefore, acceptable ABP levels for healthy 
subjects may be associated with lower CBF. Ischemia can impair cerebral autoregulation allowing CBF to vary 
directly with blood pressure leading to brain lesion[78]. 
2.6 Clinical Probems in treating TBI 
TBI can be divided into primary and secondary injury and the relationship between the two is depicted in figure 2.8 
[104]. Normal ICP of healthy people is usually around 5-15 mmHg, while in TBI, an ICP of > 20 mmHg is widely 
accepted as intracranial hypertension (ICH) [105], [106]. The management of ICP for TBI is based on avoidance of 
secondary injury, maintenance of cerebral perfusion pressure, and optimization of cerebral oxygenation[107]. The 
national guidelines recommended treatment of CPP>70 mmHg at the beginning, but reduced this number to 60 
mmHg later. However, this guideline ignored individual patient variability and inury- specific factors. Moreover, 
there is ongoing debate over the importance of ICP monitoring, especially after a recent randomized controlled trial 
that did not show an outcome benefit in patients undergoing ICP monitoring with a treatment threshold of 20 mmHg 
when compared to patients that were not monitored .  
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Fig. 2.8 The inter-relationship between primary and secondary injury in TBI is shown[104]. Secondary 
physiological insults can potentiate ischemia and lead to exacerbation of secondary injury.   
However, one of the principle clinical reasons to monitor ICP is to allow calculation of CPP, the main driven force 
of CBF to meet the need of the brain, regulated by CA. One of the most systematically investigated approach to CA 
assessment, using ICP as an input, is the pressure reactivity index (PRx) described by Czysnyka et al [21]. It is 
calculated as the correlation coefficient between slow waves of ABP and ICP, while small PRx is associated with 
good CA, and big PRx (>0.3) reflects impaired CA [108]. High PRx was also found to be related with worse patient 
outcome, plateau waves and refractory ICP clinically [31], [109]. In TBI, PRx has also demonstrated a reliable index 
to calculate ‘optimal CPP’ for individual patient, with patients whose CPP were close to CPPopt showed best 
optimal outcome.  However, its clinical application has been limited due to its discontinuity and instability. 
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CHAPTER 3 STATE OF THE ART FOR CURRENT METHODOLOGY OF AUTOREGULATION 
MONITORING 
As described in Chapter 2, CA mechanisms protect against cerebral ischaemia due to hypotension and against 
excessive flow (hyperaemia) during hypertension, when capillary damage, oedema, diffuse haemorrhage and 
intracranial hypertension might otherwise result. CA has been monitored in the setting of neuro critical care unit 
(NCCU) to aid prognostication in many centres and retrospective studies showed failure of autoregulation is 
associated with a worse outcome in various acute neurological diseases [31], [110]–[112]. 
CA is a universal physiological mechanism, that has been studied in a similar way across a large number of acute 
and chronic neurological diseases [30], [113], [114]: changing or observing spontaneous variations in CPP or ABP 
when ICP is not measured, a situation typical for ischaemic stroke outside NCCUs and recording synchronized 
changes in CBF or other modalities, believed to be coupled to changes in CBF or cerebral blood volume (such as FV, 
brain oxygenation). 
Clinical methods for assessment of autoregulation can be divided into measurement and monitoring methods. 
Measurement methods take place when a known stimulus is applied and the CBF (direct or indirect) response is 
recorded. Pharmacologically induced changes in ABP, leg-cuff release, body tilt, hand-grip, lower-body negative 
pressure, squat–stand manoeuvres, slow breathing, transient compression of the carotid artery, etc., all can be 
classified as measurement methods. The accuracy of measurement methods is usually good because a known pattern 
of stimulus is helpful for detecting a synchronized response of CBF and thus assessing CA. However, the 
measurement methods can be performed in limited time and are usually not repeated more frequently than once a 
day. 
In contrast, continuous monitoring methods are based on observing the CBF/FV response to continuous spontaneous 
fluctuations of CPP or ABP. The stimuli (ABP or CPP fluctuations) are usually weaker, not necessarily repetitive 
and, therefore the signal-to-noise ratio (SNR) remains more unfavourable. However, these methods have the 
advantage of assessing autoregulation continuously. Autoregulation is a quite fragile brain protective mechanism, it 
fluctuates in time as CPP may change, PaCO2 concentration may change, body temperature, endothelial functions, 
level of anaesthesia, etc. may also fluctuate. Therefore, monitoring of CA continuously in time is desirable. 
Moreover, continuous monitoring allows for individual targeting of CPP or ABP levels to achieve optimal 
autoregulatory strength [38]. One important point to discuss is the differentiation between ‘static’ and ‘dynamic’ 
autoregulation assessment/monitoring methods. Static CA refers to steady-state autoregulation, measured with slow 
changes in CPP (or ABP), while dynamic CA characterize autoregulation through small changes or short-term 
oscillations in CPP (or ABP). These transients and oscillations cannot be too fast, as properly working 
autoregulation can be compared with a high-pass filter. In general, fluctuations of CPP/ABP faster than 0.05 Hz are 
believed to carry a diminished amount of information about CA in comparison to slower waves. 
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Figure 3.1 Example of evaluation of static rate of autoregulation. Arterial blood pressure has been increased from 95 
mm Hg to 114 mm Hg with vasopressor. Changes in CBF were recorded using transcranial Doppler ultrasonography 
(FV). ABP: arterial blood pressure; FV: flow velocity. 
 
In many studies, ‘static’ and ‘dynamic’ autoregulation have been compared and the correlation between the methods 
has always been far from perfect. However, comparisons between methods belonging to one family (static–static or 
dynamic–dynamic) are also not that  exact. This is because each method has its own limited accuracy. It has not 
been definitively proven that ‘static’ and ‘dynamic’ components of autoregulation may be dissociated 
physiologically. 
3.1 Current widely used methods for cerebral autoregulation assessment  
Though it is clinically appealing to record spontaneous changes in ABP and CBF velocity, assessment of CA at rest 
may not reveal the full capacity of autoregulation because of the presence of intrinsic non-linearity. In addition to 
the TCD methods, other neuro-imaging techniques, such as magnetic resonance imaging (MRI), positron emission 
tomography (PET) or perfusion computed tomography (PCT), appear suitable because of their availability in acute 
care situations, high spatial resolution and excellent safety record. Through these techniques, the CBF, blood volume, 
oxygen extraction fraction (OEF) and oxygen consumption rate (CMRO2) can be measured in multiple regions. The 
relationships between changes in blood volume and changes in CBF velocity or changes in CMRO2 were analysed 
to assess CA [103], [115]. However, these methods, in general, are expensive and have a poor temporal resolution ( 
minutes) and can be challenging to use in bedside studies. 
Most studies of CA relied on linear (cross-spectral or correlation-based) methods to assess the integrity of 
autoregulation. If the pressure–flow relation displays a low coherence (i.e. if it lacks linear dependence), often 
interpreted as the sign of intact CA [116], the relation between pressure and CBF cannot be quantified via linear 
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analyses. In other words, autoregulation itself creates uncertainty in its linear estimates. This is a problem of the 
analytical technique, not the input signal (spontaneous oscillations vs induced BP manipulation). The limitation can 
be overcome by using non-linear approaches. 
Understanding the advantages as well as the limitations of these methods will be helpful for clinicians to choose 
appropriate methods for their studies of CA in clinical diagnosis or management.  
3.1.1 Autoregulation index (ARI)  
ARI is a gauging system to quantify the status of CA [12], [13]. The index is defined by introducing a sharp drop in 
ABP produced by a rapid deflation of thigh cuffs to grade the ensuing CBFV response with a parametric, second-
order model [87]. It grades CA into 10 levels (from 0–9), where ARI = 0 shows that the changes in FV follow 
entirely the changes in ABP and thus reflects completely abolished autoregulation; ARI = 9, on the other hand, 
means that FV returns to the baseline value rapidly and therefore indicates highly effective autoregulation (Figure 
3.2). At the heart of this method there is a second order differential equation that simulates 10 possible CBF velocity 
responses to an ideal step change of ABP by giving 10 sets of pre-defined parameters, including a damping factor, 
time constant and, gain parameter. By comparing the recorded CBF velocity with the 10 simulated CBF velocities, 
the index number is determined by finding the best match (Fig. 3.3).  
 
Figure 3.2 Response of cerebral autoregulation model to a step change in blood pressure. 
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Table 3.1  Parameters related to the autoregulation index[12]  
T,s D K ARI dROR,%/s 
… 0.00 0 0 0, No autoregulation 
2.00 1.60 0.20 1 2.5 
2.00 1.50 0.40 2 5.0 
2.00 1.15 0.60 3 10.0 
2.00 0.90 0.80 4 15.0 
1.90 0.75 0.90 5 20.0, Normal autoregulation 
1.60 0.65 0.94 6 30.0 
1.20 0.55 0.96 7 40.0 
0.87 0.52 0.97 8 60.0 
0.65 0.50 0.98 9 80.0, Fastest autoregulation 
T is the time constant, D is a damping factor, K is the autoregulatory dynamic gain, ARI is the autoregulation index, 
and dROR is the dynamic rate of regulation.  
 
Figure 3.3 Example of deflation of leg cuffs to test cerebral autoregulation. On left: pattern specific for working 
autoregulation: In response to deflation, blood pressure (ABP) drops and so does blood flow velocity in MCA. With 
working autoregulation FV starts to recover before ABP increases back to baseline (left panel). With autoregulation 
disturbed, FV stays decreased, as long as ABP remains decreased[117]. 
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ARI can also be derived from the analysis of spontaneous waves in ABP and FV, by means of impulse response (IR) 
estimation [31], [118] . In the original Tiecks model, p(n) is the normalized change in ABP from its baseline value 
(the value before ABP drop). However, in IR based ARI, we use impulse signal as input and the baseline signal is 
assumed to be 0, so p(n) equals the impulse ABP signal. V (n) in Equation 3.4 presents the FV, and here, it means 
IR of Tiecks’ model. f represents the sampling frequency. x1 and x2 are just intermediate variables, which were 
assumed to be equal to 0 initially [31]. 
 
            
                      
                        
                                                               (Equation 3.1) 
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                                                        (Equation 3.3) 
                                                                                     (Equation 3.4) 
which can be written as a second-order equation: 
                                                                   (Equation 3.5) 
                                                                         (Equation 3.6) 
Or  
      
              
           
     
              
           
       (Equation 3.7) 
where    and     refers to second derivative and first derivative of velocity,     and     refers to second derivative 
and first derivative of pressure, T is the time constant, D is a damping factor, K is the autoregulatory dynamic gain, f 
is sampling frequency.  
This grading method is simple and easy to implement and interpret. However, this method either requires 
manipulation of ABP or presumes a pre-defined linear and stationary relationship between ABP and CBF velocity, 
which is generally not true. The actual responses of CBF velocity are more diverse and dispersed. Therefore, the 10 
pre-defined cases are not enough to explain all situations, resulting in inappropriate assignments of the index number 
in some cases and having large individual variability. 
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Figure 3.4 The upper panel shows the step response (A) and impulse response (B) of original Tiecks’ model. The 
lower panel shows the transfer function (TF) characteristics of Tiecks’ model (C and D). (A) From bottom to top, 
each line represents autoregulation index (ARI) value of 0 to 9, respectively. (B) From bottom to top, the solid lines 
stand for ARI 9 to ARI 0. The dashed line is a sample of the IR between real ABP and real FV of one patient. (C) 
The gain of Tiecks’ model; (D) The phase of Tiecks’ model[31].  
 
3.1.2 Transfer function analysis (TFA) 
Transfer function analysis has been used widely in renal autoregulation[119], [120], cardiovascular control[121] and 
respiratory sinus arrhythmia[122]. The basic idea of transfer function comes from looking at the frequency response 
of a linear system, describing the oscillatory components at individual frequencies of output signal through the input 
signal. Recently, the TFA method has been used to analyse the dynamic properties of CA, which is regarded as a 
high-pass filter [14]–[16]. The principle is that autoregulation is supposed to attenuate the influence of ABP on CBF 
velocity by preventing a direct transmission of pressure waves into blood flow waves at a low frequency range 
(normally <0.2 Hz) [17]. Three parameters, gain, phase shift and coherence, can be derived from the transfer 
function at each frequency[123], [124]. Gain quantifies the compression of the relative changes in the amplitude of 
CBF velocity to ABP, whereas phase shift indicates the time lag (given a specific frequency) between ABP and CBF 
velocity
 
[99]. Gain is a continuous value. For example, a value of 0.5 suggests that 50% of the relative amplitude of 
CBF velocity is attenuated with respect to a unit of changes in ABP. Phase shift is denoted in degree or radians. The 
larger the phase of CBF velocity is shifted from ABP, the better the autoregulation is taking effect [126], [127]. 
Such a linear-response theory analysis does not consider the fact that slow fluctuations of CBFV may occur 
independently of changes in ABP, or may, in fact result from a non-linear relationship. Therefore, the criterion of 
coherence–the degree of linearity between input and output–is often used to test the validity of the model [120]. A 
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high coherence is thought to indicate a high reliability of the calculated phase and gain parameters because the 
assumption of linearity is clearly met, whereas a low coherence is thought to indicate a low reliability of phase and 
gain parameters, possibly caused by external noise or a non-linear relationship [17]. However, it can also be argued 
that coherence per se could be an indicator of CA, with high coherence indicating impaired CA (because in this 
situation slow variations in CBFV (output) are linearly and passively related to slow variations in ABP (input)), and 
low coherence indicating properly functioning CA (because in this situation the generally non-linear character of the 
physiological autoregulatory curve may reveal itself in a non-linear relationship between CBFV and ABP) [17], 
[128]. A series of studies of the performance and implementation of TFA by multi-centres were recently published 
by the society of Cerebral Autoregulation Research Network (CARNet) [126].  
 
TF parameters can be obtained through the Fast Fourier Transform (FFT) algorithm below:  
From the temporal sequences of ABP (P(t)) and FV (V(t)), the auto-spectrum and cross-spectrum of blood pressure 
(P(f)) and flow velocity (V(f)) can be obtained. They are calculated as the expected value of the complex product 
with themselves (Equation 3.8, Equation 3.9) by averaging four segments of data. 
 
                                                             (Equation 3.8) 
                                                              (Equation 3.9) 
where Spp(f) and Svv(f) are the auto-spectra of ABP and FV, respectively. Similarly, the cross spectrum (Spv(f)) is 
calculated through Equation 3.10. It provides a statement of how common activity between two signals is distributed 
across frequency. The cross-spectrum can also be calculated as the FFT of the crosscovariance function (ccvf). As 
the ccvf is not symmetric around τ = 0, the cross-spectrum is a complex-valued function. 
                                                                (Equation 3.10)    
The coherence function is defined as a normalization of the cross spectrum by the product of the two auto-spectra, 
its value will be between 0 and 1 and can be calculated through Equation 3.11. 
  
         
            
                                                           (Equation 3.11) 
Coherence reflects the linear relationship between input and output. For example, if input and output are identical 
processes, their power spectra are equal and to the cross-spectrum. In this case, the coherence will be 1 at all 
frequencies.  However, if the input and output are completely independent, then the cross-spectrum will be 0, as is 
the coherence. 
The TF is a complex-valued function, it can be obtained by Equation 3.12 and can be described as Equation 3.13, 
where HR and HI are the real part and imaginary parts of Hf.  
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                                                           (Equation 3.12) 
                                                                  (Equation 3.13) 
The TF gain (      ) can tell us what magnitude of change in FV is caused by a change in MABP. The TF phase 
(    ) describes the time shift from input to output at a specific frequency[129]. They can be obtained through 
Equation 3.14 and Equation 3.15.   
          
    
  
   
                                                (Equation 3.14) 
           
     
     
                                                         (Equation 3.15) 
Finally, the IR of the system can be obtained by the inverse FFT (IFFT) of the TF, as described in Equation 3.16. In 
this study, before doing ifft, the TF was filtered with a cut-off frequency of 0.5 Hz.  
                                                                          (Equation 3.16) 
 
Figure 3.5 Analysis of the phase shift between slow fluctuation of mean ABP and blood flow velocity. High phase-
shift at high coherence means good autoregulation. In this subject, compared with the right side (solid line), the 
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recovery of the blood flow of the left side (dashed line) was slower, the phase shift was lower, and the coherence 
was higher[130]. 
3.1.3 Time correlation 
The time-correlation method allows continuous estimation of CA through a moving linear correlation between slow 
waves of ABP and ICP (pressure reactivity index, PRx), or CBF velocity and CPP (mean flow index, Mx), or ABP 
and PbtO2 (TOxa). These parameters can reflect the compliant ability of cerebral vessels in response to changes in 
ABP or CPP. They have been widely used for continuous monitoring of CA in patients requiring neuro intensive 
care predominantly. One of the limitations of this method is that calculation of the correlation coefficient may be 
influenced by the time scales used and signal preprocessing (e.g. degree of smoothing applied or detrending). 
Mean Flow Index (Mx), Systolic Mx (Sx) and Diastolic Mx (Dx) 
Mean flow index (Mx), estimates CA through the correlation coefficient between slow fluctuations (20 seconds to 3 
minutes) of mean FV and CPP [23], [131]–[133]. It is a purely time-domain measurement, based on the concept that 
if CA is intact, there will be no correlation between changes in CPP and changes in FV (Mx = zero or negative), 
whereas when CA is exhausted changes in CPP will be directly correlated with changes in CBFV (Mx ~ +1). 
Importantly, Mx has been shown to be associated with outcome in different patient groups including carotid 
occlusive disease, stroke and subarachnoid haemorrhage [114], [134]–[140].  The maximal and minimal values of 
FV from every 1.5 s period were calculated and treated as the peak-systolic and end-diastolic components, 
respectively. Systolic Mx (Mxs) is the correlation coefficient between 10s mean of peak-systolic FV (FVs) and CPP; 
while diastolic Mx (Mxd) refers to the relationship between 10s mean value of end-diastolic FV (Fvd) [132]. The 
study showed that Sx had a better performance in distinguishing favourable and unfavourable outcomes than Mx.  
 
 
Figure 3.6 Graphs comparing the observed difference in analysed indices between favourable/unfavourable outcome 
and survival/death using invasive indices—with CPP (A) and non-invasive indices—with ABP(B) [132]. In all cases 
the biggest differences were observed for indices using systolic FV, regardless of the outcome measures and whether 
CPP or ABP was used for calculation, indices utilizing CPP for calculation demonstrate larger differences between 
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outcome groups than those using ABP. ABP arterial blood pressure, CPP cerebral perfusion pressure, Dx and Dxa 
diastolic ﬂow velocity index using CPP and ABP, respectively, Mx and Mxa mean ﬂow velocity index using CPP 
and ABP, respectively, Sx and Sxa systolic ﬂow velocity index using CPP and ABP, respectively. *P < 0.05 
 Pressure reactivity index (PRx) 
The pressure reactivity index (PRx) is a moving linear correlation between spontaneous slow waves of ABP and ICP, 
and can reflect the ability of cerebral vessels to change diameter in response to changes in blood pressure [21]. 
Studies also showed that PRx is a useful secondary index of vascular deterioration leading to a fatal outcome and a 
variable for setting the individual target for CPP management [141]–[143]. A significant increase in mortality after 
TBI has been demonstrated to occur with increasing PRx [144]. It is calculated as the moving linear correlation 
coefficient between 30 consecutive, 10-s averaged values of ABP and corresponding ICP signals [55], [145]. 
Averages over 10 secs were used to suppress the influence of the pulse and respiratory–frequency wave components. 
Under reduced intracranial compliance, a positive correlation between ABP and ICP at low frequency is indicative 
of passive cerebral vasculature and impaired autoregulation. Zero or negative correlation between ABP and ICP at 
the same frequency is indicative of reactive vasculature and intact autoregulation [57], [102], [146].   
3.2 Wavelet analysis for CA autoregulation 
However, the methods described above are either simple correlation indices (such as PRx), suitable for linear, 
stationary signal analyses, such as the TF approach [31], [32], or assume the system being analyzed are linear or the 
statistical parameters of the signals are constant over time ( stationary signals) [31], [32].  With the clarification of 
the non-stationary nature and non-linearity of CA [28], [147], many attempts have been made to perform more 
sophisticated analyses to quantify the coupling mechanism of  ABP and ICP, including high-order Volterra kernels, 
phase-synchronization methods, and WT signal-processing techniques [148]–[150]. The WT method, has been 
widely applied in geophysics and economics, and is particularly useful for analysing noisy, transient and non-
stationary signals by enabling simultaneous optimal interpretation of spectral and temporal information using a data 
window of variable width [34], [151]. It is a method for decomposing a signal into a time-scale  plane (the scale 
being roughly speaking an inverse of frequency) through the convolution of the signal with a scaled wavelet 
function  [13], [14]. One advantage of wavelet analysis is the ability to reveal signal features with the right balance 
of the temporal and frequency resolution appropriate to the frequencies studied, higher temporal resolution for 
higher frequency and higher scale (inverse frequency) resolution for lower frequency [34], [35].   
Two useful parameters that can be derived from WT include wavelet transform phase shift (WTP) and wavelet 
transform coherence (WTC); both can be calculated through the cross-wavelet transform (XWT). WTP characterizes 
the localised (in the time-frequency plane) phase difference between input (ABP) and output (ICP) in the time and 
frequency dimensions, while WTC, in very simplified terms, identifies local (again, in the time-frequency plane) 
correlations between two XWTs. In this way, locally phase-locked behaviour can be uncovered. A value of WTC = 
1 indicates a high common power between two time series at a certain time and frequency. A value of WTC = 0, on 
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the other hand, is obtained for a vanishing correlation [152], [153], and is mathematically associated with high 
variance of the phase-shift estimator  [154]. Therefore enforcing a certain minimal threshold for WTC is often used 
to guarantee a reliable phase and gain estimation [155].  
There are also some other methods to study the non-linear relationship between ABP and FV or ICP, CA, such as 
multimodal pressure flow (MMPF) method, which is based on the Hilbert-Huang transform (HHT) [156]. The 
principle is to calculate the phase-shift between ABP and CBF velocity without assuming a linear relationship a 
priori. The ABP and CBF velocity are empirically decomposed into a series of modes from fast to slow waves, 
respectively. The mode that is considered the most relevant to autoregulation is then identified and the instantaneous 
phase of ABP and CBF velocity is computed by a Hilbert transform. The phase difference between the variables can 
then be calculated readily. Several studies have shown that it can deal with the non-linear relationship of ABP and 
CBF velocity. However, the validity and effectiveness of these methods need to be further tested or replicated in 
multi-centre studies. Table 3.2 contains a brief description of methods used in CA assessment. 
3.3 Clinical application of CA assessment  
Over the years, a dynamic patient-targeted CPP protocol, based on the CA ability of cerebral vasculature has been 
proposed. Since Czosnyka et al introduced PRx to assess CA, widely accepted as a marker for cerebral 
autoregulatory status in many neurocritical care settings [157], because it can be determined from periodic variations 
in ICP and MAP, two widely and commonly measured parameters in TBI patient modalities, without needing 
external stimuli. Moreover, taking the additional step of plotting PRx against CPP will often generate a ‘U’-shape 
curve, the base of which represents the CPP corresponding to the smallest value of PRx, where the CA response is 
most active [27]–[29], the point termed CPPopt. Steiner et al. introduced this concept in 2002 looking at CPPopt 
calculated from the whole monitoring period [36]. In 2012, Aries et al. proposed and tested an automated CPPopt 
algorithm based on a moving four-hour calculation window in a different (retrospective) cohort of TBI patients by 
showing improved outcome in patients with CPP close to the averaged automated CPPopt [38]. 
Over the years, other observational studies have confirmed that adult and paediatric patients whose median CPP is 
closer to their determined CPPopt seem to have better clinical outcomes [37], [159], [160]. A clinical trial of 
CPPopt-targeted therapy is now essential to determine whether CPPopt is purely prognostic, or if CPPopt represents 
a true physiologic target that, if achieved, will improve outcomes. 
Problematic for the design of such a study is the fact that CPPopt can only be generated during approximately 44% 
of the monitoring time in these retrospective studies [161]. Weersink et al. identified six factors that were 
independently associated with the absence of the CPPopt curve [162]. Depreitere et al. introduced an innovative 
multi-window-based algorithm for CPPopt calculation using minute-by-minute monitoring data typically available 
from electronic medical records systems [161]. They used a low-resolution version of PRx, which they termed LAx, 
and calculated a moving weighted-average value of CPPopts based on seven windows of different length (1, 2, 4, 6, 
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8, 12, 24 hours), instead of a single four-hour-long moving window. The weighting system was based on two criteria: 
the better a ‘U’-shape curve could be fitted and the lower the LAx value corresponding to the plot-specific CPPopt, 
the higher the weight of that window. Bases on their study, the mathematical approach needs to be improved further 
by increasing the window number and applying a weighting system that incorporates more characteristics of the 
PRx–CPP plot. Moreover, a validation study in a much larger population of TBI patients is necessary.   
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Table 3.2 Methods for cerebral autoregulation assessment and monitoring  
Method Method Monitors Principle Limitations 
 
 
 
 
 
 
 
 
Static 
 
 
Pharmacological 
increase or decrease 
in ABP 
 
 
 
TCD, PET, 
Perfusion  
Computed 
Tomography (CT) 
or Radionuclide 
CBF compared 
with CPP or ABP 
 
The test involves measurement of CBF at baseline and after 
a rise in ABP induced by a vasopressor. The static rate of 
autoregulation is calculated as the ratio of relative rise in 
cerebral vascular resistance (CVR) divided by relative rise 
in CPP or ABP[163].  
sRoR (%) = 100 (%ΔCVR/%ΔCPP) 
where CVR = CPP/ CBFV 
an sRoR of 100% denotes ideal autoregulation, 0 indicates 
absolutely non-functioning autoregulation–see Fig. 3.1 
sROR:  Static rate of autoregulation. 
 
 
If autoregulation is not working, pharmacological 
increases in ABP may cause a rise in ICP, leaving 
CPP unchanged. In such a situation, CBF remains 
unchanged, giving a false impression of 
autoregulation staying functional. Such a situation 
is named in the literature as ‘false autoregulation’. 
 
Brain imaging 
techniques: 
MRI, Perfusion CT 
 
Arterio-jugular 
oxygen content 
difference 
(AJDO2) 
 
When cerebral metabolic rate of oxygen is constant, 
changes in arterio-jugular differences of oxygen (AVDO2) 
reflect changes in CBF. In these situations relative changes 
in AVDO2 can be viewed as inverse changes in CBF and 
used as an evaluation method of CO2-reactivity and 
autoregulation. [164], [165].  
 
The method was not validated.  Studies grading 
autoregulation on that basis of changes in AJDO2 
need to be interpreted with caution. 
 
MRI 
MRI has high spatial resolution and the CA can be 
calculated by comparing the observed MRI signal intensity 
change ultrasound during a standardized thigh cuff 
maneuver[166]. 
 
It is difficult to obtain beat-to-beat values of mean 
ABP inside the magnet.  
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Perfusion CT 
 
Measurement of Xe-CBF using the CT method, before and 
after alteration of ABP (pharmacologically) or vasodilation 
by acetazolamide[167]. 
 
If ICP is not measured, CPP may not follow 
changes in ABP or decrease in response to Xe or 
acetazolamide. This may disturb quantitative 
indices describing cerebrovascular reactivity. 
 
Mixture of 
static and 
dynamic 
 
Lower-body 
negative pressure 
 
Radionuclide 
methods or TCD 
compared with 
ABP monitoring 
 
Lower-body negative pressure produces arterial 
hypotension provoked by strong autonomic activation. 
Pulsatile lower-body negative pressure can also be used to 
induce slow changes in ABP and assess the phase shift 
between CBF and ABP slow rate waveforms.  
Zero phase shift indicates autoregulation is not working 
properly[168]. 
 
 
It is very difficult to resolve information regarding 
pressure autoregulation and systemic responses 
(ABP, heart rate and PaCO2) observed during 
alteration of autonomic haemodynamic control. 
 
Dynamic 
 
 
Thigh-cuff test 
 
TCD or  near 
infrared 
spectroscopy 
(NIRS) compared 
with ABP 
It involves inducing a temporary decrease in ABP after 
deflation of thigh cuffs, previously inflated above systolic 
ABP, and measuring the speed of response in CVR using a 
(parameter called RoR, rate of autoregulation)(Fig. 3.3). 
Alternatively, the response in CBF can be modelled as the 
step response of a high-pass filter. Autoregulation is 
described as the filter parameter, ARI[12]. 
 
SNR may be low as response to thigh-cuff test 
may be weak. Therefore, it is advised to repeat the 
test three times. In conscious patients, inflating 
cuffs may be painful. In patients with depleted 
pressure–volume compensatory reserve, sudden 
decrease in ABP may lead to a rise in ICP–
disturbing the assessment of autoregulation if ICP 
is not monitored. 
Transient 
hyperaemic 
response test 
TCD 
 
Doppler sonography FV recording of response to release of 
6–9 seconds compression of the carotid artery. A positive 
hyperaemic response, indicated by CBFV during 
hyperaemia divided by baseline CBFV being greater than 
1.1, denotes working autoregulation. Otherwise, 
autoregulation is judged as depleted[169]. 
Carotid arteries need to be screened to eliminate 
cases with carotid plaque, in which carotid artery 
compression may pose a risk of embolization. 
Compressions producing baroreceptor activation 
of ABP regulation may produce false response; 
ABP monitoring is advised. 
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Time correlation  
TCD compared 
with CPP or ABP 
Mx, correlation between 30 consecutive 10-s averages of 
TCD mean CBF velocity and ABP. Alternative indices for 
systolic and diastolic FV (Sx and Dx) can be 
calculated[131]. 
 
Long-term monitoring of the TCD signal is 
difficult, as the position of ultrasound probes 
cannot always be maintained. 
ABP and ICP PRx, Correlation coefficient between 30 consecutive 10-s 
averages of mean ABP and ICP[21].  
Long term monitoring of TCD signal is difficult, 
as position of ultrasound probes cannot be always 
maintained. 
NIRS compared 
with CPP or ABP 
COx or TOx, Pearson correlation between 30 consecutive 
10-s means of ABP and tissue oxygenation index[108]. 
 
Shows good affinity to gold standard assessment 
of LLA. NIRS signals, however, look like noise, 
and even if they are easier for long-term 
monitoring than TCD, one can never know when 
monitoring is valid or not. 
Diffuse 
correlation 
spectrometry 
(DCS) compared 
with ABP 
It utilizes the intensity fluctuations of near-infrared light to 
noninvasively quantify CBF at the bedside[170][171]. 
This is a new, emerging methodology, able to 
monitor instant CBF from near infrared 
spectroscopy changes. Clinical applications remain 
to be documented. The penetration depth of DCS, 
is limited compared to traditional clinical 
modalities, such as MRI and CT. 
 
PbtiO2 compared 
with CPP or ABP 
ORx, Pearson correlation coefficient between 
intraparenchymal  brain tissue oxygenation and CPP or 
ABP, calculated over longer (60 or 20 minutes) time 
window[111] 
After years of reporting, still there is no 
convincing proof that ORx is an index of 
autoregulation. 
Transfer-function 
analysis 
TCD or NIRS, or 
DCS compared 
with ABP 
If the cerebral circulation acts as a high-pass filter (high-
frequency fluctuations in ABP pass through to FV 
unimpeded while lower frequencies are dampened), TF 
phase, gain and coherence can be studied[172]. 
Phase shift is the most promising variable, but it 
can be evaluated only if the frequency of slow 
waves is stable–see Figure 3.5. Therefore, methods 
involving slow respirations or slow modulations of 
positive end-expiratory pressure (PEEP) are most 
promising in this area. 
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Valsalva 
manoeuvre 
TCD The Valsalva manoeuvre produces phasic variations in 
ABP[173]. 
 
During Valsalva, changes in ICP are possible. 
Multimodal 
pressure-flow 
(MMPF) analysis 
ABP and TCD Any ‘complex’ signal S(t) can be represented as the 
superimposition of more basic (simpler) components: S(t) = 
Σ Sk(t), where Sk are empirical modes(oscillators, in 
general non-sinusoidal). MMPF phase measure of 
autoregulation has much better repeatability/reproducibility 
than the traditional Fourier TFA[174]. 
 
Computationally complex, mode selection 
subjective, use limited to the authors and direct 
collaborators  
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CHAPTER 4 METHODOLOGICAL CONSIDERATIONS REGARDING PROJECTS INCLUDED IN THE 
THESIS 
Despite advances in the application of CA assessment, there remain many uncertainties about the theoretical and 
pragmatic relationships between the indices. The gold standard reference for CA assessment in TBI is still  to be 
determined. The methodology used in this thesis can be divided into three sections; first, the validation of 
relationships between current widely used CA parameters, including PRx, Mx, ARI and TF; second, introduction of 
a new method, a wavelet method for CA assessment; third, an improved method to calculate optimal CPP for 
clinical management of TBI patients. 
4.1 General overview of the original projects included in this thesis 
The protocol of this study is depicted in Figure 4.1.  The first step was to validate the relationship between current 
CA parameters (PRx, Mx, CA, and TF parameters) through simulated data and real monitored data. Although a few 
comparisons have been published [23]–[29],  they have been based on real measurements, which inevitably 
introduces confounding factors to the relationships such as poor fit of the assumed models or the presence of 
unknown extraneous ‘noise’ [30], i.e. components in ABP and CBFV that are not related to each other.  The 
potential for differential sensitivity of the CA indices to these confounding factors makes meaningful comparisons 
between the different methods difficult.  
Therefore, to cross-validate the relationships between the CA indices in a more controlled environment, and to try to 
find a reliable index to assess CA in TBI patients, this study used artificial or simulation data, with CBFV generated 
according to Tiecks’ ARI model [12] using real ABP signals as the input. Mx and TF parameters were calculated 
and compared with the ‘golden’ ARI values, which were used as a basic reference in this comparison. Through these 
artificial data, undisturbed by unknown confounding factors, the pure theoretical relationships between CA indices 
were studied. Afterwards, a retrospective study was conducted to analyse the relationship between these CA 
parameters via real data from a cohort of TBI patients admitted to Addenbrooke’s Hospital between 2003 and 2015. 
 
The second step of this study was to introduce a new method, wavelet methodology, to assess CA. This method was 
implemented in our own software ICM+ (http://www.neurosurg.cam.ac.uk/icmplus). The mathematical principle of 
this method is described in the next chapter. To validate the wavelet calculation, a cohort of experimental data using 
piglets was first applied. After the validation, the wavelet method was applied into 515 TBI patients, and was 
compared with traditional CA parameters. The relationship between wavelet method and patients’ outcome was also 
studied.  
The third step of this thesis was to find the best way to target optimal CPP for clinical management of TBI patients. 
The feasibility and impact on the outcome of strategies based on individualized CPP management following severe 
TBI were advocated by the Brain Trauma Foundation guidelines [175].  Attempts to identify an optimal cerebral 
perfusion pressure (CPPopt) individually based on CA has been approved through several studies. However, many 
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challenges still remain to improve the performance of CPPopt. The object of the present study was to investigate 
how the yield and the continuity of CPPopt can be enhanced, through a multi-window algorithm and a weighting 
system, which can maximally exploit and optimize the potential information about cerebral vascular pressure 
reactivity.  
Figure 4.1 describes the framework of this thesis.  
 
Figure 4.1 The framework of this research. First, is the validation of relationships between current widely used CA 
parameters, including pressure reactivity index (PRx),mean flow index (Mx), autoregulation index (ARI) and 
transfer-function (TF) parameters. Second, introduction of a new method, wavelet method for CA assessment.Third, 
optimal CPP estimation for clinical management of TBI patients. 
4.2 Data collection 
Monitoring in the intensive care unit is particularly vital, as patients deteriorate quickly and are at high risk of death 
or serious complications [176]. Health care monitoring requires the intensive use of information technologies to 
acquire and manage data, to transform the data into actionable information, and to disseminate this information so 
that it can be used effectively to improve patient care [177]. 
4.2.1 Intracranial pressure  
In the NCCU, ICP can be extremely dynamic (Figure 4.2), with information included in the ICP waveform that may 
provide important information about intracranial pathology (Figure 4.3). Continuous ICP monitoring is applied for  
patients with severe TBI in some NCCUs and [178].  
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Figure 4.2 Intracranial pressure (ICP) can be highly dynamic in the  neuro criticalcare unit[179].  
 
Figure 4.3 The waveforms of intracranial pressure (ICP) signal: pulse waves, respiratory waves and slow waves 
[179].  
An intraventricular drain inserted into one of the lateral ventricles and connected to an external pressure transducer 
is still considered to be the ‘gold standard’ method [179], [180].This method allows repetitive zeroing (at auditory 
meatus), ICP measurement and withdrawal of CSF (Figure 4.4). However, this method is most invasive, with a high 
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risk of infection at 6–11% [181], [182]. Several alternatives to the ventricular catheter include intraparenchymal 
probes, subarachnoid bolt or epidural pressure transducer (Figure 4.5) [50], [183]. The intraparenchymal probes 
most frequently used these days give higher precision than the other two [184]. It either uses a miniature strain 
gauge pressure sensor, which can transfer the changes in ICP into changes in resistance to measure, or the 
intraparenchymal probe uses a ﬁbreoptic catheter, which tests the changes of ICP through changes in reﬂection of 
the light beam. The infection rate of the intraparenchymal probe is very low, but its main disadvantage is a small 
drift of the zero reference [185] that cannot be recalibrated once the sensor has been inserted.  
 
Figure 4.4  (A) ICP monitoring. Invasive probes are placed at specific neuroanatomic positions such as the lateral 
ventricle, parenchymal tissue, and the subarachnoid and epidural space [186]. (B) A typical system for ICP 
measurement via an intraventricular drain: a: connection with drain; b: zero (should be positioned at height of 
patient’s ear) and three-way stopcock for connection with pressure transducer; c: drip chamber, adjustable in height 
over zero for CSF drainage. Depending on stopcock position (b) either pressure measurements or CSF drainage are 
possible; and d: CSF reservoir. (C) Possible conﬁguration for the intraparenchymal probe. Pressure is sensed at the 
tip of the probe by a miniature sensor consisting of piezo-elements or other pressure sensitive elements arranged as a 
Wheatstone bridge. 
4.2.2  Cerebral blood flow  
Four major arteries supply blood to the brain: the left and right internal carotid arteries (ICA), and the left and right 
vertebral arteries (VA) (Figure 4.5). The carotid arteries contributes approximately 80% to the total CBF, the 
remaining 20% coming from the two VAs [187]. Within the cranium, the VAs join to form the basilar artery, which 
is in communication with the ICAs via the posterior communicating arteries at the so-called circle of Willis. 
Considerable anatomic variation exists in the circle of Willis. Based on a study of 1413 brains, the classic anatomy 
of the circle is only seen in 34.5% of cases[188]. At the circle of Willis each ICA splits into an anterior cerebral 
artery (ACA) and a middle cerebral artery (MCA), while the basilar artery divides into the left and right posterior 
arteries (PCA). These major arteries divide into smaller and smaller arteries before branching into the capillaries, 
from which exchange of metabolites between the blood and interstitial fluid of the brain occurs [189]. The 
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capillaries then unite into intracranial veins that employ the dural venous sinuses, which transport the venous blood 
from the brain.   
As the largest branch of the internal carotid, the MCA supplies fresh blood to lateral side areas of the frontal, 
temporal and parietal lobes. It is the vessel most commonly affected by cerebrovascular accidents and is always used 
for diagnostic tests through neuroimaging tools, such as TCD. 
CBF measurement was not possible until 1945, when Kety and Schmidt used a nitrous oxide method to determine 
the global CBF based on the Fick's principle  [190]. However, this method was found to be cumbersome and 
required repeated blood sampling, other methods were introduced later, including Stochastic method, two 
compartmental models, hydrogen clearance method, microspheres technique, et al [191]. With the advent of 
computed tomography (CT) scans, methods have been developed for measurement of CBF using CT scans since CT 
scans are less time consuming, better availability, better delineation of morphology. Xenon enhanced CT and CT 
perfusion techniques have been used to test CBF[192], [193]. In recent years, methods based on other imaging 
techniques, such as single photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), 
positron emission tomography (PET) have also been investigated . However, these methods only give snapshots of 
CBF and do not allow for continuous monitoring and are associated with a radiation dose. Optical approaches have 
gained increasing attention for detection of CBF as they are simple to use, bed side and reduced risk of radiation and 
shifting of patients to complex radiological suite[191]. Three methods are normally used based on optical techniques, 
i.e. laser Doppler flowmetry, optical micro-angiography, and optical imaging of indocyanine green molecular 
dynamics analysis.  
Later, Transcranial Doppler (TCD) ultrasonography was introduced as an indirect assessment of blood flow [194] . 
It has several advantages in the NCCU, such as non-invasive detection, reproducible measurement and, safe 
procedure. However, it is movement sensitive and the result does depend on the operator’s experience.  It utilises the 
Doppler shift to assess the changes in flow velocity of the moving red blood cell. It should be remembered that TCD 
measures only the flow velocity and not the absolute CBF value, on assumption that the radius of arteries keep 
constant, then TCD can be used as a noninvasive estimate of CBF.  TCD has been clinically used to monitor the 
CBF in cardiopulmonary bypass, carotid endarterectomy, head injury, vasospasm, brain death, etc. Its use also has 
been described to monitor the CBF in resuscitation during cardiac arrest[195], [196]. 
TCD ultrasonography is based on the principle of the Doppler effect [197]. According to this principle, ultrasound 
waves emitted from the Doppler probe are transmitted through the skull and reflected by moving red blood cells 
within the intracerebral vessels. The difference in the frequency between the emitted and reflected waves, is caused 
by the moving red blood cells (blood flow velocity). Because blood flow within the vessel is laminar, the Doppler 
signal obtained actually represents a mixture of different Doppler frequency shifts forming a spectral display of the 
distribution of the velocities of individual red blood cells on the TCD monitor (Figure 4.5) [194]. The relationship 
between flow velocity (reflector speed) and Doppler shift frequency is expressed below:  
Methodological considerations regarding projects included in the thesis 
 
63 
 
 
          
                       
            
                                       Equation 4.1 
Vr refers to reflector speed, Fi refers to the incident frequency, θ is the angle of insonation, Vp refers to the 
propagation speed, which is a constant that can be obtained for various media.  
 
Figure 4.5 An example of spectral Doppler frequency display of the middle cerebral artery 
Spectral analysis of the Doppler signal can then be used to obtain the envelope (the peak velocity in the middle of 
the artery), or the mean velocity. In general, four main acoustic windows have been used (Figure 4.6): (1) The 
transtemporal window; (2) the transorbital window; (3) the submandibular window and (4) the transforaminal 
window [194], [198]. In this study, we used TCD to monitor FV in MCA through the transtemporal window. 
 
Figure 4.6 Four acoustic windows commonly used in transcranial Doppler examination: (1) transorbital window; (2) 
submandibular window; (3)transforaminal  window; (4) transtemporal window. 
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4.2.3 Data monitoring 
In this study, continuous monitoring of ABP, ICP and FV were obtained. ABP was monitored invasively through the 
radial or femoral artery using a standard pressure monitoring kit (Baxter Healthcare, CardioVascular Group, Irvine, 
CA). ICP was monitored using an intraparenchymal probe (Codman ICP MicroSensor, Codman & Shurtleff, 
Raynham, MA) inserted into the frontal cortex [38]. FV from MCA was monitored via the transtemporal windows 
bilaterally using Doppler Box (DWL Compumedics, Germany) or Neuroguard (Medasonic, CA) [132], [199], [200]. 
The insonation depth was from 4 to 6 cm and the examinations were performed during the first three days after head 
injury [201]. Each TCD recording lasted for 20 minutes to 2 hours.  
All signals were sampled at 30–240 Hz (the sampling rates were increased over the years) and recorded using 
ICM+® software (University of Cambridge, Cambridge Enterprise, Cambridge, UK, 
http://www.neurosurg.cam.ac.uk/icmplus) through an A/D converter (DT9801, Data Translation, Marlboro, MA) or 
digitally directly from GE Solar monitors.  Artefacts as sudden and short erratic peaks of the signal introduced by 
tracheal suctioning, arterial line flushing or transducer malfunction were removed manually. Data were recorded and 
analysed anonymously as part of a standard audit approved by the Neurocritical Care Users Group Committee 
(Figure 4.7) .  
 
Figure 4.7 Data monitoring in neuro critical care unit in Addenbrooke’s hospital, Cambridge 
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4.3 The database 
Clinical data 
Retrospective data from clinical patients and experimental piglets were employed in this study. For the analysis of 
the relationship between different methodologies of CA assessment, a database of patients with TBI admitted to the 
NCCU, Addenbrookes’ Hospital, between 2003 and 2015, has been used. The data base comprises the largest 
population, with over 525 TBI patients archived.  
Patients were managed according to current institutional TBI guidelines (adapted from Menon et al., 1999) [202]. In 
brief, patients were sedated, intubated, ventilated, and paralyzed with CPP managed according to ICP/CPP 
management protocol for severe TBI. Interventions were aimed at keeping ICP < 20mmHg using positioning, 
sedation, muscle paralysis, moderate hyperventilation, ventriculostomy, osmotic agents and, induced hypothermia. 
CPP was maintained above 60 to 70 mmHg using vasopressors, inotropes, and intravenous ﬂuids. Pressure reactivity 
parameters analysed in this study were not included in the protocol and therefore analysis of their association with 
the outcome was valid. 
The relationship between the analysed CA parameters and patients’ outcome at six months was evaluated. The 
Glasgow Outcome Scale (GOS) was used to assess patients’ outcome at six months (obtained at rehabilitation clinic 
or by phone interview). For the purpose of the statistical analysis, the patients’ outcomes were dichotomized in two 
ways: favourable outcome (good outcome and moderate disability) versus unfavourable outcome (severe disability, 
vegetative state and death); fatal outcome (death) versus non-fatal outcome (good outcome, moderate disability, 
severe disability and vegetative state). Although the dichotomisation might lose some group information and conceal 
any non-linearity in the relation between the variable and outcome, it greatly simplifies the statistical analysis 
and leads to easy interpretation and presentation of results. It separates patients’ outcome into most obvious 
two groups[203]. 
Experimental piglets’ data 
In Chapter 5, a new method for CA assessment is introduced, which is the WT methodology. To validate the 
algorithm, two separate cohorts of subjects were analysed, one with induced, sinusoidal ABP waves at a frequency 
of 1/min and another with spontaneous ABP wave activity. All procedures were approved by the Johns Hopkins 
University Animal Care and Use Committee or the Baylor College of Medicine Animal Care and Use Committee 
and conformed to the standards of animal experimentation of the National Institutes of Health [204]. The piglets 
underwent induction of anaesthesia with inhaled isoflurane. Following tracheostomy and placement of central 
venous access subjects were maintained under anaesthesia with mechanical ventilation, narcotic infusion and 
isoflurane (0.5-0.8%) through the method previously described [205]. At the time of the experiments, the monitoring 
data were saved on hard disk digitally for further methodological studies .  
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The stability of the PRx in time series, and the SNR is improved by the use of controlled ABP wave activity [205]. 
This is mainly due to inadequate coherence between ABP and ICP. Low coherence between the ABP and ICP can 
result from physiologic events unrelated to autoregulation that can affect the ABP, ICP or, both. Periods without 
wave activity within the frequency range of the autoregulatory mechanism also have low coherence between ABP 
and ICP and result in random noise in the PRx. To examine the influence of those random effects on the relationship 
between the wPRx and PRx we performed analysis first on a dataset from experiments with induced high amplitude 
waveforms in ABP [205] and then repeated the analysis in a set of experiments with spontaneous ABP waves only 
[206].   
In the first set the data were collected from 12 piglets, where regular, sinusoidal, ABP oscillations were induced 
using modulated positive end-expiratory pressure (PEEP) during volume-controlled ventilation [205]. A primary 
wave with a fixed tidal volume of 50 cc (cubic centimetres) at a rate between 15 and 25 min
-1
 was applied to a 
customized ventilator (Impact Instrumentation, West Caldwell, NJ). A secondary wave component in a sine-wave 
pattern of one minute period was introduced into the PEEP control. Once a stable recording was obtained the piglets 
were haemorrhaged by syringe-pump withdrawal at a rate of 12% calculated blood volume/h, which allowed the 
procedure of gradual ABP reduction over 3-4 hours before demise.  
In the second group, only spontaneous ABP and ICP signals from 16 piglets with naïve (n = 8) or elevated ICP (ICP 
= 20 mmHg, n = 8) were studied. For the elevated ICP group, artificial CSF (KCl 3.0 mmol/l, MgCl2 0.6 mmol/l, 
CaCl2 1.3 mmol/l, NaCl 131.8 mmol/l, NaHCO3 24.6 mmol/l, urea 6.7 mmol/l, and glucose 3.6 mmol/l) was 
infused in an external ventricular drain catheter at varying rates to achieve and maintain a steady-state ICP of 20 
mmHg throughout the experiment [204], [206]. A 5F oesophageal balloon catheter (Cooper Surgical, Trundall, CT) 
was placed in the femoral veins and was gradually inflated by infusion of saline from a syringe pump slowly to 
lower CPP to 10 mmHg in both the naïve ICP group and elevated ICP group after achieving a steady state of mean 
ICP. The ABP was reduced continuously over the next three hours.   
In both groups of experiments, ABP, ICP, and CBF were monitored continuously. ABP was transduced invasively 
with a clinical monitor (Marquette Solar 8000, GE Healthcare, Little Chalfont, UK).  ICP was monitored through an 
external ventricular drain after craniotomy. Bilateral laser Doppler probes (Moor Instruments, Devon, UK) were 
placed to monitor CBF after additional craniotomies over each parietal cortex. The signals were all sampled at 200 
Hz, digitized using an A/D converter (DT9801, Data Translation, Marlboro, MA), and  were recorded using a laptop 
computer with ICM+®  software (University of Cambridge, Cambridge Enterprise, Cambridge, UK, 
http://www.neurosurg.cam.ac.uk/icmplus). The data from both experiments were originally used in previous  
publications [204]–[206] . 
Data summary in different chapters 
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Chapter Data M/F Age ABP 
Chapter 5.1  34 TBI pateients data, 
138 data recordings 
8 females and 
26 males 
29 ± 16 years olld 82.0 ± 10.5 mmHg 
Chapter 5.2 288 TBI patients 66 females and 
222 males 
33 ± 16 years olld 91.2 ± 11.9 mmHg 
Chapter 6.1 12 piglets experimental 
data 
/ / Regular sinusoidal ABP 
oscillations were induced using 
modulated PEEP during 
ventilation. ABP was decreased 
through withdrawal. 
Chapter 6.2 16 piglets experimental 
data 
/ / 8 piglets with naive ICP and 8 
piglets with elevated ICP.  
Chapter 6.3 515 TBI patients 210 females 
and 305 males 
38 ± 16 years olld 94.8 ± 15.0 mmHg 
Chapter 7.2  526 TBI patients 219 females 
and 307 males 
38 ± 16 years olld 93.6 ± 8.3 mmHg 
Chapter  7.3 427 TBI patients  157 females 
and 270 males 
37 ± 16 years olld 93.3 ± 8.0 mmHg 
Chapter 8.1 119 TBI patients, with 
24 patients showed 30 
plateau waves 
5 females and 
19 males 
33 ± 13 years olld 94.2 ± 12.8 mmHg at baseline and 
93.8 ± 11.5 mmHg at plateau  
Chapter 8.2 12 patients 3 females and 
9 males 
27 ± 11 years olld 99.8 ± 17.0 mmHg at baseline and 
96.7 ± 17.2 mmHg at plateau 
 
4.4 Statistical analysis  
Statistical analyses were performed using the IBM SPSS Statistics (version 21 or version 19) software. The 
characters of relationships between various parameters were studied either using a linear regression method or non-
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linear regression curve estimation method (polynomial regression and four-parameter logistic functions were 
employed).  Pearson’s correlation coefficient (r) was used to examine linearity of the relationships. 
Independent-samples t-test was used to analyse the ability of different parameters in distinguishing patients’ 
outcome groups (favourable versus unfavourable outcome, fatal versus non-fatal outcome). Results were considered 
as signiﬁcant at p < 0.05.  
When applicable, the receiver-operator characteristic curve (ROC) with calculation of the area under the curve 
(AUC) were used to compare the abilities of different parameters in distinguishing patients’ outcome. Statistical 
differences between ROC curves were verified using DeLong's test for two correlated ROC curves (R package 
pROC) [207]. 
Bland-Altman plots were used to investigate the agreement between these parameters.  In addition, R-software was 
used to test the statistical significance of the difference between the areas under the two ROC curves for different 
outcome groups. The specific statistical methods used in each project are described in detail in the respective 
chapters.  
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CHAPTER 5 RELATIONSHIP BETWEEN DIFFERENT CA PARAMETERS IN TBI 
5.1 Cross-validation and cross-calibration of CA indices – a modelling study 
5.1.1 Introduction 
Accurate and quantitative assessment of CA is important, as transient episodes of cerebral ischaemia, or 
uncontrolled increases in CBF, are thought to be detrimental in a number of critical conditions, including stroke, 
subarachnoid haemorrhage and TBI [30], [113], [114]. As described in Chapter 3, many studies tried to assess CA 
using different methods. Initially, clinical studies mainly used ‘static’ methods to evaluate CA, which was assessed 
by analysing the CBF response to slow manipulations of ABP or CPP [5]–[8]. However, this process is not routinely 
applicable as it requires potentially harmful ABP manipulations [5]. Later on, TCD was introduced, which allowed 
dynamic CA assessment by analysing CBFV response to rapid changes in ABP, either externally induced or 
occurring spontaneously [9]–[11]. Most widely used methods for dynamic CA assessment includes ARI, Mx, 
transfer function analysis [19], [23], [132], [133]. As described in chapter 3, ARI grades FV response to changes in 
ABP into 10 levels. The Mx is a purely time-domain measurement, and has been shown to be associated with 
outcome in different patient groups[6], [114], [135], [136], [138], [140], [201]. In patients with no ICP monitoring, 
Mx is calculated using CBFV and ABP instead, and in the clinical literature this index is denoted as Mxa. 
TFA assumes that functional CA can be described as a high-pass filter that readily transmits rapid (high-frequency) 
changes in ABP to CBFV, but attenuates the transmission of slower (LF) ABP perturbations to CBFV [159]. 
Parameters derived from TF include phase shift, gain and coherence [96], [160], [127], [129].  
Although a few comparisons between these CA parameters have been published [22]–[29], they have been based on 
real measurements, which inevitably introduces confounding factors to the relationships, such as poor fit of the 
assumed models or the presence of unknown extraneous ‘noise’ [20], i.e. components in ABP and CBFV that are not 
related to each other. The potential for differential sensitivity of the CA indices to these confounding factors makes 
meaningful comparisons between the different methods difficult. To cross-validate the relationships between the CA 
indices in a more controlled environment, this study generated artificial CBFV according to Tiecks’ ARI model of 
CA [21] using real ABP signals from TBI patients as input. Using these signals, Mxa and TF parameters were 
calculated and compared with ARI values to elucidate the theoretical relationships between CA indices, undisturbed 
by unknown confounding factors. In addition, a varying degree of ‘exogenous’ noise was imposed on the simulated 
data to study its influence on these relationships. 
 5.1.2 Materials and methods 
138 data recordings (lasting 30 minutes each) from 34 randomly selected patients suffering from TBI admitted in the 
NCCU, Addenbrooke’s Hospital, between 2003 and 2013 were retrospectively analysed. All recordings with 
available ABP were eligible for analysis. The inclusion criterion was invasive monitoring of ABP with at least half 
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an hour recording. All patients were sedated, ventilated and managed according to a CPP- and ICP-oriented 
protocols for management of head injury with CPP maintained at >60 mmHg and ICP < 20–25 mmHg [202].  
Data monitoring  
Data were collected as described in Chapter 4. Artefacts introduced by tracheal suctioning, arterial line flushing or 
transducer malfunction were removed. Data were recorded and analysed anonymously as part of a standard audit 
approved by the Neurocritical Care Users Group Committee.   
Patients’ demographics 
The average age of this cohort was 28.8 years (standard deviation, SD, 15.9 years) with 8 females and 26 males. 
Mean ABP was 82.0 ± 10.5 mmHg (mean ± SD) and average ICP was 19.9 ± 6.8 mmHg. The GOS scores at six 
months were distributed as follows: good outcome, n = 10 (29%); moderate disability, n = 5 (15%); severe disability, 
n = 10 (29%); persistent vegetative state, n = 3 (9%) and death, n = 6 (18%). 
Data before 2000 were analysed under the approval of Addenbrooke’s Hospital Neurocritical Care Unit Users 
Committee as part of an anonymised clinical audit. After 2000, informed consent was obtained from all patients (or 
their next of kin) for the use of collected data for research purposes. The study was approved by the relevant 
research ethics committee (29 REC 97/291).  
5.1.3 Data analysis 
Generation of artificial flow velocity waveforms  
Artificial mean FV waveforms were generated according to the mathematical model proposed by Tiecks et al. [12]
 
using real ABP recordings (Equations 3.1-3.4). The model provides a second-order high-pass filter representation of 
the relationship between ABP and CBFV that can be adjusted for different ‘strengths’ of autoregulation (graded by 
ARI). The strength of autoregulation is divided into 10 levels, according to a set of parameters: the time constant (), 
damping factor (D), and the autoregulatory dynamic gain (K) (Section 3.1.1).  
Transfer-function phase, gain and coherence calculation 
TF phase, gain and coherence between the real ABP and the generated flow velocities for the 138 recordings were 
calculated through the method described in chapter 3, Section 3.1.2. The analysis mainly focuses on two frequency 
ranges: very-low-frequency range (VLF, 0-0.05 Hz) and low frequency range (LF, 0.05-0.15Hz).  We use gain_VLF 
as the abbreviation for gain in the VLF range, and gain_LF for the gain in the LF range. Similarly, phase_VLF and 
phase_LF refer to phase in the VLF and LF ranges, respectively, while coh_VLF and coh_LF stand for squared 
coherence in the VLF and LF ranges, respectively. 
The generated FV and ABP were ﬁrst normalized (mean subtracted, and divided by SD), and then divided into four 
data segments of 120-second duration (amounting to 50% segment overlap) and transformed with the FFT algorithm 
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(Welch method) [208], [210]–[213]. TF phase and gain between artificial CBFV and ABP were calculated in VLF 
and LF using the method described in Section 3.1.2. All the calculations were performed through a 300-second 
moving window and updated every 10 seconds.  
Mxa calculation 
The mean flow index (Mxa), time correlation coefficient between 10s averages of ABP and the artificial mean 
CBFV, was calculated using a 300s data window. All the parameters were averaged over each recording session for 
further analysis.  
Adding noise to the artificial data and testing the robustness of CA parameters  
To investigate the robustness of the examined parameters and their relationships in a more ‘real-life’ scenario, we 
simulated exogenous noise by adding coloured noise to the generated CBFV signals. We used a Gaussian white 
noise signal and filtered it using a low-pass filter (Butterworth) with the cut-off frequency at 0.2 Hz, and setting the 
signal-to-noise ratio (SNR) to 3 (the-low power noise), 0.9 (middle-power noise) and 0.3 (high-power noise).  
Statistical analysis  
SPSS software (version 19, IBM, Armonk, NY, USA) was used for statistical analysis.  Curve fitting methods 
(polynomial regression and four-parameter logistic function) were used to describe cross-relationships between ARI, 
Mxa and TF parameters. Pearson’s correlation coefficient (r) was used to examine linearity of the relationship across 
certain value ranges. Results were considered significant at p < 0.05.  
5.1.4 Results 
Simulated cerebral blood flow velocity 
Figure 5.1 shows one example of 10 normalized mean CBFVs (divided by the mean value of CBFV 9, upper panel) 
generated from a fragment of a real ABP signal recording (lower panel) using ARI ranging from 0 to 9. In the upper 
panel FV 0–9 correspond to ARI 0–9, respectively. Differences in amplitudes and phases of the waves are clearly 
visible.   
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Figure 5.1 The real blood pressure (lower panel) and 10 artificial flow velocities (upper panel) generated for one 
patient. FV0 refers to the flow velocity generated according to the model with dysfunctional autoregulation (ARI 0). 
FV9 refers to the flow velocity generated in the model of ideal autoregulation (ARI 9). ARI: autoregulation index; 
FV: flow velocity.  
Theory Relationship between ARI and Mxa 
The relationship between ARI and Mxa through artificial data is shown in Figure 5.2. The non-linear character of 
the relationship can be captured using a 4-parameter logistic function: Mxa = 1.02 – 0.69/(1 + exp(4.41 – ARI)) (r = 
0.999, Figure 5.2 A). From ARI 3 to ARI 6, the usual range of values seen in clinical practice, the relationship 
between these two indices is practically linear (Fig. 5.2 B, Mxa = –0.151  ARI + 1.338, r = 0.885). 
 
Figure 5.2 The relationship between mean Mxa and ARI. (A) The mean value of Mxa for different groups of 
artificial flow velocities generated from ARI0 to ARI9. (B) The mean value of Mxa from ARI3 to ARI6, and the 
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relationship is approximately linear between ARI 3 and 6. Mxa: mean flow index using arterial blood pressure as 
input; ARI: autoregulation index. Error bars: standard errors of the 138 simulated data. 
Relationship between ARI and estimated TF parameters 
Figure 5.3 describes the phase, gain and coherence relationships between ARI and TF in both VLF and LF ranges. 
There is a highly linear relationship between ARI and gain_VLF (Figure 5.3 A, r = –0.995, p < 0.001): gain_VLF = 
0.982 – 0.104  ARI, and a non-linear, humped, relationship between ARI and gain_LF (p<0.001). 
Fig. 5.3 B depicts the relationship between phase and ARI. For both frequency ranges, this relationship is positive 
and highly monotonic. Furthermore, from ARI 3 to 6, it becomes almost purely linear (phase = 13.82  ARI – 18.38, 
r = 0.986 for the VLF range and phase = 8.43  ARI – 13.89, r = 0.992, for the LF range). 
 
Figure 5.3 The relationship between ARI and the estimated transfer function parameters. ARI: autoregulation index; 
Gain_VLF: transfer function gain in very low frequency range;  Gain_LF: gain in low frequency range; Phase_VLF: 
phase in very low frequency range; Phase_LF: phase in low frequency range; Coh_VLF: coherence in very low 
frequency range; Coh_LF: coherence at low frequency range. VLF: very low frequency range, 0-0.05 Hz; LF: low 
frequency range, 0.05-0.15 Hz. The points in the graphs are actually expressed as mean and error bar, however, as 
the data is simulated, the error is very tiny.  
Relationship between Mxa and TF parameters 
Figures 5.4 A to 5.4 C show the relationship between Mxa and estimated TF indices. A nearly linear, negative 
relationship exists between Mxa and Phase_VLF (Phase_VLF = 106.13 – 99.24  Mxa; r = –0.941), which is not 
quite the case for Mxa and phase_LF (r = –0.894). The gain in VLF was also monotonically, though not quite 
linearly, related to Mxa (r = 0.928), while the gain in LF did not show a consistent relationship with Mxa. 
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Figure 5.4  Relationship between Mxa with transfer function parameters. (A) The mean value of Mxa versus mean 
value of the gain in VLF and LF. (B) Mean Mxa versus the phase in VLF and LF. (C) Mean Mxa versus the 
coherence in VLF and LF. VLF: very low frequency (0-0.05 HZ), LF: low frequency (0.05-0.15 HZ). Mxa: mean 
flow index using ABP as input.  
Analysis of the effects of exogenous noise 
Figure 5.5 displays the relationship between Mxa and CBFV without noise as well as CBFV with three different 
levels of SNR corresponding to low-, middle- and high-noise power. Despite a general preservation of the overall 
character of the relationship between Mxa and ARI, the actual ‘steepness’ of this relationship, and its uncertainty, 
change with the different levels of noise.  
Figure 5.5 D shows that, as expected, the coherence between ABP and CBFV decreased with noise added, 
furthermore, in the presence of noise, a clear monotonic relationship between the estimated coherence and ARI was 
revealed in the VLF range.   
We also tested the relationship between estimated TF gain/phase and ARI under different levels of added noise 
(Figure 5.5, Table 5.1). With increased noise, more uncertainty was introduced into the CA parameter estimates, 
demonstrated by the increase in their standard errors. With the artificially calculated data, gain_VLF and gain_LF 
were increased while the noise was increased (Figure 5.5 B). The character of the relationship between TF phase and 
ARI remained almost the same, while the values were generally decreased in both the VLF and LF bands. 
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Figure 5.5 The relationships between Mxa, TF parameters and ARI with different intensities of added noise. In the 
panel grid, rows (from top to bottom) represent different indices: Mx, Gain, Phase and Coherence, and columns 
(from left to right) represent increasing intensity of noise. Black bar: VLF; Grey bar: LF. Mxa: mean flow index; 
ARI: autoregulation index; TF: transfer function.  Error bars: standard error.  
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Table 5.1 The Pearson correlation coefficient (r) between ARI and other cerebral autoregulation parameters. 
 No Noise Low Noise Middle Noise High Noise 
Mxa –0.926 –0.88 –0.802 –0.519 
Gain_VLF –0.995 –0.983 –0.889 –0.298 
Gain_LF –0.599 –0.6 –0.532 –0.183 
Phase_VLF 0.973 0.858 0.674 0.373 
Phase_LF 0.966 0.95 0.917 0.547 
Coh_VLF –0.934 –0.924 –0.87 –0.425 
Coh_LF –0.133 –0.594 –0.549 –0.243 
ARI: autoregulation index. TF: transfer function; Mxa: mean flow index using ABP as input; VLF: 0–0.05 Hz; LF: 
0.05–0.15 Hz. Black: TF parameters in VLF; the p values for all the parameters in this form are below 0.01. 
Gain_VLF, Phase_VLF and Coh_VLF refer to gain, phase and squared coherence in the VLF range; Gain_LF, 
Phase_LF and Coh_LF refer to gain, phase and squared coherence in the LF range. 
 
5.1.5 Discussion 
This section used artificial data to explore rigorously the interrelationships between the commonly cited CA 
methodologies –TF analysis, non-parametric modelling and time-based correlation. Using this approach, the studied 
indices were cross-validated against each other to elucidate the true relationships between CA estimates; a 
relationship fully independent from the assumptions and uncertainties that plague experimental or clinical data. 
Finally, how these indices behave in response to sequential exogenous noise was investigated to explore the 
robustness of each CA index. Together, these analyses add insights to both the interpretation of previously published 
literature and the design of future cerebral haemodynamic investigations. 
Mxa versus ARI 
The character of the relationship between Mxa and ARI confirmed the general interchangeability of these two 
indices. However, because the actual shape of the relationship follows an inverted ‘S’-shape curve,  Mxa may only 
be useful for grading CA in the middle range (ARI 2 to 7) because it saturates outside of this range (Figure 5.2). For 
noise-free simulation, the range that Mxa can be used as a scale is between 0.38 and 0.90, which equates to ARI 3 to 
6. However, in practice, as shown by our noise simulations, one should expect this range to shorten and shift 
towards lower values of Mxa (Figure 5.6). 
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Figure 5.6  Comparison of Mxa-ARI relationship between real data and modelled data. The real curve measured in a 
cohort of TBI patients (solid black) is plotted against (A) curve obtained using modelled data under high-power 
noise conditions (red dashed line); and (B) against the pure, noise-free model generated curve, recalibrated using 
measured Mxa values for exhausted and intact autoregulation (red dashed line). ARI: autoregulation index; Mxa: 
Mean flow index using blood pressure as input.  
Transfer function analysis versus ARI and Mxa 
The phase showed a stable relationship with autoregulation indices in both frequency ranges. A negative, albeit non-
linear, relationship between phase and ARI as well as phase and Mxa in both frequency ranges was demonstrated for 
‘noise-free’ simulations. A roughly ‘S’-shape relationship exists between phase and ARI, with VLF showing a 
plateau for high ARI.  The relationship between phase and Mxa was, as expected, inverse, and nearly linear for the 
LF range. This indicates that for a noise-free situation, a phase from 0 to 70 degrees in VLF and from 0 to 80 
degrees in LF can be used to grade CA, with the former saturating at ARI of 7, while the latter spans the whole 
range of ARI. With ‘noise’ added, the relationship is flattened: the higher the noise power, the smaller the phase. 
This effect was particularly pronounced in the VLF range, while LF-derived phase kept its relationship to ARI 
relatively stable until high noise levels.  
However, bearing in mind that values of ARI above 7 are unlikely to be observed in reality, and if they do occur 
their clinical significance is rather limited, the use of the LF or VLF range seems to provide equivalent information, 
as far as the relationship with ARI is concerned. Nevertheless, considering the highly non-linear relationship of the 
phase with Mxa in the LF region, our results seem to favour the use of the VLF range for the phase parameter. 
The gain only showed a stable, non-linear relationship with ARI and Mxa in the VLF range. The higher gain was 
associated with lower ARI and higher Mxa. The gain in the LF band did not show a consistent relationship with 
either ARI or Mxa, and therefore its use in this range cannot be recommended. This relationship might be because 
the transfer function characteristics of Tiecks’ model shown in Figure 3.4, where the phase showed constant 
relationship with ARI, while gain demonstrated complex result with ARI in difference frenquencies.   
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Simulated noise  
By generating artificial CBFV data, the original analyses necessarily excluded all external noise from the CA 
estimates. To simulate a more realistic scenario and investigate the influences of the noise on CA assessment, we 
used three levels of intensity of added artificial noise (low-, middle- and high-power noise). How well such artificial 
noise approximates the real-world scenario of clinical CA assessment is not certain; however comparison with 
previously published data indicates that such artificial noise may be relevant [214]. In Figure 5.6 A, the relationship 
between ARI and Mxa using the noise-added artificial data of the current analysis is qualitatively similar to the 
relationship between ARI and Mxa derived from the real data of 288 TBI patients
 
[214].  This reasonably good 
match between the noise-added simulated real data indicates that our rather simplistic approach provides a decent 
approximation to the exogenous noise seen in real data.  
As expected, the intensity of noise has a big influence on all CA parameters, but particularly on the relationship 
between the coherence and ARI (Fig.5.5 D). On the one hand, in the presence of noise, notably at higher levels, 
there is a strong linear relationship between the VLF coherence and ARI seemingly providing justification for using 
coherence as a measure of CA (Table 5.2). However, the character of the coherence–ARI relationship changes 
dramatically at different noise intensities, and is almost completely flat in a noise-free model. This means using 
coherence to assess CA depends on having just the right amount of noise, which makes the applicability of 
coherence questionable. 
The other TF parameters, Mxa and, their relationships to ARI were affected by the noise as well, to varying degrees. 
Interestingly, although the shape of the relationship curve between the parameters and ARI remained largely 
unchanged, the scaling was significantly affected. Therefore, in different ‘noise’ conditions (bearing in mind that by 
‘noise’ we understand any exogenous process), the same TF parameter value or Mxa value will correspond to 
different ARI (i.e. strengths of autoregulation) levels. This can potentially explain the difficulties in comparing CA 
across different patient cohorts.  
Recalibration of the various autoregulation indices according to the ‘background’ exogenous ‘noise’ for a particular 
patient population may therefore be necessary for consistent CA grading. This may not, of course, be a practical 
solution, as the level of ‘background noise’ will be unknown in reality, possibly varying and generally unmeasurable. 
However, if one, for example, compares the real Mxa–ARI characteristics measured in TBI patients with a curve 
obtained via simple recalibration of the pure model function using only two measured values of Mxa (for intact and 
exhausted autoregulation) in that cohort of patients (Fig. 5.6 B), it is easy to see the appeal of this sort of way of 
thinking. 
5.1.6 Limitations 
In this section, a particular model (Tiecks’ model) of CA was used to generate CBFV signals and whether it is the 
same as the noise-free physiological system still needs further investigation. Therefore, the relationships described 
will predominantly hold for that particular model and may not necessarily accurately reflect the actual relationships 
Relationship between different CA parameters in TBI 
 
79 
 
 
in recorded datasets. However, the model has been shown to provide a good fit to the data recorded during leg-cuff 
tests, where a clearly defined stimulus (release of leg cuffs) was applied [215].  Furthermore, the observations in this 
section are rather generic for any type of high-pass-like relationship between ABP and FV and therefore the 
interpretations and recommendations are likely to hold in practice.  
 
Finally, the representation of confounding exogenous processes and non-linear effects as an additive coloured 
Gaussian noise signal is a gross simplification.  However, in the absence of a better model, this approach provides us 
with an adequate platform for investigating, at least qualitatively, the effects of these unknown factors on the 
performance and interrelationships of these CA indices.  
5.1.7 Conclusions 
This section explored theoretical relationships between the most commonly used indices of CA: ARI, Mxa and TF 
phase and gain. ARI, Mxa and TF phase (but not gain) were generally interchangeable while coherence should only 
be used with a full understanding of its interpretation and significance. The study also examined the influence of 
exogenous noise and highlighted the importance of considering the ‘recalibrating’ effects brought about by 
exogenous processes and model misfits.  
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5.2 Comparison of  frequency- and time-domain methods of CA assessment in TBI 
This study has been published as a full paper in the Journal of Cerebral Blood Flow & Metabolism [214].  
The theoretical relationships and interchangeability of assessments of CA using ARI, Mx and TF parameters have 
been validated through the simulated data described above. However, how these commonly used parameters 
correlate with each other in real data analysis for TBI patients still needs further investigation. In this section, we 
analyse the relationship using real data. Moreover, the effects of different inputs (ABP or CPP) for CA assessment 
are also studied. 
5.2.1 Materials and methods 
A data base of 288 TBI patients admitted to the NCCU, Addenbrooke’s Hospital in the United Kingdom between 
the years 2003 and 2013 (713 data recordings in total) was employed. The mean age of this population was 33 ± 16 
years (mean ± SD) and the mean Glasgow Coma Scale (GCS) at the scene was 6 ± 3 (mean ± SD).  
Daily TCD, used to monitor FV from the MCAs, was a part of the clinical assessment of the state of CA required by 
the clinical protocol. Data were recorded and analysed anonymously as part of a standard audit approved by the 
Neurocritical Care Users Group Committee. Patients were managed according to current institutional TBI guidelines 
[202], as described in Chapter 3. In brief, patients were sedated, intubated, ventilated and paralysed.  
5.2.2 Monitoring and data analysis  
ABP and CBFV were collected continuously as described in Chapter 4. ARI, PRx, TF phase, gain and coherence 
were calculated according to the method described in Sections 3.1.1-3.1.3. TF parameters mainly focused in two 
frequency ranges: 0–0.05 Hz (VLF) and 0.05–0.15 Hz (LF). Both ABP and CPP were used as input, and we use ‘a’ 
or ‘c’ for abbreviations (Table 5.2), for example, ARIa refers to the ARI value between ABP and FV.  
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Table 5.2  Abbreviations used in this section 
Abbreviation Full Name Abbreviation Full Name 
Phase_a_VLF Phase between ABP and FV at 
very low frequecy 
Phase_a_LF Phase between ABP and FV at low 
frequecy 
Phase_c_VLF Phase between CPP and FV at 
very low frequecy 
Phase_c_LF Phase between CPP and FV at low 
frequecy 
Gain_a_VLF Gain between ABP and FV at 
very low frequecy 
Gain_a_LF Gain between ABP and FV at low 
frequecy 
Gain_c_VLF Gain between CPP and FV at 
very low frequecy 
Gain_c_LF Gain between CPP and FV at low 
frequecy 
Coh_a_VLF Coherence between ABP and 
FV at very low frequecy 
Coh_a_LF Coherence between ABP and FV at low 
frequecy 
Coh_c_VLF Coherence between CPP and 
FV at very low frequecy 
Coh_c_LF Coherence between CPP and FV at low 
frequecy 
ARIc Autoregulation index between 
CPP and FV 
ARIa Autoregulation index between ABP and 
FV 
Mxc Mean flow index between CPP 
and FV 
Mxa Mean flow index between ABP and FV 
 
All autoregulatory indices were calculated from daily monitoring sessions and were then averaged for each patient, 
giving one value for each subject, which was compared with the patient’s outcome later. The outcome was assessed 
with the GOS six months after injury via rehab clinic or phone interview, which we dichotomized into two groups: 
favourable group (good outcome, moderate disability) and unfavourable group (severe disability, vegetative state 
and death). 
5.2.3 Statistical analysis 
Statistical analysis was performed using the IBM SPSS Statistics (version 19) software. The cross-relationship 
between these autoregulation indices was studied using a non-linear regression curve-estimation method. The 
Pearson correlation coefficient r between these parameters was calculated. In addition, the independent-samples t-
test was used to analyse differences in autoregulatory indices in the two outcome groups (favourable and 
unfavourable). Results were considered significant at p < 0.05. 
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5.2.5 Results 
Patients’ demography 
Patients’ demography were distributed as follows: good outcome, n = 75 (26%); moderate disability, n = 69 (24%); 
severe disability, n = 74 (26%); persistent vegetative state, n = 9 (3%) and death, n = 61 (21%). Fifty per cent of 
patients achieved a favourable outcome. An ARI value of 9 (both ARIa and ARIc) indicates hyperresponsive 
autoregulation, which is rarely seen in healthy subjects. In this study, fewer than eight ARI measurements of nine 
were observed. As this group was disproportionately smaller than other groups, it was excluded from further 
outcome analysis. 
 
Table 5.3. Patients’ Characteristics 
Index Unit Mean value Standard Deviation 
ABP mmHg 91.24 11.93 
ICP mmHg 17.99 9.78 
FV cm/s 62.5 27.22 
CPP mmHg 73.2 12.8 
GOS – 2.69 1.44 
GCS – 6.6 3 
ABP: arterial blood pressure; ICP: intracranial cerebral pressure; FV: flow velocity; CPP: cerebral perfusion 
pressure; GCS: Glasgow coma scale; GOS: Glasgow outcome scale. 
Table 5.4 Mean Value of CA parameters 
 Mxa Mxc ARI
a 
ARI
c 
Phase_a 
(degree) 
 
Phase_c 
(degree) 
 
Gain_a 
 
Gain_c Coh_a 
(squared) 
Coh_c 
(squared) 
VL
F 
LF VLF LF VLF LF VLF LF VLF LF VLF LF 
Mean 
value 
0.22 0.03 3.7 4.6 7.3 4.5 -17.3 -16.6 1.4 2.0 1.2 2.0 0.4 0.4 0.5 0.5 
S.D. 0.23 0.29 1.7 2.1 24.
7 
26.0 37.1 40.6 0.9 1.5 0.7 1.2 0.1 0.1 0.1 0.1 
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The relationship between parameters using CPP as input 
The relationship between Mx and ARI using CPP as input is presented in Figure 5.7 A. ARI was significantly 
related to Mx, though non-linearly (r = –0.404, p < 0.001); from ARI = 0 to 2, Mx was constant, whereas from ARI 
2–8 the relationship was strongly negative: Mxc = 0.401 – 0.081 × ARIc (p < 0.001, Figure 5.7 A). 
 
 
Figure 5.7 The relationship between ARI and Mx:  (A) ARIc and Mxc (B) ARIa and Mxa (C) ARIa and Mxc. Error 
bars: standard deviation. 
 
Of the TFs, only phase was correlated with ARI in the LF range (p = 0.001, r = 0.126, Figure 5.8 E), but not in the 
VLF range (p = 0.235, r = –0.045, Figure 5.8 B). The relationship between ARIc and phase_c_LF from ARIc = 1 to 
ARIc = 6, can be described by the linear model: Phase = –28.68 + 4.22   ARIc (p < 0.001, Figure 5.8 E). 
There was no significant relationship between ARIc and Gain_c in either of the frequency ranges (p > 0.05, Figure 
5.8 A and Figure 5.8 D). No significant relationship was found between ARIc and squared coherence_c either (p > 
0.05, Figure 5.8 C and Figure 5.8 F). 
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Figure 5.8 The relationship between ARIc and Gain_c at VLF (A) and LF (B) as well as the relationship between 
ARIc and Phase_c at VLF (C) and LF (D). Figures C and F show the relationship between ARIc and squared 
coherence at VLF (E) and LF (F). VLF: very low frequency, 0-0.05 Hz; LF: low frequency, 0.05-0.15 Hz. The unit 
for phase is degree. Error bars: standard deviation. 
The relationship between parameters using ABP as input 
Using ABP as the input signal, the ARIa and Mxa were strongly correlated, presenting a significant negative, non-
linear, relationship between them (r = –0.38, p < 0.001, Figure 5.9 B). 
The relationship between ARIa and Mxc was also studied. A significant negative relationship between these two 
parameters is shown in Fig. 5.7 C (r = –0.382, p < 0.001). From ARIa = 1 to 9, the relationship can be described by a 
linear function: Mxc = 0.401 – 0.081  ARIa (p < 0.001, Figure 5.9 C). 
For TF parameters, ARI correlated significantly with phase_a in both VLF (p < 0.001, r = 0.206, Figure 5.9 B) and 
LF ranges (p < 0.001, r = 0.291, Figure 5.9 E). LF Phase_a and ARIa were linearly related: Phase_a = –10.681 + 
4.93  ARIa (p < 0.05, Figure 5.9 E). No obvious relationship between ARIa and Gain_a was found (Figure 5.9 A 
and Figure 5.9 D). The squared coherence_a was unrelated to ARIa at both frequency ranges (Figure 5.9 C and 
Figure 5.9 F). 
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Figure 5.9 The relationship between ARIa and Gain_a at VLF (A) and LF (B) as well as the relationship between 
ARIa and Phase_a at VLF (C) and LF (D). E and F demonstrates the relationship between ARIa and squared 
coherence at VLF (E) and LF (F). VLF: very low frequency, 0-0.05 Hz; LF: low frequency, 0.05-0.15 Hz. Error bars: 
standard deviation. 
Outcome analysis 
Significant differences could be found in both ARI and Mx (p < 0.05, Figure 5.10) for the two groups of patients 
with dichotomized GOS scores (1–2: favourable or 3–5: unfavourable). Patients with favourable outcomes attained 
higher ARI values (ARIa: 4.09 ± 1.63, ARIc: 4.89 ± 1.91) and lower Mx values (Mxa = 0.18 ± 0.24 and Mxc = –
0.04 ± 0.29). For the unfavourable outcome group, mean ARI scores were lower (ARIa = 3.48 ± 1.64, ARIc = 4.42 ± 
1.97) and Mx scores were higher (Mxa = 0.26 ± 0.21, Mxc = 0.09 ± 0.28). The differences between favourable and 
unfavourable outcome groups were greater for ARIa than for ARIc (F = 9.56; p = 0.002 and F = 4.14; p = 0.043, 
respectively). By contrast, Mxc showed much better performance in differentiating the two groups than Mxa (F = 
15.38, p < 0.0001, F = 10.08, p = 0.002, respectively). Neither TF, gain, phase nor coherence showed any 
relationship with outcome in this cohort. 
 
Figure 5.10 Mean values and SD in patients with favorable and unfavorable outcomes. (A) ARIa: ARI between ABP 
and FV; (B) ARIc: ARI between CPP and FV; (C) Mxa: Mx between ABP and FV; (D) Mxc: Mx between CPP and 
FV. Error bars: standard deviation. 
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5.2.6 Discussion 
Mx and ARI as cerebral autoregulation indicators 
Several methods for CA assessment using spontaneous fluctuations in ABP and FV (such as ARI, Mx, TF phase and 
gain) have been applied to patients with  stroke, carotid stenosis and subarachnoid haemorrhage [139], [216], [217]
 
. 
However, their application for TBI has not been fully validated. This paper compared the results of three important 
autoregulation monitoring methods in a cohort of TBI patients. The result showed a significant negative relationship 
between Mx and ARI. The linear relationship between ARI and Mx from ARI = 2 to ARI = 7 agreed with the 
findings in our previous study [201].  The finding that between ARI 0 to 2, Mx remained at 0.3 could indicate that 
0.3 is the threshold for disturbed autoregulation and normal autoregulation, which was also found in a study by 
Sorrentino et al. [218].  
Mx describes the stability of CBF in the face of CPP or ABP changes. It is a non-parametric, i.e. model-free, method 
and only assesses whether, and to what extent, variation in one parameter (pressure) is significantly associated with 
variations in the other (flow). It reflects the shape of Lassen’s curve, with stable CBF within and pressure-passive 
CBF outside the limits of autoregulation. On the other hand, ARI explains how fast FV can recover from any 
changes in ABP or CPP and it is based on the mathematical model proposed by Tiecks. Therefore, as a parametric 
method, ARI depends on how accurately the model can reflect the physiology of the CBF autoregulation. 
Theoretically, if the assumptions are met, parametric methods will be more sensitive to changes in physiology than 
non-parametric methods. In this respect, if the Tiecks model describes the CA system accurately, ARI should 
perform with greater accuracy than Mx. On the other hand, if the model assumptions are not entirely met, a non-
parametric method like Mx should give more reliable results. In the present study, the quality of fit of the estimated 
IR to the model, though satisfactory in most cases, was sometimes poor, suggesting assumption violation. Perhaps 
some sort of combination of these approaches might yield more satisfactory results. 
Transfer function indices as cerebral autoregulation indicators 
 Many factors can cause rhythmic fluctuations in both ABP and ICP, such as pulse wave, respiratory wave and slow 
waves. However, the pulse wave and even the respiratory wave are too fast to engage CA effectively [129]. 
According to the ‘high-pass filter’ model, the variation in CBF due to changes in ABP would be effectively damped 
only in the LF range, and therefore LF waves are considered to be most relevant for testing/monitoring CA [210]. 
These slow waves can be generally classified further as A-waves, B-waves and C-waves [219]. A-waves, known 
also as ‘plateau waves’, are characterised by a steep increase in ICP reaching a plateau lasting for more than five 
minutes. B-waves, described originally by Lundberg, refer to the spontaneous fluctuations occurring in the 
frequency range of 0–0.05 Hz [219]–[221]. C-waves refer to oscillations with a frequency of 4–8 waves/min, often 
termed the Mayer (M) waves [219]. In this study, we chose two frequency ranges that include A-/B-waves (around 
0–0.05 Hz) and M waves (0.05–0.15 Hz) to be our main targets for TFA. 
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TFA allows us to look at the character of transmission from input to output of a linear system at different 
frequencies. The TF characteristics are always described via two components: phase and gain. Theoretically, 
increases in steady-state cerebrovascular resistance or decreases in vascular compliance during cerebral 
vasoconstriction should be directly reflected in changes in gain and phase of the TF [222]. In this study, however, 
we found that only phase was consistently related to the strength of autoregulation as measured by ARI. A linear 
relationship existed between ARI (in the range of 1 to 6) and phase at LF range. This suggested that, at least in our 
cohort of patients, the model is best applicable to the frequency range of 0.05–0.15 Hz. The VLF cerebral FV may 
contain cerebral vasomotion itself rather than being a pure response. In contrast, as demonstrated in Figure 5.8 and 
Figure 5.9, there was no relationship between gain and ARI. This might potentially be explained by the nature of TF 
characteristics in Tiecks’ model (Figure 3.2). In Tiecks’ model, phase increases along with the increase of ARI 
across the frequencies of interest. In contrast, gain does not have a uniform relationship with ARI; at lower 
frequencies, lower gain corresponds with higher ARI, whereas at higher frequencies, higher gain corresponds with 
higher ARI. 
Predictors of patients’ outcome 
Many investigations have indicated that the failure of CA after TBI is associated with a poor outcome [12], [131], 
[223], [224]. From this aspect, any reliable parameter that is claimed to assess CA should also have a significant 
relationship with patients’ outcome. To test this notion on the studied parameters, autoregulation monitoring results 
were compared with GOS scores taken at six-month post injury. We demonstrated a significant reduction in ARI 
and an increase in Mx from favourable to unfavourable outcome. This was verified in a large sample, the previous 
findings that both ARI (ARIa and ARIc) and Mx (Mxa and Mxc) were significantly associated with outcome [201]. 
Mx, contrary to the other approaches studied here, is a non-parametric method, except for the fact that it requires 
prior removal (smoothing) of high-frequency variations (like pulse and respiratory component). In this study, Mxc 
performed better than ARIa, indicating that its qualitative nature is on average more robust than linear modelling for 
CA assessment in TBI. Indeed, according to Lassen’s curve, the relationship between CBF and CPP shows that CBF 
stays flat, constant, within the autoregulatory range. It is at the lower and upper limits of CA that the relationship 
becomes highly non-linear [225]. For TBI patients, the plateau length of Lassen’s curve might be shortened to a 
great extent, thus making it more likely for CPP to be within the non-linear part. Therefore, linear modelling (Tiecks) 
may be less applicable for CA analysis in TBI. Mx, being more a qualitative than a quantitative method, is probably 
less sensitive to those effects. 
Moreover, the actual ‘driving force’ of the CBF is CPP, not ABP alone. In patient populations where no pathology 
of increased ICP is expected, changes in CPP and ABP practically amount to the same thing. However, the same 
cannot be said for TBI, where intracranial-hypertension-induced high-amplitude ICP waves are common. In those 
patients, neglecting ICP effects will lead to increased estimation errors, illustrated by the fact that Mxc showed a 
better correlation with the outcome than Mxa. This is in agreement with a previous study of Lewis et al. [226]. 
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Nevertheless, ARI showed better association with the outcome than using ABP alone. This effect is a little puzzling 
but is perhaps a consequence of a further violation of the linearity assumption of the underlying CA model 
introduced by the ICP-moderated feedback mechanism (explored by the popular PRx index [21], [37]). This, 
coupled with the lack of any association of phase and gain parameters to outcome may perhaps suggest that linear 
‘high-pass filter’ model-based approaches to assessment of CA do not perform very well in severe TBI patients. 
Limitations 
In this study, the TCD technology was used to monitor FV for CA assessment. Because of issues with probe 
repositioning and fixation, it is currently only practical to make intermittent (e.g. daily) short recordings of FV and 
prolonged monitoring over hours and days is unfeasible. In TBI patients, with their highly dynamic course of 
pathology over the first few days post injury, such intermittent measurements are likely to miss the development of 
transient pathological processes, e.g. plateau waves, that are likely to affect the final outcome, thus weakening the 
associations to outcome measures. More frequent TCD examinations or development of self-focusing/adjusting 
ultrasound probes seem to be the only ways these problems can be overcome. 
Finally, blood FV of MCA was used as a surrogate for CBF on the basis that the diameter of MCA remains constant 
during the monitoring period. However, there are still some ongoing discussions about the influences of diameter 
changes of MCA affecting the pressure–flow relationship. Many researchers have demonstrated that CBF velocity 
measurements correlated closely with changes in CBF in healthy volunteers and patients with extracranial or 
intracranial artery stenosis [13], [227]–[229], but whether this is also the case in severe TBI is not entirely certain. 
Conclusion 
This second study confirms that the IR-based ARI correlates significantly with the time correlation-based index Mx 
in TBI patients. Both parameters are significantly related to patients’ outcome, although Mx correlates more strongly 
than ARI. There is also a linear relationship between ARI and phase in the frequency range of 0.05–0.15 Hz. The TF 
parameters (phase and gain) have a poor relationship with the outcome; we cannot, therefore, recommend them for 
autoregulation measurements. 
5.3 Conclusion 
This chapter confirms the relationship between commonly used parameters for CA assessment through both 
simulated data and real TBI patients’ data. The results showed that the IR-based ARI correlates significantly with 
the time correlation-based index Mx. Both parameters are significantly related to patients’ outcome, although Mx 
correlates more strongly than ARI. There is also a linear relationship between ARI and phase in the frequency range 
of 0.05–0.15 Hz. The TF parameters (phase and gain) have a poor relationship with the outcome; we cannot, 
therefore, recommend them for autoregulation measurements.  
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CHAPTER 6 INTRODUCTION OF A NEW, TIME-FREQUENCY ANALYSIS METHOD FOR CA 
ASSESSMENT  
6.1 Introduction  
The interrelation between ABP, ICP and FV provides information about the functioning of CA[77], [128], [230]–
[233]. However, the methods mentioned in the previous chapter, such as Mx, TF, ARI are either simple correlation 
indices or are assumed to be suitable for linear signal analysis. This chapter introduces a new time–frequency 
analysis method for CA assessment, the wavelet transform, which is suitable for non-stationary, noisy signal 
analysis. It is able to perform local analysis and reveal signal features with desired temporal–frequency resolution in 
different frequency ranges using a window of variable width
 
 [34], [151],[25], [26].  
In this chapter, the WT algorithm is introduced as a fundamental method for CA assessment. WTP is calculated with 
WTC as a threshold, determined through a quantitative analysis using amplitude-adjusted ABP and ICP surrogate 
signals from more than 10000 computer simulations. A validation study was conducted on two cohorts of 
experimental piglet data. Then, the method was implemented into our own software ICM+® (University of 
Cambridge, Cambridge Enterprise, Cambridge, UK, http://www.neurosurg.cam.ac.uk/icmplus). Afterwards, the 
wavelet method was applied to 515 TBI patients and compared with traditional PRx. The relationship between the 
two parameters with patients’ outcome was also studied. Figure 6.1 describes the framework of this chapter. 
 
Figure 6.1 Flow Chart of chapter 6.  WTC, wavelet transform coherence; TBI, traumatic brain injury; WT, wavelet 
transform; CPPopt, optimal CPP value.  
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6.2 Validation of Cerebral Autoregulation Assessment Using Wavelet Method 
Paper submitted to JCBFM (December 2016) 
6.2.1 Introduction 
The aim of this study was to introduce wavelet-transform based method for CA assessment using continuous 
measurements of ABP and ICP and to validate the calculation of the wavelet method with PRx, a well-established 
CA index.  
6.2.2  Materials and methods 
Materials and Data recordings 
Two separate cohorts of subjects were analysed for this study, one with induced, sinusoidal ABP waves at a 
frequency of 1/min and another with spontaneous ABP wave activity. The stability of the PRx in time series was 
tested, and the SNR is improved by the use of controlled ABP wave activity [205]. This is mainly due to inadequate 
coherence between ABP and ICP. Low coherence between the ABP and ICP can result from physiologic events 
unrelated to autoregulation that can affect the ABP, ICP or, both. Periods without wave activity within the frequency 
range of the autoregulatory mechanism also have low coherence between ABP and ICP and result in random noise 
in the PRx. To examine the influence of those random effects on the relationship between the wPRx and PRx, we 
performed analysis first on a dataset from experiments with induced high-amplitude waveforms in ABP [205] and 
then repeated the analysis in a set of experiments with spontaneous ABP waves only [206].   
The hypotension experiment procedure was described in detail in Chapter 4. In the first set, the data were collected 
from 12 piglets, where regular, sinusoidal, ABP oscillations were induced using modulated PEEP during volume-
controlled ventilation [205]. A primary wave with a fixed tidal volume of 50 cc at a rate between 15 and 25 min
–1
 
was applied to a customized ventilator (Impact Instrumentation, West Caldwell, NJ). A secondary wave component 
in a sine-wave pattern of one minute period was introduced into the PEEP control. Once stable recording was 
obtained, the piglets were haemorrhaged by syringe-pump withdrawal at a rate of 12% calculated blood volume/h, 
which allowed the procedure of gradual ABP reduction over 3–4 hours before demise. For later analysis, this group 
was labelled the PEEP Group. 
In the second group, only spontaneous ABP and ICP signals from 16 piglets with naïve (n = 8) or elevated ICP (ICP 
= 20 mmHg, n = 8) were studied. A 5F oesophageal balloon catheter (Cooper Surgical, Trundall, CT) was placed in 
the femoral veins and was gradually inflated by infusion of saline from a syringe pump slowly to lower CPP to 10 
mmHg in both the naïve ICP group and elevated ICP group after achieving a steady state of mean ICP. The ABP 
was reduced continuously over the next three hours. Later, this group was labelled as the non-PEEP Group. 
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All procedures were approved by the Johns Hopkins University Animal Care and Use Committee or the Baylor 
College of Medicine Animal Care and Use Committee and conformed to the standards of animal experimentation of 
the National Institutes of Health [154]. 
In both groups of experiments, ABP, ICP and CBF were monitored continuously through the method described in 
Section 4.3. ABP was transduced invasively with a clinical monitor (Marquette Solar 8000, GE Healthcare, Little 
Chalfont, UK). ICP was monitored through an external ventricular drain after craniotomy. Bilateral laser Doppler 
probes (Moor Instruments, Devon, UK) were placed to monitor CBF after additional craniotomies over each parietal 
cortex. The signals were all sampled at 200 Hz, digitized using an A/D converter (DT9801, Data Translation, 
Marlboro, MA), and recorded using a laptop computer with ICM+® software (University of Cambridge, Cambridge 
Enterprise, Cambridge, UK, http://www.neurosurg.cam.ac.uk/icmplus). The same software was later used for the 
retrospective analysis of all stored signals. The data from both experiments were originally used in previous 
publications [204]–[206]. 
Methodology 
The continuous WT is defined as the convolution of a scaled mother wavelet function   with the analysed signal 
g(t), 
                                                (Equation 6.1) 
In order to get the phase information, the most commonly used mother wave, the complex Morlet wave was applied, 
which is a Gaussian function modulated with a complex sinusoid, defined as 
        
 
 
                  
       
         (Equation 6.2) 
where f0 is the central frequency of the mother wavelet, t is time. The second term in the brackets is known as the 
correction term, as it corrects for the non-zero mean of the complex sinusoid of the first term [151]. In practice it 
becomes negligible and can be ignored when f0 >>  , in which case, the Morlet wavelet can be written in a simpler 
form as [151] 
        
 
 
           
                                           ( Equation 6.3) 
We define the scale s as  
f = f0/s = w0/2 s                                                   (Equation 6.4) 
where w0 is the reference coefficient, w0 =     , which shifts the balance between frequency resolution and time 
resolution.  
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Therefore, the wavelet function based on the Morlet wavelet function can be expressed as   
         
 
               
                                      (Equation 6.5) 
The discrete form of the CWT of a sequence xn is  
           
  
        
 
                                               ( Equation 6.6) 
  
        
 
   
  
 
 
 
 
   
        
 
                                         (Equation 6.7) 
where    is the complex conjugate of the normalized wavelet function; n is the time-series index, and    is the 
sampling time.  
The wavelet power density estimator of xn is defined as               
       
  is the complex conjugate of 
     . The complex argument of the time series      gives a representation of the instantaneous phase of xn.  
The finite length of the analysed signal results in so called edge artefacts of WT. It is therefore, useful to introduce 
an index, the Cone of Influence (COI), in which the edge effect is significant and the power spectrum should be 
considered as dubious.  For the Morlet wave, the COI is    , where the wavelet power for discontinuity at the edge 
drops by a factor of     [205], [234]. The points within the edge effect area were removed prior to the 
phase/coherence point extraction. COI is larger for larger s. 
The cross-wavelet transform   
The cross-wavelet transform (XWT) of two time series xn and yn is deﬁned as  
                                                            (Equation 6.8)  
where * denotes complex conjugation. The complex argument pha(Wxy) can be interpreted as the instantaneous 
phase difference between xn and yn in time-frequency space [155], [205], [210].  
Wavelet transform coherence  
WTC can be used to find correlated areas in time-frequency space of two signals. The squared WTC estimator is 
deﬁned as the squared absolute value of the smoothed cross-wavelet spectrum, normalized by the smoothed wavelet 
power spectrum of the two signals, 
  
       
    
  
         
 
   
             
  
        
                                          (Equation 6.9) 
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where   
  and   
  
 are the wavelet spectral density functions,   
  
 is the cross-wavelet spectrum and the angular 
brackets indicate the smoothing operator. This deﬁnition of the wavelet coherence corresponds to the Fourier-based 
coherence and maintains its value between 0 and 1.  
The smoothing operator is achieved by a convolution in time and scale. 
                                                                       (Equation  6.10) 
where Sscale denotes smoothing along the wavelet scale axis and Stime means smoothing in time. The time 
convolution is performed with a Gaussian  
   
    , which is the absolute value of the wavelet function in each scale. 
The time convolution will double the edge artefact to 2s  . The scale convolution is performed by a rectangular 
window with a length of      , where         is the empirical scale decorrelation length for the Morlet wavelet 
[235], 
               
                     
                         (Equation 6.11) 
c1 and c2 are normalization factors and  is the rectangular function. 
Wavelet coherence threshold evaluation 
The Monte Carlo-simulations approach was used to evaluate the distribution of estimated wavelet coherence values 
corresponding to two uncorrelated signals.  As described by Faes [236], coherence threshold levels depend on the 
choice of the surrogate signals used and their similarity to the analysed signals. To improve the accuracy of the 
analysis, we made the inputs of the simulation resemble the investigated signals of ABP and ICP as much as 
possible.  This was done by randomly selecting a sample of 14 recordings from the experimental piglets’ data, and 
generating amplitude-adjusted Fourier transform surrogates of real ABP and ICP, with amplitude kept but phase 
randomized through white noise generator[237]. By doing this, we could generate a test distribution of WTC values 
between ABP and ICP signals, in which the internal relationship has been destroyed [238].  
Theoretically, the estimated WTC of such pairs of signals should be close to 0. The simulations were conducted 
10000 times and WTC in the band of 0.0067–0.05 Hz was calculated. If the actual value of WTC was higher than 
the 95% of WTC values obtained in this artiﬁcial unrelated surrogate distribution, the WTC value was assumed to be 
high enough to indicate a signiﬁcant relationship between input and output. We then estimated the significance level 
for each scale or central frequency, which equals angular frequency (w0) divided by 2π. Four w0s were tried, 
namely, 2π, 10, 20 and 30 radians/second.  
In the subsequent calculations, the estimated 95% confidence WTC threshold was used to reject corresponding 
phase values, which were deemed unreliable.  
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Wavelet transform pressure reactivity index (wPRx)   
WTP between ABP and ICP in the frequency range 0.0067 Hz to 0.05 Hz was calculated through complex wavelet 
transform, described above. The Morlet mother wave was applied with the central frequency set at 1 Hz. A 500-
second window was used to calculate WTP, and updated every 10 seconds. WTC was used to reject corresponding 
unreliable phase values, with the threshold calculated through the Monte Carlo-simulations approach (described 
above). Random noise is generated when the phase shift is calculated between two incoherent signals, thus 
coherence analysis acts as a filter to remove epochs with inadequate waveform activity for autoregulation analysis. 
Individual WTP values with WTC higher than the threshold were recorded, while the WTP values obtained with 
WTC lower than the threshold were deleted. The cosine of WTP was calculated afterwards, labelled as the wavelet-
transform pressure reactivity index (wPRx), which limited the wPRx range between –1 (180 degrees phase shift) to 
+1 (0 degrees phase shift), and rendering a metric with direct correspondence to PRx.  In addition, the cosine 
operation offers a practical solution to the problem of phase wrapping.   
Determining the Lower Limit of Autoregulation for the piglet data  
To compare the performance of PRx and wPRx, we measured the accuracy of wPRx and PRx to detect CPP below 
each subject’s individual LLA derived from laser Doppler cortical blood flow monitoring. Delineation of the LLA 
with this experimental protocol using laser Doppler recordings has been described previously [204], [239]. Briefly, a 
scatter plot of one-minute average laser Doppler flow versus CPP was made for each piglet. The CPP at the left 
intersection of two lines defined by a piecewise linear regression model is defined as LLA (Fig. 6.2). When CPP is 
below LLA, the subject is asserted to have impaired CA and when CPP is above LLA the subject is asserted to have 
intact CA. 
To delineate the accuracy of PRx and wPRx to detect CPP below LLA, both metrics were categorized and averaged 
in 5-mmHg bins of CPP for each piglet. 
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Figure 6.2 Demonstration of lower limit of autoregulation (LLA) using laser Doppler cerebral blood flow (CBF) and 
cerebral perfusion pressure (CPP) as a breakpoint between two linear sections estimated using the least mean square 
distance.  
 
Pressure reactivity index (PRx) 
The PRx was calculated according to previously published methods. First, ABP and ICP were filtered to remove 
pulse and respiratory frequency waveforms with 10 second averaging. A moving Pearsons correlation coefficient of 
30 consecutive samples (300 seconds) renders the standard PRx [21].  In addition, we repeated the same calculation 
using a 500-second moving window (50 samples per PRx) for direct comparison to the wPRx which is done with a 
500 second calculation period.  
Statistical analysis   
SPSS software (version 21, IBM, Armonk, NY, USA) was used for statistical analysis. Linear regression was used 
to describe relationships between PRx and wPRx. Pearson’s correlation coefficient (r) was used to examine the 
linearity of the relationship. The independent-samples t-test was used to analyse the ability of PRx and wPRx in 
distinguishing intact CA (CPP above LLA) and impaired CA (CPP below LLA). A ROC test was also done, 
rendering an area under the ROC curve (AU-ROC) for each parameter. Statistical differences between AU-ROC 
were verified using DeLong's test for two correlated ROC curves (R package pROC) [157]. Bland–Altman plots 
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were used to investigate the agreement between the two variables. The Kruskal–Wallis test was used to compare the 
SDs of PRx and wPRx. The results were considered significant at p < 0.05. 
6.2.3 Results  
Wavelet transform calculation 
A representative example of WTP and WTC between ABP and ICP from a single experimental dataset is shown in 
Fig. 6.2. With gradually decreased ABP (Fig. 6.3a), the phase shift between ABP and ICP showed a coupling 
decrease over time at the frequency of the input PEEP wave, demonstrated by the colour change from red to blue 
along the solid line in Fig. 6.3c. This change in phase shift from roughly three radians to less than one radian is 
interpreted as the transition from intact autoregulation to impaired autoregulation, induced by the overall lowering of 
the CPP. In the same protocol, the WTC at the same frequency remained stable and high across the whole period, 
shown by the red colour along the solid line in Fig. 6.3d. Fig. 6.3e shows the average value of WTC across the 
whole frequency range at each time point, and it was clear that for this sample, the frequency-averaged WTC was 
above the significance level in most time periods. 
 
Figure 6.3 Demonstration of WTP and WTC between ABP and ICP of one piglet in the PEEP Group. (a) Arterial 
blood pressure, ABP. (b) Intracranial pressure, ICP. (c) The WTP map between ABP and ICP. Red color indicates 
higher value and blue color implies lower value. (d) The WTC map. (e) The average value of WTC across the whole 
frequency average at each time point. The dashed line is the significance level of WTC. The Morlet coefficient w0 = 
2π. WTP: wavelet-transform phase shift; WTC: wavelet-transform coherence.    
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Wavelet coherence threshold 
The distribution of WTC using random, scrambled ICP and ABP is shown in Fig 6.4. The use of higher reference 
w0 (higher central frequency) resulted in lower WTC thresholds. For w0 of 2 , 10, 20, and 30 radians/second, the 
WTC threshold was 0.48, 0.46, 0.45 and 0.43 respectively. Although higher threshold will limit the dynamic range 
of the estimates, and lower values are preferred if possible, regarding to the bigger edge effect that higher w0 will 
produce, the Morlet coefficient w0 = 2π (i.e. central frequency  = 1 Hz) and WTC threshold of 0.48 were 
subsequently used for analysis.  
 
Fig.6.4 The distribution of wavelet transform coherence of 10000 simulations using Monte Carlo simulations based 
on surrogate signals of ICP and ABP, through different mother wave central frequencies, i.e. wavelet reference 
index w0. w0= 2π, 10, 20, 30.   
 
The relationship between wPRx and PRx  
Figure 6.5 shows the relationship between the 30-minute average values of wPRx and PRx. The strongest 
correlation between wPRx and PRx was observed when ABP oscillations were controlled with the PEEP modulation 
protocol (r = 0.88, Fig. 6.5A). In the non-PEEP Group, the correlation between wPRx and PRx was weaker(r = 0.68, 
Fig. 6.5B). The study showed no difference between PRx using a 500-second window and traditional PRx based on 
a 300-second window calculation (p > 0.05). Therefore, only the 300-window-based PRx was used for the 
subsequent analysis. 
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Figure 6.5 Relationships between PRx and wPRX in the PEEP wave-manipulated group (A) and in the spontaneous 
ABP waves (B). PRx: pressure reactivity index; wPRx: wavelet PRx; PEEP: positive end-expiratory pressure. Each 
dot represent 30-minutes average value of wPRx and PRx.  
Stability of PRx and wPRx 
For the first group, where the ABP was manipulated through regular sinusoid waves, there was no significant 
difference in standard deviation of PRx and wPRx (SD of PRx = 0.47 ± 0.06, SD of wPRx = 0.48 ± 0.07, p > 0.05). 
However, for the spontaneous group, wPRx showed a more stable result than PRx, demonstrated through lower SD 
(SD of PRx = 0.402 ± 0.19, SD of wPRx = 0.34 ± 0.17, p < 0.001). 
Comparing wPRx and PRx against LLA in the PEEP Group 
The purpose of determining LLA for each piglet was to have a standard against which to define good autoregulation 
(CPP above LLA) and bad autoregulation (CPP below LLA). The average LLA of the first group with ABP being 
manipulated through sinusoid waves was 33.75 mmHg (95% confidence interval (CI): 27.6–39.9 mmHg). Fig. 6.6 
displays PRx and wPRx of a piglet in this group, normalized to LLA, taking the origin of the abscissa at the LLA. 
The mean PRx or wPRx value at each 5-mmHg bin was calculated and displayed. It is clearly seen that while CPP 
dropped below LLA, both PRx and wPRx were increased, demonstrating worse autoregulation with more positive 
values. 
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Figure 6.6 Comparison of PRx and wPRx against a standard LLA in PEEP group. (A) An example of ABP, ICP, 
PRx and wPRx along continuous ABP decrease. Cerebral autoregulation indices are binned in 5 mmHg increments 
of CPP for comparison against the LLA: (B) PRx, (C) wPRx. Positive CPP-LLA value is related with intact CA, and 
negative CPP-LLA implies impaired CA. PRx: pressure reactivity index; wPRx, wavelet pressure reactivity index, 
cosine of wavelet phase shift between arterial blood pressure and intracranial pressure, using wavelet coherence as 
threshold. Analysed frequency was 0.0067 – 0.05 Hz. LLA: lower limit autoregulation. 
 
Previous studies have already compared PRx against LLA and demonstrated that higher PRx is linked to worse CA, 
represented by CPP below LLA[36], [204]. In this PEEP group, AUC-ROC curve validated that wPRx can 
differentiate normal and impaired CA as PRx (p <0.05, Table 6.1). The DeLong’s test showed no significant 
difference between the two AUC-ROC curves of PRx and wPRx (p=0.78, Table 1).In the non-PEEP Group, both 
wPRx and PRx can distinguish good and bad CA, no significant difference between the two AU-ROC values was 
found (p > 0.05). 
Table 6.1 The ability of PRx and wPRx in distinguishing good CA (above LLA) and impaired CA (below LLA) for 
PEEP group and non-PEEP group (spontaneous ABP at naïve ICP and elevated ICP).  
 PEEP group Non-PEEP group (Naïve ICP and 
elevated ICP together) 
PRx AUC-ROC=0.944 
**
 AUC-ROC=0.85 
**
 
wPRx AUC-ROC=0.931 
**
 AUC-ROC=0.87 
**
 
P value between two AUC-ROC 
curves (PRx and wPRx) 
p = 0.781 p = 0.779 
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 The area under the curve is where a value of 1 indicates maximum sensitivity and specificity. CA: cerebral 
autoregulation; ICP, intracranial pressure; LLA, lower limit of autoregulation. PEEP: positive end-expiratory 
pressure. AUC-ROC: Area under a receiver-operator characteristic (ROC) test. ** means p < 0.001, demonstrating 
significant difference between good and bad CA.  
Comparing wPRx and PRx against LLA in the non-PEEP Group  
Fig. 6.7 shows an example of recordings of ABP and ICP in the non-PEEP Group at different brain compliance 
states (naïve ICP and elevated ICP = 20 mmHg). 
 
Figure 6.7 Influences of ICP on lower limit of autoregulation (LLA) . A, Determining LLA for one piglet with naive 
ICP. ABP (mmHg), ICP (mmHg), LD ﬂux (LDOPPLER, AU), were recorded while a balloon catheter in the inferior 
vena cava was gradually inﬂated over two to four hours. B, example of a piglet with an ICP of 20 mmHg. Before a 
reduction in ABP, the ICP was increased to 20 mmHg by a steady-state infusion of artiﬁcial cerebrospinal ﬂuid, 
which was maintained throughout the experiment.  
 
The LLA was different among the two ICP levels, which matches the original, previously published analysis of this 
dataset [206]. The average LLA for the naïve and moderately elevated (ICP = 20 mmHg) was 31.1 mmHg (95% CI: 
26.2–35.9 mmHg) and 37.8 mmHg (95% CI: 31.0–44.6 mmHg), respectively. Both PRx and wPRx showed a 
significant decrease from bad CA to intact CA at naïve ICP and elevated ICP (p < 0.05 Figure 6.8, Table 6.1). 
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Figure 6.8 Performance of PRx and wPRx in distinguishing good cerebral autoregulation (CPP above LLA) and bad 
autoregulation (CPP below LLA) at two ICP levels. p < 0.05 implies significant difference. The white colour bar 
implies impaired CA with CPP below LLA; the stripedbar refers to intact CA with CPP above LLA.  Error bar: 
standard error. PRx: pressure index; wPRx: wavelet PRx; ICP, intracranial pressure; CPP, cerebral perfusion 
pressure; LLA, lower limit of autoregulation; CA: cerebral  autoregulation.     
 
6.2.4 Discussion 
The main finding of this study was that wPRx and PRx have similar accuracy at delineation of the LLA, and wPRx 
demonstrates an improvement in precision over PRx by mitigating the noise introduced by the use of spontaneous 
ABP waves to monitor autoregulation. The PRx is mainly useful for delineation of the optimal CPP for patients with 
TBI. Deviation from optimal CPP defined by PRx monitoring is associated with death and permanent neurologic 
disability. Maintenance of CPP at the optimal range defined by PRx monitoring is associated with the highest rate of 
survival with intact neurologic function. Studies that have shown this are taken as evidence for the accuracy of PRx 
monitoring. However, it is known that the PRx is imprecise, due to transient fluctuations in the ABP and ICP signals 
unrelated to autoregulation. This imprecision necessitates prolonged time-averaging of the PRx reliably to delineate 
optimal CPP. Improvements in the precision of PRx monitoring have the potential to decrease this time requirement. 
The use of WT with coherence filtering, as demonstrated in this study, is a viable method to improve the SNR in the 
PRx and decrease the monitoring time required to find optimal CPP. 
Wavelet analysis 
The WT expands time series into a time–frequency space with desired temporal–frequency resolution, to fit various 
needs for non-stationary signal analysis [128]. In his review, Smith highlighted the use of wavelet-based techniques 
to aid the interpretation of complex time-variant signals by producing qualitative and quantitative evidence of 
cerebrovascular autoregulation that is ‘not possible using other methods’[33], [240]. To introduce the wavelet 
method to analyse CA through ABP and ICP is one of the main purposes of this study. The Morlet wavelet, a 
complex function, is a natural choice when phase feature extraction is needed. Coherence (in this case WTC) 
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threshold is often used to ensure a reliable estimate of the phase relationship between input and output. This 
combination of wavelet-derived instantaneous phase accompanied by coherence-derived quality control makes it a 
more robust method for non-stationary signal analysis. 
However, defining an appropriate threshold for coherence is generally not trivial as it will vary depending on the 
values of various parameters of the estimation calculation process[236]. Therefore, we chose to establish that 
threshold using Monte Carlo simulations, in which surrogates of ABP and ICP with destroyed phase relationship 
were generated and analysed. This was also repeated for different Morlet mother wavelet central frequencies or 
angular frequencies (ω0). The simulations showed that increasing ω0 would shift the distribution of WTC towards 
lower values, thus decreasing the WTC threshold (effectively improving the statistical properties of the coherence 
estimation). However, high ω0 results in a more pronounced edge effect (see Section 6.2.2), which reduces the 
effective data points for analysis, and that was ultimately considered to be of more importance to the current analysis 
than a small gain in the reliability of the coherence estimation. 
Validation of wPRx 
As the most frequently used parameter for CA assessment in TBI patients, PRx was applied as a ‘standard’ for 
comparison with wPRx. ICP and ABP are common modalities available in NCCUs, and PRx is perhaps the most 
extensively validated of all metrics of autoregulation. However, PRx is calculated as a simple moving linear 
correlation between mean ABP and ICP, and it has a low SNR due to extraneous effects influencing ICP or ABP. To 
remove the effects of noise from this source, and to examine the pure relationship between wPRx and PRx, we used 
recordings from experiments with a persistent, LF ABP wave introduced by adding a PEEP modulation to the 
ventilator [205], [206]. 
For this cohort of piglets’ data with regular fluctuations in ABP, wPRx is not expected to perform any better that 
PRx, as the strong, deterministic component of approximately fixed frequency and amplitude induced in ABP 
removes any advantages of a non-stationary approach. However, the good agreement of the two parameters validates 
that the wPRx principle works. The potential advantages of wPRx lie in dealing with the input signal (ABP) when it 
is composed of spontaneous slow waves of varying intensity and frequency. Transmission of these variable waves 
into the output signal (ICP) waveforms may be partially masked by other sources of fluctuations, thus causing the 
coherence to decrease. In this case, the phase relationship is unreliable, and thus an indiscriminate measure like PRx 
will return random noise. Using coherence as a filter to mitigate the noise caused by non-stationary signals can 
produce a more stable result, which is demonstrated in this study with increased stability of the wPRx when 
spontaneous ABP waveforms are used. 
In both experiments, hypotension was induced by decreasing ABP manually until CPP was below the lower limit of 
CA, thus a clear CA state can be defined for impaired CA and intact CA [204], [206]. In both sets of experiments, 
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wPRx and PRx demonstrated similar results in distinguishing the two CA states. wPRx and PRx showed a 
significant increase from intact CA (above LLA) to impaired CA (below LLA). 
Interpretation of PRx 
Although a commonly used parameter for CA assessment in TBI, there are still some concerns about PRx with 
regard to its simplicity to assess the complex autoregulatory system. The high correlation between wPRx and PRx in 
this study provides further evidence that PRx is principally driven by the phase relationship between ABP and ICP 
[195]. 
6.2.5 Limitations 
As is well known, ABP is not the only determinant of CBF. Other parameters, such as CO2, have a vasodilatory 
effect on cerebral vessels[242]. If there are variations of CO2 during the analysis period of wPRx, then ideally it 
should be considered, possibly via using multivariate wavelet analysis. 
The dataset used in this study was from two groups of experimental piglets. The data of the PEEP Group validated 
wPRx for CA assessment, and the non-PEEP Group data showed wPRx with a more stable result. However, the 
analysis focused on the frequency range 0.0067 to 0.05 Hz, with Morlet wavelet with a central frequency of 1 Hz 
used as the mother wave. More frequency ranges and central frequencies can be tried in the future. 
6.2.6 Conclusion 
This section introduced the wavelet method to assess CA in two groups of hypotension experimental data from 
piglets [205], [206]. To exclude unclear noises that might be introduced into ABP or ICP, and examine the pure 
relationship between wPRx and PRx, the first experiment added a strong sinusoid wave to the ventilator to produce a 
persistent LF ABP. The result validated the wPRx principle through a significant linear relationship and high 
agreement between wPRx and PRx. Afterwards, spontaneous ABP waves and ICP waves of 20 piglets with 
hypotension experiments were applied, demonstrating the benefits of using wPRx to assess CA through lower SD. 
The result also showed that both PRx and wPRx can distinguish impaired CA and intact CA clearly. 
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6.3 Cerebovascular pressure reactivity using wavelet analysis in TBI 
Paper submitted to PLOS Medicine (November 2016) 
6.3.1 Introduction 
Section 6.2 introduced a new, time–frequency-based method for CA assessment, and validated the algorithm 
through two cohorts of experimental piglets’ data. The third section of this chapter applies the WT approach to 
assess CA in 515 TBI patients. The method was compared with the well-known CA parameter, PRx. In addition, the 
clinical potential of PRx/wPRx is in examining it versus CPP, which allows indicating the range of CPP values 
where autoregulation is preserved, or most active, also offering an individualised target for CPP management, called 
CPPopt. In this section, we calculated the CPPopt according to both PRx and wPRx and then compared it with 
patients’ outcome after six-month admission.  
6.3.2 Material and methods  
A total of 515 TBI patients’ data were used, admitted tp Addenbrooke’s Hospital between 2003 and 2015 with 
continuous monitoring of ABP and ICP. ABP and ICP were collected through the method described in Chapter 3. 
Artefacts introduced by tracheal suctioning, arterial line flushing or transducer malfunction were removed manually. 
The computerized data storage protocol was reviewed and approved by the local ethics committee of Addenbrooke’s 
Hospital, Cambridge University and the Neuro Critical Care Unit User’s Group. Patients were managed according to 
current institutional TBI guidelines (adapted from Menon et al., 1999) [202].  
Data Analysis 
CA parameters: Time-averaged values of ICP, ABP and CPP (CPP = ABP – ICP) were calculated using waveform 
time integration over 10-s intervals. PRx was calculated as a moving Pearson correlation coefficient between 10 s 
averages of ABP and mean ICP, using a 300 s data window [55]. 
Wavelet analysis. WTP between ABP and ICP in the frequency range 0.0067 Hz to 0.05 Hz was calculated through 
complex wavelet transform, described in Section 5.2 [155], [234]. The Morlet mother wave was applied with the 
central frequency set at 1 Hz. A 500-s window was used to calculate WTP, and updated every 10 s. The Monte 
Carlo simulation approach was applied to evaluate the distribution of estimated WTC values corresponding to two 
uncorrelated signals. 10000 simulations were conducted and the 95% confidence WTC threshold was used to reject 
corresponding phase values that were deemed unreliable. Individual WTP values with WTC higher than the 
threshold were kept, while the points with WTC lower than the threshold were ignored. The cosine of WTP was 
calculated afterwards, labelled wavelet (transform) pressure reactivity index (wPRx), which on one hand can limit 
the wPRx range from –1 to +1, making wPRx directly comparable with PRx; in addition, the result of this operation 
also help address the problem of phase wrapping. 
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Outcome analysis. To analyse the relationship between PRx/wPRx and outcome, the averaged values of each 
parameter were calculated across the whole monitoring period. The GOS was used to assess patients’ outcome at six 
months (obtained at rehabilitation clinic or by phone interview). For the statistical analysis, the patients’ outcomes 
were dichotomized in two ways: favourable outcome (good outcome and moderate disability) versus unfavourable 
outcome (severe disability, vegetative state and death); fatal outcome (death) versus non-fatal outcome (good 
outcome, moderate disability, severe disability and vegetative state). 
Optimal cerebral perfusion pressure. 
To test the ability of wPRx in the determination of the optimal cerebral perfusion pressure (CPPopt), the curve 
fitting methodology described by Aries et al. [38] was used to estimate CPPopt based on both wPRx (CPPopt_wPRx) 
and PRx (CPPopt_PRx) for this cohort of TBI patients. In summary, a 5-min median of CPP minute-by-minute time 
trend was calculated alongside PRx (or wPRx). These PRx (or wPRx) values were divided and averaged into CPP 
bins spanning 5 mmHg. An automatic curve fitting method was applied to the binned data to determine the CPP 
value with the lowest (w)PRx. CPPopt was calculated using a four-hour calculation window with an update every 
minute. The first CPPopt curve could be generated when at least 50% of the required data points of (w)PRx were 
available, i.e. after a minimum of two hours of monitoring. We calculated the average value of CPPopt across the 
whole monitoring period for each patient. In addition, the difference between median CPP and CPPopt was 
calculated continuously (ΔCPP = median CPP – CPPopt) and averaged for the whole monitoring period.  
6.3.3 Statistical analysis 
Statistical analyses were performed using the IBM SPSS Statistics (version 21) software. The cross-relationship 
between PRx and wPRx was studied using a linear-regression method (one data per patient). Pearson’s correlation 
coefficient (r) was used to examine the linearity of the relationship. The independent-samples t-test was used to 
analyse the ability of PRx and wPRx in distinguishing different outcome groups (favourable versus unfavourable 
outcome, fatal versus non-fatal outcome). Results were considered signiﬁcant with p < 0.05. In addition, 2 tests 
were used to describe the ‘degree of equivalence’ of examined CA parameters with dichotomized patients’ outcome 
groups by ROC curve analysis. R-software was used to test the statistical significance of the difference between the 
areas under two ROC curves for different outcome groups. The SDs of wPRx, PRx, CPPopt_PRx and 
CPPopt_wPRx were calculated to show the stability of these parameters. 
6.3.4 Results  
Patients’ demographics  
The group of patients included 210 females and 305 males. Their mean age was 38.4 ± 16 years (mean ± SD) , 
median GCS score was 7 (interquartile range, IQR: 3–9). The initial GCS and GOS scores were missing in 34 and 
73 patients, respectively. The average ABP and ICP of this cohort were 94.8 ± 15 mmHg and 16.2 ± 12 mmHg, 
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respectively. Average CPP was 79.6 ± 15 mmHg. The outcome was distributed as follows: good recovery, n = 75 
(17.0%); moderate disability, n = 117 (26.5%); severe disability, n = 142 (32.1%); persistent vegetative state, n = 11 
(2.5%) and death, n = 97 (21.9%). The mean recording time per patient after artefact removal was 118.6 hours 
(range from 1 h to 536 h). 
 
Figure 6.9 Example of data analysis using ICM+, showing time trends of arterial blood pressure (ABP), cerebral 
perfusion pressure (CPP), pressure reactivity index (PRx),wavelet pressure reactivity index (wPRx). The U-shape 
curves at the bottom panels were used to determine automated optimal CPP (CPPopt) with curve fitting software. 
The (w)PRx-CPP plot was created using CPP 5 minute mean value as x-axis, with averaged (w)PRx values in CPP 
bins spanning 5 mmHg as y-axis.  
 
Relationship between PRx and wPRx  
Figure 6.10 A shows the relationship between PRx and wPRx. There was a significant linear relationship between 
the two parameters, which can be described as: wPRx = 0.81  PRx + 0.32 (p < 0.001, r = 0.79). The SD of wPRx 
was significantly smaller than that of PRx (wPRx 0.31 ± 0.06 vs PRx 0.37 ± 0.06, p < 0.001). 
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Figure 6.10 Relationship between PRx and wPRx (one dot per patient, n=515). A, there is a linear relationship 
between PRx and wPRx. B, Bland Altman plot of wPRx and PRx showing high agreement of the two parameters. 
PRx: pressure reactivity index; wPRx: wavelet PRx, the cosine of wavelet phase shift between arterial blood 
pressure and intracranial pressure (ICP).  
Outcome analysis 
A significant difference existed between favourable and unfavourable outcomes, demonstrated by both PRx and 
wPRx (Figure 5.11A–B). Mean (±SD) PRx was 0.03 ± 0.13 in the favourable outcome group and 0.10 ± 0.17 in the 
unfavourable group (p < 0.001, AUC = 0.613); wPRx was significantly different between patients with a favourable 
outcome compared with those with an unfavourable outcome (0.31 ± 0.17 vs 0.42 ± 0.18, p < 0.001, AUC = 0.675). 
The R analysis showed a significant difference between the two ROC curves of PRx and wPRx (z = 3.6, p = 0.0002). 
For the fatal and non-fatal groups, PRx and wPRx also showed significant differences between the two groups 
(Figure 5.11C–D). Mean (±SD) PRx was 0.05 ± 0.14 in the non-fatal outcome group and 0.15 ± 0.19 in the fatal 
group (p < 0.001, AUC = 0.66); wPRx was significantly different between patients with non-fatal outcome 
compared with those with fatal outcome (0.34 ± 0.17 vs 0.48 ± 0.19, p < 0.001, AUC = 0.73). The R analysis of the 
two ROC curves showed better performance with wPRx than PRx in distinguishing the two groups (z = 2.9941, p = 
0.003). 
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Figure 6.11 The mean values of PRx, and wPRx in different patients’ outcome groups. Both parameters could 
distinguish between favourable and unfavourable outcomes, as well as between fatal and nonfatal outcomes. PRx: 
pressure reactivity index; wPRx: wavelet PRx, the cosine of wavelet phase shift between arterial blood pressure 
(ABP) and intracranial pressure (ICP). AUC: area under curve.  
 
CPPopt analysis 
Figure 6.12 shows the relationship between (w)PRx and binned CPP for 515 TBI patients using the data across the 
whole monitoring period. A linear relationship exists between average CPPopt_wPRx and CPPPopt_PRx for the 
whole monitoring time, which can be described as CPPopt_wPRx = 0.89  CPPopt_PRx +10.42 (p < 0.001, r = 0.81, 
Figure 6.12 C). Figure 6.12 A–B shows that for the total cohort of patients, the CPPopt would be 70 mmHg 
according to PRx methodology and 80 mmHg according to the wPRx methodology. A significant positive 
relationship exists between CPPopt_wPRx and mean CPP (p < 0.001, r = 0.40, Figure 6.12 D). 
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Figure 6.12 (A) PRx- vs CPP plot for the whole cohort. (B) wPRx-CPP plot for the whole cohort. (C) 
Therelationship between CPPopt_wPRx and CPPPopt_ PRx (one dot per patient, n=515). (D) CPPopt_wPRx vs 
mean CPP (one value per patient). PRx: pressure reactivity index; wPRx: wavelet PRx, the cosine of wavelet phase 
shift between arterial blood pressure (ABP) and intracranial pressure (ICP).  
 
An overall determination of an individual CPPopt across the whole time was possible in 502 patients according to 
wPRx or PRx. The CPPopt yield rate was significantly increased by using wPRx (CPPopt_PRx 53.2% ± 20 vs 
CPPopt_wPRx 59.6% ± 27, p < 0.001). SD of CPPopt_PRx and CPPopt_wPRx were 8.45 ± 2.90 and 7.05 ± 3.78, 
respectively (p<0.001).  
Figure 6.13 demonstrates the relationship between favourable outcome, unfavourable outcome, mortality rate, 
severe disability rate and ΔCPP. The mortality increased steadily with the median CPP shifting below the threshold 
of CPPopt both according to both wPRx and PRx (Figure 6.13 C). An inverse ‘U’-shape curve with the highest 
favourable outcome rate appeared at the smallest difference between CPP and CPPopt as seen in Fig.6.13 B. In 
contrast, the unfavourable outcome showed a rate increasing below or above CPPopt (Figure 6.13 A). The disability 
rate was increased while median CPP is above CPPopt (Figure 6.13 D).  
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Figure 6.13 Graphs of the relationship between favourable outcome, unfavourable outcome , mortality rate, severe 
disability rate and the difference between median cerebral perfusion pressure (CPP) and optimal CPP according to 
PRx (CPPopt_PRx) and wPRx (CPPopt_wPRx). A, a ‘U’-shape curve demonstrating that the smallest incidence of 
unfavourable outcome was associated with median CPP around CPPopt. B, this graph shows the asymmetrical 
inverted ‘U’-shape curve between favourable outcome and the difference between the median CPP-CPPopt; C, the 
mortality increases steadily when median CPP is increasingly below CPPopt. D, severe disability increased while 
CPP median is above CPPopt.  
 
Age and ICP 
There was a significant relationship between PRx and age (r = 0.24, p < 0.001), also between wPRx and age (r = 
0.124, p = 0.01) in this 515-cohort of TBI patients. CA seems to deteriorate with increase of age, shown by 
increased PRx and wPRx. wPRx showed a stronger relationship with ICP (r = 0.32, p < 0.001) than PRx did (r = 
0.11, p = 0.029). 
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Figure 6.14 The relationship between cerebral autoregulation parameters and age. A, The mean PRx was increased 
with the age developing. B, wPRx also showed a slight increase while the age was increased. C, relationship 
between PRx and ICP (one dot per patient, n=515); D, relationship between wPRx and ICP (one dot per patient, 
n=515).  
 
6.3.5 Discussion 
The WT is a time–frequency method that facilitates more accurate analysis of biological signals containing 
components that are non-stationary[243]. We have developed and validated a wavelet-based methodology of 
continuous assessment of CA for 515 TBI patients. We have shown that there is a close relationship between wPRx 
and the established PRx index. For PRx, a negative correlation indicates a pressure-active vascular bed with 
preserved cerebrovascular reactivity, whereas a positive correlation indicates a pressure-passive vascular bed with 
impaired reactivity [243]. For wPRx, bigger wPRx values reflect smaller phase shifts between fluctuations in ABP 
and ICP. The fact that we have achieved such high correlation between the two indices strongly suggests that PRx 
actually represents a cosine of the phase shift between those two modalities. 
Despite similar performance from both indices, the wPRx approach seemed to produce more stable time trends, as 
reflected by its smaller SD than PRx. The reason might be the robustness of the wavelet method; on the one hand, 
the application of WTC can guarantee the most associated values and remove unreliable points; on the other hand, 
the calculation of wPRx was focused on the specific frequency range of CA, while PRx covers the whole frequency 
band, which includes uncertain noises. 
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In this retrospective study, the wavelet method demonstrated better performances than PRx in distinguishing 
favourable and unfavourable outcomes, as well as fatal and non-fatal outcomes according to the GOS score. 
However, in the optimal CPP calculation, wPRx revealed an asymmetrical ‘U’-shape curve, which might suggest 
that a CPP below the averaged optimal level can impair CA much more than a CPP above the averaged optimal 
level. 
wPRx makes CPPopt estimation more continuous and stable by showing higher yield rate and lower SD than PRx. 
Normal ageing is associated with many well-recognized changes in the cardiovascular system, such as increases in 
systolic blood pressure, decreases in systemic artery compliance, cardiac baroreceptor sensitivity and decrease of 
cortical CBF [244]–[248]. Several types of research have already studied the relationship between age and CA in 
healthy volunteers, and no relationship existed between CA and age using ABP and FV as input[249], [250]. 
However, in TBI patients, whether age influences CA is still not very clear. In this research, the analysis showed an 
age-related deterioration in CA, which means that dynamic CA in older TBI patients no longer performs as 
efficiently as in younger TBI patients. This relationship was captured by both PRx and wPRx. 
6.3.6 Limitations 
This retrospective analysis has been performed on a person for whom the outcome was known, more studies need to 
be done to analyse the ability of wPRx to predict patients’ outcomes. 
This research analysed the relationship between ABP and ICP in the frequency range 0.0067 Hz to 0.05 Hz. More 
signals and more frequency ranges can be tried. 
6.3.7 Conclusion 
This study validates a sophisticated, wavelet-based method for CA assessment in TBI patients. Based on our results, 
wPRx showed potential in distinguishing different patients’ outcome groups and showed more stable behaviour, 
which can be used in optimal CPP determination. 
6.4 Conclusion 
This study introduced a new method for assessment of CA using wavelet-derived phase shift between ABP and ICP 
and validated it against PRx in two hypotensive experiments in piglets. To exclude other noise that PRx might 
contain and compare the new method with PRx purely, the study introduced sinusoid manipulated waves to ABP to 
induce persistent LF ABP waves. The result showed a significant linear relationship between wPRx and PRx. 
Moreover, this study employed spontaneous ABP and ICP from hypotensive piglets to show wPRx with a more 
stable result. 
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After being validated through the piglets’ experimental data, the wPRx was applied to 515 TBI patients. wPRx was 
linearly related with PRx and showed a more stable result. It has also been demonstrated that wPRx can produce 
more continuous optimal CPP for this cohort of patients, showing a similar result with the outcome as PRx. 
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CHAPTER 7 AN INNOVATIVE METHOD TO MONITOR CPPOPT IN TBI 
7.1 Introduction 
Survival after TBI depends on the control of intracranial hypertension and the provision of haemodynamic support 
to achieve an ‘adequate’ CBF, with CPP being one of the main driving forces. However, setting an adequate CPP 
target for the individual TBI patients at the bedside remains challenging. Maintaining a CPP above 70 mmHg was 
proposed as a method for preventing secondary injuries [1], [2]. However, a large randomized controlled trial could 
not demonstrate a benefit of a fixed CPP-targeted therapy [4]. The recent Brain Trauma Foundation guidelines 
advocated exploring the feasibility and the impact on the outcome of strategies based on individualized 
autoregulation-guided CPP management [2]. 
As described in Chapter 3, plotting PRx against CPP will often generate a ‘U’-shape curve, the minimum turning 
point of which represents the CPP corresponding to the smallest value of PRx, where the CA response is most active 
[27]–[29], and the point is termed CPPopt [38]. Observational studies have confirmed that adult and paediatric 
patients whose median CPP is closer to their determined CPPopt seem to have better clinical outcomes [37], [159], 
[160]. However, there are still some problems with traditional CPPopt, calculated through single 4-hour window 
such as low yield, high variability, which limit the clinical application of the method. Based on Depreitere’s 
method[161], which was introduced in 2014 using an innovative multi-window-based algorithm for CPPopt 
calculation, we extended this method to combine more windows and applied a weighting system that incorporates 
more characteristics of the PRx–CPP plot. Instead of using 7 windows of different length (1, 2, 4, 6, 8, 12, 24 hours), 
we use 36 windows from 2 hours to 8 hours, increased at 10-minute step. We also extended the weighting system 
criteria from 2 to 4. A validation study in a much larger population of TBI patients is conducted in this chapter.   
7.2 Monitoring of CPPopt in TBI using a multi-window weighting algorithm based on PRx 
Paper submitted to Critical Care Medicine (November 2016) 
7.2.1 Materials and methods  
Patients’ demographics  
This section is a retrospective study on 526 severe TBI patients (391 males) admitted in the NCCU of 
Addenbrooke’s Hospital between 2003 and 2015. Mean age (SD) was 38.6 ± 16.5 years. Continuous recordings of 
ABP and ICP were part of the local monitoring protocol in severe TBI patients [251], recorded according to the 
method described in Chapter 3.  
All patients were sedated, intubated and, mechanically ventilated during the recording period. A CPP/ICP-oriented 
protocol for TBI management was used with CPP maintained > 60 mmHg and ICP < 20 mmHg [251]. The baseline 
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neurological status of each patient was determined using the GCS. The post-resuscitation GCS was used in patients 
who had sedation discontinuation immediately following hospital admission. The clinical outcome was assessed at 
six months after hospital admission using the GOS [252]. Artefacts introduced by tracheal suctioning, arterial line 
flushing or transducer malfunction were removed manually. Data were recorded and analysed anonymously as part 
of a standard audit approved by Neurocritical Care Users Group Committee. The same software was later used for 
the retrospective analysis of all stored signals. 
Preprocessing  
Time averaged values of ICP, ABP, and CPP were calculated using waveform time integration over 60-sec intervals. 
Cerebrovascular PRx was calculated as a moving Pearson correlation coefficient between 30 consecutive, 10-s 
averaged values of ABP and corresponding ICP signals [21]. Averages over 10 s were used to suppress the influence 
of the pulse- and respiratory-frequency wave components. Artefacts were identified and excluded manually from 
analysis after the data collection. 
Traditional CPPopt calculation  
CPPopt was calculated according to a published curve-fitting algorithm using four hours of ABP and ICP recording 
(Aries et al. 2012) described in Chapter 5. In summary, a 5-min median CPP time trend was calculated alongside 
PRx. These PRx values were divided and averaged within CPP bins spanning 5 mmHg. The upper limit and lower 
limit of CPP for the CPPopt calculation were set at 40 and 120 mmHg, respectively. For each CPP bin, the 
corresponding values of PRx were assembled. The mean value and standard error (S.E.) of each bin were then 
plotted against the bin’s mean CPP values to create the error bar chart representing the relationship between PRx 
and CPP. An automatic curve fitting method was applied to the error-bar plot to determine the CPPopt value 
automatically at the lowest associated PRx. The curve fitting error was calculated as the square root of SSE (average 
sum of the squared differences) between the 5 mmHg bin averaged PRx data and fitted values (Figure 6.1B, left 
panel).  
 Theoretically, this PRx-CPP relationship should form a smooth ‘U’-shaped curve, i.e. with the best cerebrovascular 
pressure reactivity at the lowest point (vertex). Importantly, before the curve-fitting process, PRx data were first 
processed using a Fisher Transform, in order to achieve a normal distribution eliminating the ceiling effect of the 
maximum PRx value of 1.0[38].  
Multi-window CPPopt calculation with weighting 
In this study, we applied a multi-window approach for CPPopt, with the length of calculation window varying from 
two to eight hours, increased in 10-minute steps. Hence, for each time point, 36 PRx-CPP plots were generated after 
8 hours of monitoring. These plots were given a combined weight factor based on three rules (see below), and the 
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final resulting CPPopt value was computed as the weighted average of the 36 available CPP values.  The weighting 
rules were as follows: 
1. The longer the window duration, the lower the weight factor (Figure 7.1A); 
2. The smaller the curve ‘fit error’, the higher the weight factor (Figure 7.1B, the thick black line). Alternatively, the 
full ‘fit error’ was calculated as the error between the original PRx data points and the fitted curve, instead of the 5 
mmHg bin average data and the fitted curve (Figure 7.1B); 
3. Fitted curves that did not include the turning point with minimum value were also given lower weight (Figure 
7.1C–D); 
 
 
 
Figure 7.1 The three weighting rules for CPPopt calculation using multi-window approach. A, longer window 
duration lowers the weight factor; B, the smaller the curve ‘fit error’, the higher the weight factor; the fit error was 
calculated as the error between the original data points and the fitted curve (right panel), instead of between bin 
average data and the fitted curve (left panel) ; C-D: curve that includes the turning point of minimum value receives 
higher weight factor (C) then the one that does not (E). ABP: arterial blood pressure; CPP: cerebral perfusion 
pressure; PRx: pressure reactivity index; CPP 5min: 5-minute mean value of CPP. 
 
The weighting process can be described mathematically as: 
 
       
 
               
 
 
                
                                                                                     (Equation 7.1) 
 
Additional fit criteria  
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To try to improve the quality of individual curve fitting, the following two extra calculation options were 
investigated:   
1. inclusion of error weighting (the S.E. of the error bars) in the process of curve fitting (Figure 7.2B) and  
2. a criterion enforcing the curve to overlap (at least partially) the range of PRx values <–0.3,0.6> (Figure 7.2A), thus 
forcing the algorithm not to return any CPPopt value when PRx was always very high (complete loss of CA), or 
very low (entirely intact CA). 
 
Figure 7.2 A, CPP bins were excluded for CPPopt calculation in the PRx regions of completely impaired (PRx > 0.6, 
upper panel) or completely working (PRx < -0.3, bottom panel) cerebral autoregulation. Figure 7.2B, inclusion of 
error weighting in the process of curve fitting (right panel) and exclusion of error weighting in the process of curve 
fitting (left panel). PRx represents pressure reactivity index. 
 
CPPopt and outcome  
Previously published papers from our group demonstrated that patients with averaged CPP close to CPPopt tended 
to have a more favourable outcome[38]. We repeated this same analysis on a larger number of patients using the 
new multi-window weighted CPPopt calculation method as well as the original single window (4 h) CPPopt 
calculation-approach. In order to investigate influence of the newly introduced parameters/options for the CPPopt 
calculation the analysis was repeated several times as detailed in Table 7.1. The following naming convention was 
adopted for the suffix of CPPopt parameters labels: 
S–single-window calculation (a four-hour window); 
M–multiple window calculation (36 windows); 
Y–enforcing the curve to overlap a specific range of the y-axis (PRx values: –0.3 to 0.6); 
E–error-bar weighting (the SE of the error bars); 
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W–using a weighting algorithm, each plot was given a combined weight factor based on the three rules (window 
length, full-fit error and vertex; Equation 7.1); 
A – average.  
Table 7.1 Abbreviations of labels for CPPopt calculation  
Label Calculation 
window 
Use 
error-bar 
weighting 
Enforcing the 
curve to overlap 
a specific range 
of the y-axis 
Use multi-
window 
weighting 
system 
Description 
CPPopt_S Single NA NA NA Using four-hour window 
 
CPPopt_SYE Single Y Y NA Using four-hour window, with 
algorithm of error-bar 
weighting and forcing the curve 
to overlap the range of PRx 
values <–0.3, 0.6> 
CPPopt_MA Multiple NA NA NA Calculate the average value of 
CPPopts based on multi-
window approach 
CPPopt_MAYE Multiple Y Y NA Calculate the average value of 
CPPopts based on multi-
window approach, with 
algorithm of error-bar 
weighting and forcing the curve 
to overlap the range of PRx 
values <–0.3, 0.6> 
CPPopt_MW Multiple NA NA Y Calculate the weighted-average 
value of CPPopts based on 
multi-window approach; the 
weighting factors include 
window length, full-fit error 
and parabolic vertex 
CPPopt_MWYE Multiple Y Y Y Calculate the weighted-average 
value of CPPopts based on 
multi-window approach, with 
algorithm of error-bar 
weighting and forcing the curve 
to overlap the range of PRx 
values <–0.3, 0.6>; the 
weighting factors include 
window length, full-fit error 
and parabolic vertex 
Y: use this function, NA: not apply this function. 
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We calculated the difference between the median CPP (CPPmed) and each of the calculated CPPopt values every 
minute. Subsequently, for outcome analysis, these values were averaged over the whole monitoring period for each 
patient (CPP). The outcome was dichotomized in two ways: favourable (good recovery, moderate and disability) 
vs unfavourable outcome (severe disability, persistent vegetative state and death) and mortality vs survival. 
7.2.2 Statistical analysis 
Statistical analysis was performed using the IBM SPSS Statistics (version 21) software. The yield was calculated as 
the ratio between the count of CPPopt and the count of CPP across the whole monitoring period in every patient. 
The stability of CPPopt was calculated as the SD of the differences between two consecutive values of CPPopt 
(CPPopt (t) – CPPopt (t – 1)) over the whole monitoring period. Fatal and non-fatal outcome groups were compared 
using the non-parametric Kruskal–Wallis test because the values in most groups were not normally distributed. 
ANOVA test was used to compare the yield of different CPPopt calculation methods (Table 7.3). We assumed 
=0.05. ROCs were used to compare the ability of different CPPopts to distinguish patients’ outcomes, rendering an 
area under the ROC curve for each parameter [253]. Bland–Altman plots were used to investigate the agreement 
between CPPopt_S and CPPopt_MA for the pooled data of all TBI patients. 
7.2.3 Results 
Patient Demographics 
The group of patients included 219 females and 307 males, with their characteristics described in Table 2. Their 
mean age was 38.6 ± 16.5 (mean ± S.D.) years old, median GCS score was 7 (interquartile range [IQR]: 4-9). The 
GCS and GOS score were missing in 190 and 18 patients. The average ABP and ICP of this cohort was 93.6 ± 8.3 
mmHg and 16.6 ± 9.9 mmHg, respectively. For the outcome analysis, patients with GOS score missing were 
excluded. The outcome was distributed as follows: good recovery, n= 84 ( 16.5%), moderate disability, n = 136 
(26.8%), severe disability, n = 165 (32.5%); persistent vegetative state, n = 12 (2.3%); and death, n = 111 (21.9%). 
The mean recording time per patient after artefact removal was 142.0 hours (range from 1 hour to 697 hours).  
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Table 7.2 Patient demographics, clinical variables, and outcome 
 N Age GCS ABP ICP CPP PRx 
Death 111 44.4 
±17.8 
6.0 
 (IQR:3-8) 
94.2 
±14.0 
20.4 
±12.3 
75.0 
±13.6 
0.16 
±0.20 
Vegetative 
state 
12 40.5 
±16.8 
5.0  
(IQR:3-9) 
90.3 
±11.6 
16.1 
±8.3 
72.9 
±9.5 
0.06 
±0.20 
Severe 
disability 
165 39.0 
±15.4 
6.0 
(IQR:4-8) 
94.2 
±7.4 
16.6 
±10.0 
78.6 
±9.7 
0.04 
± 0.16 
Moderate 
disability 
136 35.7 
±15.4 
7.0 
 (IQR: 4-10) 
92.8 
±8.3 
15.3 
±8.8 
77.8 
 ± 8.2 
0.04 
 ± 0.16 
Good 
recovery 
84 34.9 
±16.6 
8 (IQR:4-10.5) 93.3 
±7.8 
14.7 
 ± 7.6 
79.1 
± 7.0 
0.01 
 ± 0.13 
Total 526 (18 
GOS 
missing) 
38.6  
± 16.5 
7  
(IQR: 4-9) 
93.6  
± 8.3 
16.6 
± 9.9  
77.7  
± 9.9  
0.07  
± 0.18 
GOS, Glasgow Outcome Scale; M/F, males/females; GCS, Glasgow Coma Score; ABP, arterial blood pressure; ICP, 
intracranial pressure; CPP, cerebral perfusion pressure; PRx, pressure reactivity index. wPRx: wavelet pressure 
reactivity index; Values are shown as mean ± SD or median and interquartile region. SD: standard deviation; IQR: 
interquartile range. ABP, ICP, CPP, PRx and wPRx were averaged in each patient over the whole monitoring period. 
 
CPPopt yield  
Figure 7.3 shows two examples of CPPopt trends in TBI patients with long-term recordings. In both cases the single 
window CPPopt trend (CPPopt_S) contains many missing values (gaps) while the multi-window trend (CPPopt_MA) 
is entirely free of those gaps.  
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Figure 7.3 Examples of CPPopt trends. ABP: arterial blood pressure; CPP: cerebral perfusion pressure; CPPopt_S: 
CPPopt calculated according to PRx using a four-hour moving window; CPPopt_MA: a simple average value of 
CPPopts of window lengths varying from two hours to eight hours, with 10 minutes as the increasing step.                          
                                                                                                                                                                  
Table 7.3 shows the average (±SE) yield per patient result of CPPopt. The yield was significantly increased from 51% 
± 0.94% by using a single window to 94% ± 2.1% ( p < 0.05) while using the multi-window. There was no 
significant difference in CPPopt yield between different variants of the multi-window approach (p > 0.05). 
Stability of CPPopt  
The standard deviation of differences (SDD) between the sample-to-sample difference of CPPopt is shown in Table 
7.3. The stability of CPPopt was improved significantly by using the multi-window algorithm; SDD of CPPopt_S 
was 0.83±0.015, while SDD of CPPopt_MA was 0.58±0.015 (p < 0.05).  
Table 7.3 The yield result and standard deviation of differences (SDD) between two consecutive values of CPPopt 
across the whole recording duration of CPPopt using single-window calculation (CPPopt_S or CPPopt_SYE ) and 
using the multi-window algorithm (CPPopt_M). 
 CPPopt_S CPPopt_SYE CPPopt_MA CPPopt_MAYE CPPopt_MW CPPopt_MWYE 
Yield (Mean ± 
SE) 
50.5% 
± 0.94% 
46.1% 
± 0.95% 
94.2% 
±2.11% 
92.3% 
± 2.09% 
94.2% 
± 2.13% 
92.3% 
± 2.08% 
SDD (Mean ± 
SE) 
0.83 
±0.015 
0.74 
±0.014 
0.58 
±0.015 
0.61 
±0.016 
0.69 
±0.016 
0.72 
±0.019 
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PRx: pressure reactivity index. CPPopt_S: optimal CPP calculated using the single four-hour window; CPPopt_M: 
optimal CPP based on the multi-window algorithm.  
Relationship between CPPopt_single window  and CPPopt_multi-window 
We use CPPopt_MA to represent the multi-window approach. There was a linear relationship between CPPopt_MA 
and CPPopt_S, shown in Figure 7.4A (r = 0.89). The Bland-Altman plot demonstrates high agreement between the 
two methods. For this cohort of patients, CPPopt varied from 60 mmHg to 110 mmHg. The faint, parallel lines in 
the charts are associated with CPPopt values obtained from ‘incomplete’ ‘U’- shape curves (i.e. only descending or 
ascending parts), and represent lowest/highest values of the CPP bins (central point) contained within the curve (thus 
explaining the granularity of 5mmHg).    
 
Figure 7.4 Relationship and Bland–Altman plot of CPPopt_S and CPPopt_MA. CPPopt_S refers to CPPopt 
calculated through a four-hour window and CPPopt_MA implies CPPopt calculated as the average value of multi-
window CPPopts. Red lines: mean and 95% CI. 
Outcome analysis  
Figure 7.5 demonstrates the relationship between patients’ outcomes and CPP (the difference between CPP and 
CPPopt). Both CPPopt_S and CPPopt_M variants showed similar performance in relation to patients’ outcome, with 
CPP values below CPPopt more likely to result in a fatal outcome. 
For both approaches, the highest incidence of a favourable outcome was associated with averaged median CPP 
around CPPopt (CPP = 0). A nearly linear relationship between median CPP values above the optimal CPP 
threshold (CPP > 0) and severe disability rate can be seen. 
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A ROC test showed that CPP based on a single window or multi-window can distinguish the fatal and non-fatal 
outcome group significantly (p < 0.001); AUC of CPP based on CPPopt_S was 0.72 and AUC of CPP based on 
CPPopt_MA was 0.69. 
 
Figure 7.5 Graphs of the relationship between mortality, favourable outcome, severe disability, unfavourable 
outcome rate and the difference between averaged median cerebral perfusion pressure (CPP) and CPPopt using the 
moving window of four hours (A) and using weighted multi-window calculation (B).  
7.3 Monitoring of CPPopt in TBI using a multi-window weighting algorithm based on wPRx 
In Chapter 6,  we introduced a new method for CA assessment, wavelet PRx (wPRx) and validited it versus PRx. 
The result showed that wPRx can reflect CA and distinguish good CA from impaired CA. In Section 7.3, we also 
applied the multi-window algorithm to wPRx, to see whether there is improvement against the traditional single-
window method for CPPopt estimation.  
7.3.1 Materials and data monitoring  
Data of 427 TBI patients (70 females) admitted to the NCCU of Addenbrooke’s Hospital between 2003 and 2015 
were used. Continuous ABP and ICP were recorded through the method described in Chapter 3. The computerized 
data storage protocol was reviewed and approved by the local ethics committee of Addenbrooke’s Hospital, 
Cambridge University and the Neurocritical Care Unit User’s Group. 
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7.3.2 Methods  
Time-averaged values of ICP, ABP and CPP were calculated using waveform time integration over 60-s intervals. 
Cerebrovascular PRx was calculated as a moving Pearson correlation coefficient between 30 consecutive, 10-s 
averaged values of ABP and corresponding ICP signals [21]. Averages over 10 s were used to suppress the influence 
of the pulse– and respiratory–frequency wave components. A positive correlation between ABP and ICP at low 
frequency is indicative of passive cerebral vasculature and impaired autoregulation. Zero or negative correlation 
between ABP and ICP at the same frequency is indicative of reactive vasculature and intact autoregulation [36].  
The wavelet wPRx between ABP and ICP in the frequency range 0.0067 to 0.05 Hz was calculated. A Morlet 
wavelet was applied as the mother wavelet with the central frequency set at 1 Hz. wPRx was calculated as described 
in Section 6.1 using a 500-second window. Higher wPRx implies worse autoregulation; in contrast, lower wPRx 
demonstrates better autoregulation. Artefacts were identified and excluded manually from analysis after the data 
collection. 
CPPopt_wPRx (CPPoptw) was calculated according to a curve-fitting algorithm described in the last section, with a 
5-min median CPP time trend calculated alongside wPRx. These wPRx values were divided and averaged into CPP 
bins spanning 5 mmHg. An automatic curve-fitting method using a weighting system was applied to the binned data 
to determine the CPPopt value at the lowest associated wPRx. Before the curve fitting, wPRx data were first 
processed using a Fisher Transform to achieve a normal distribution, eliminating the ceiling effect of the maximum 
wPRx value of 1.0 [254]. The same strategy as Section 7.2 was applied to wPRx, with the calculation done through 
ICM+ software. The different simple codes in this section are described in Table 7.4. 
 
Table 7.4 Abbreviations of codes using wPRx for CPPopt calculation through multi-window or singl-window 
approach. 
Code Window type 
 
Use error 
weighting 
Enforce y region  
(0–0.8) 
Use weighting system (window length, 
fit error, non-parabolic and full-fit 
error) 
CPPoptw_S Four hour window NA NA NA 
CPPoptw_SYE Four hour window Y Y NA 
CPPoptw_MA Multi-Window NA NA NA 
CPPoptw_MAYE Multi-Window Y Y NA 
CPPoptw_MW Multi-Window NA NA Y 
CPPopt_MWYE Multi-Window Y Y Y 
Y: use this criterion; NA: not applied in this calculation. 
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The difference between median CPP (CPPmed) and CPPoptw over the whole monitoring period was calculated, 
labelled as CPPw. The outcome was dichotomized in two ways: favourable (good recovery, moderate and 
disability) vs unfavourable outcome (severe disability, persistent vegetative state and death) and fatal outcome 
(death) vs non-fatal outcome (persistent vegetative state, severe disability, moderate disability and good recovery). 
To test the extent of the erratic nature of CPPoptw, the SD of the difference between minute-to-minute CPPopt was 
calculated. 
7.3.3 Statistical analysis 
Statistical analysis was performed using the IBM SPSS Statistics (version 21) software. Groups were compared 
using the non-parametric Kruskal-Wallis test because the values in most groups were not normally distributed. 
ANOVA test was used to compare the yield of different CPPopt calculation methods (Table 7.5). We assumed 
=0.05. The ROC curve was used to compare the ability of different CPPopts to distinguish patients’ outcomes. A 
ROC test was also done, rendering an area under the ROC curve for each parameter. Bland–Altman plots were used 
to investigate the agreement between CPPoptw_S and CPPoptw_MA. 
7.3.4  Results 
CPPopt_wPRx yield  
Figure 7.6 shows CPPopt_wPRx using single window (CPPopt_S) and multi-window weighted (CPPopt_MWYE) 
approaches. The latter approach showed a more stable and continuous result.  
 
Figure 7.6 Demonstration of CPPopt calculation according to wPRx. ABP: arterial blood pressure; CPP: cerebral 
perfusion pressure; CPPoptw_S: CPPopt calculated according to wPRx through a 4-hour moving window; 
CPPoptw_MWYE: average value of CPPopts through various length moving windows, from two hours to eight 
hours, with 10 min as the increasing step.       
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Figure 7.7 shows that the average yield result of CPPopt_wPRx using 4 hour window was 52.5%, while the multi-
window algorithm resulted in a significantly increased yield result of 94.5% (p<0.05). The application of enforcing 
PRx region and using standard deviation in bins to weight the curving system, did not cause big difference.  
 
Figure 7.7 Yield result of CPPopt_wPRx using 4 hour window and multi-window. wPRx: cosine of wavelet phase 
shift between arterial blood pressure and intracranial pressure.      
Variability of CPPopt_wPRx 
The SDDs between the sample-to-sample differences of CPPopt_wPRx are shown in Table 7.5. No big differences 
between the stability of CPPopt_wPRx based on the single-window system and multi-window system were found 
(p > 0.05). 
Table 7.5 The yield result and SDD between two consecutive values of CPPopt across the whole recording duration 
of CPPopt using the single-window calculation (CPPopt_S or CPPopt_SYE) and the multi-window algorithms 
(CPPopt_M). 
 CPPopt_S CPPopt_SYE CPPopt_MA CPPopt_MAYE CPPopt_MW CPPopt_MWYE 
Yield (Mean ± 
SE) 
52.5% 
± 0.94% 
46.5% 
± 0.95% 
94.5% 
±2.11% 
93.0% 
± 2.09% 
94.5% 
± 2.13% 
93.0% 
± 2.08% 
SDD (Mean ± 
SE) 
0.49 
±0.013 
0.48 
±0.013 
0.36 
±0.014 
0.36 
±0.015 
0.41 
±0.017 
0.42 
±0.018 
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Relationship between CPPopt_single window  and CPPopt_multi-window 
The CPPopt using a single window (four-hour window) is linearly related to CPPopt using the multi-window-
average method (Figure 7.8, p < 0.001). The relationship can be expressed as: CPPoptw_MA = 0.96  × CPPoptw_S 
+ 2.91 (r = 0.92, p < 0.001). The result also showed that for this cohort of patients, CPPopt varied from 60 mmHg to 
100 mmHg. The Bland–Altman analysis showed high agreement between the two CPPopts. 
 
Figure 7.8 Relationship between CPPopt_wPRx using the four-hour window and using multi-window system. wPRx: 
cosine of wavelet phase shift between arterial blood pressure and intracranial pressure.  Per point per patient 
(N=427).  
Outcome analysis 
Figure 7.9 demonstrates the relationship between patients’ outcomes (the mortality rate, favourable outcome rate 
and severe disability rate) and the difference between CPP and CPPopt. The result shows that CPP close to CPPopt 
was related to a better outcome, either using a single window or multi-window (Figure 7.9A). The mortality 
increases steadily when median CPP is increasingly below the threshold of optimal CPP and decreases slightly with 
increasing values above optimal CPP (Figure 7.9C); a nearly linear relationship between median CPP values above 
the optimal CPP threshold and severe disability rate can be seen (Figure 7.9D). A ‘U’-shape curve demonstrated that 
the smallest incidence of an unfavourable outcome was associated with median CPP around optimal CPP (Figure 
7.9B). 
An innovative method to monitor CPPopt in TBI 
 
128 
 
 
 
Figure 7.9 Graphs of the relationship between favourable outcome, unfavourable outcome, mortality and severe 
disability and the difference between cerebral perfusion pressure (CPP) and CPPopt_wPRx using the moving 
window of four hours and using a multi-window calculation.  
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7.4 Discussion 
Although continuous assessment of CPPopt seems to have prognostic value, its potential for clinical use in an 
intervention study is limited in part because of its apparent instability and frequent discontinuities. We have built on 
concepts presented by Depreitere et al. and implemented a new method of CPPopt calculation that improves the 
quality of the curve fit and improves yield and stability by taking advantage of multiple calculations from 
incrementally extended data windows.  
This method extended the number of windows that Depreitere et al. used from 7 to 36, varying from two hours to 
eight hours, and took more factors into account. The results showed a marked increase in CPPopt yield (>90%), and 
a significant improvement in the stability of CPPopt, compared with traditional single-window-based CPPopt. This 
was of course not unexpected, given the methodology involved. It is easy to see that the algorithm should be able to 
fit an acceptable curve from windows of increasing sizes, all the way up to eight hours. The averaging operation is 
also likely to have a stabilising effect on the CPPopt trend. The question is, however, if by increasing the window 
length as far back as eight hours, are we calculating values that may perhaps be less relevant to the current state? 
The first factor in our weighting system, the window length penalty, is such that a shorter window was given a 
higher weight to gauge the curve fitting, which should help to address this problem. The algorithm then favours the 
shorter windows, which are more related to the most recent changes in CA, thus leading to more local curve fits. 
An ideal ‘U’-shape curve with a clear minimum at the middle gives more confidence in identification of the best 
vasoreactivity (CPPopt), while only descending or ascending lines might introduce some underestimation or 
overestimation, although they also carry information about vasoreactivity[255]. In our weighting approach, higher 
weight was set to a perfect ‘U’-shape curve and lower weight was assigned to only monotonic lines. Through this 
approach, we believe it can estimate the CPP point with the best autoregulation more reasonably. 
Another criterion in the weighting approach was the fit error. To consider more data points, the full-fit error was 
calculated between the individual PRx data points and the fitted curve, with a higher weight assigned to the curve 
with a smaller fit error. Through this penalty, the curves that have better performances in curve fitting can have more 
influence in the final CPPopt calculation. 
To make the CPPopt estimation more reasonable, we excluded the PRx/wPRx range of entirely intact CA (PRx < –
0.3 or wPRx< 0, where no CPPopt is needed) and completely damaged CA (PRx > 0.6 or wPRx > 0.8, where 
CPPopt cannot be recommended even if there is a ‘U’-shape curve). The current weighting parameters used in this 
study were decided roughly on a small sample study; further research needs to be done to find the best value of these 
different weighting factors. However, even with current settings, it already showed significant improvement in the 
estimation of CPPopt, which indicates future clinical use. 
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Both PRx and wPRx were used to estimate CPPopt. Previous studies have indicated a relationship between patients’ 
outcome and deviation from CPPopt [204], [239], [256]. We did not expect the relationship with the outcome to 
change using the multi-window algorithm, as this is done on patient averaged values. What we did want to achieve 
is better stability and availability of the curve, without introducing errors that make the statistics with outcome 
worse. From this point, the fact that no significant difference was found between the recommended CPPopt using 
both multi-window or single-window approaches is actually reassuring. 
Researchers have already confirmed that treating a patient with individualized optimal CPP has a better 
discrimination value than a fixed threshold of 60 or 70 mmHg[255]. This, larger, study of 515 TBI patients, showed 
CPPopt varying from 60 mmHg to 110 mmHg, sustaining the notion that one fixed CPP target for all patients may 
not be appropriate [2], [257], and that a dynamic CPP target based on pressure autoregulatory capacity is more likely 
to be recommended [216], [217]. With the presented multi-window methodology that ensures the CPPopt values 
available nearly 95% of the time, with markedly reduced short-term variability, the technique should be much more 
applicable to future clinical trials. 
7.5 Conclusion 
The new CPPopt methodology increased the availability of valid CPPopt values (according to PRx or wPRx) during 
most of the monitoring time. The method, which can easily be programmed in an automated tool at the bedside, has 
the potential to make the technique of ‘optimal CPP’ management widely applicable in most ICUs. 
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CHAPTER 8 CEREBRAL AUTOREGULATION DURING INTRACRANIAL HYPERTENSION 
Raised ICP has been proved to be associated with a poorer outcome in the past [21], [260], [261]. A small study of 
severe TBI patients showed that some TBI patients whose initial CT scan was normal, with no mass lesion or 
midline shift, developed raised ICP greater than 20 mmHg that lasted more than five minutes [262], which can result 
in secondary injury. In adults, the normal ICP under resting conditions is 0–10 mmHg with 15 mmHg being the 
upper limit of normal. The main reasons for raised ICP include mass lesions, CSF accumulation, vascular congestion 
and cerebral oedema [263], [264]. Small increases in mass may be compensated for by a reduction in CSF volume 
and cerebral blood volume but, once such mechanisms are exhausted, ICP rises with increasing pulse pressure and 
the appearance of spontaneous waves (plateau and B-waves) [180]. Known as a Lundberg A-waves, an ICP plateau 
refers to sudden increases in ICP up to 50–80 mmHg lasting 5–20 min. It may be triggered by usual ICU procedures 
such as tracheal suctioning, lowering the head of the bed and routine hygiene [43]. 
A sudden transient decrease in ABP, with intact CA, will lead to a rapid compensatory dilation of cerebral blood 
vessels. Accordingly, the blood volume will be increased, which will in turn, under conditions of ‘tight’ brain, cause 
an increase in ICP. Based on the concept of CPP, the difference between ABP and ICP, this will bring further 
decrease in CPP and further vasodilation until maximum vasodilation is reached[180], [265]–[267]. This triggers a 
cycle that leads to ever reducing CPP vasodilatory cascade (Fig. 8.1). 
 
Figure 8.1 The complex vasodilatory cascade. 
In the last three chapters, we have investigated the relationship between traditional CA assessment methods (e.g. 
PRx, TF phase and gain, ARI and Mx) in TBI patients, we also introduced a sophisticated new method for CA 
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assessment in TBI, the WT method (wPRx). The multi-window approach improved targeted optimal CPP 
significantly in clinical practice, with a more stable result than with the single-window algorithm. 
In this chapter, we tried these different methodologies for CA assessment in some special clinical cases, they are 
ICP plateau waves and patients with refractory ICP to see the performance of these parameters.  
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8.1 Cerebral autoregulation assessment in plateau waves 
The result presented in this section have been published in Acta Neurochir Suppl. 2016 [268].  
8.1.1 Introduction 
ICP plateau waves refer to ICP rising up to 50–100 mmHg for 5 to 20 min, returning to normal values either 
spontaneously or in response to treatment [109], [180], [269]. The rapid termination of the wave has been described 
by a vasoconstriction cascade model in which active vasoconstrictive events lead to decreases in CBV and ICP and 
an increase in CPP [216], [223]. Theoretically, plateau waves are always associated with degradation of the CBF 
autoregulation ability as the vessels reach the state of maximum dilation [270]. 
Many methodologies have been introduced to assess CA, both in the frequency domain and the time domain. In this 
section, we used plateau wave recordings from TBI patients as a ‘test bench’ to compare the performance of those 
parameters in their ability to distinguish between the ICP baseline and plateau phases. Furthermore, we calculated 
ARI, Mx and TF parameters using either ABP or CPP as inputs and FV as output. 
8.1.2 Materials and methods 
119 TBI patients admitted to Cambridge University Hospital (Addenbrooke’s) between 2003 and 2013 were studied 
retrospectively (total number of 495 daily recordings). Daily TCD recording to assess CA may be considered in 
standard management in our NCCU. Data were recorded and analysed anonymously as part of a standard clinical 
audit approved by the Neurocritical Care Users Group Committee. Continuous ICP signals and FV of MCA were 
monitored in the way described in Chapter 3. The complete dataset has been screened for plateau waves and this 
resulted in a reduced dataset of 30 plateau waves recordings, in 24 patients. 
The ARI value was calculated by comparing IRs estimated from real data with IRs derived from Tiecks’ model 
(described in Section 3.1). TF gain, phase as well as coherence in the frequency range of 0.01–0.05 Hz (VLF) and 
0.05–0.15 Hz (LF) were calculated through the FFT algorithm, as described in Section 3.2. Both ABP and CPP were 
used as input and here we use ‘a’ or ‘c’ for abbreviation, for example, gain_a_VLF refers to the gain between ABP 
and FV at the VLF range (Table 8.1). All the calculations were updated every 10 s. 
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Table 8.1 Abbreviations used in this section 
Abbreviation Full Name Abbreviation Full Name 
Phase_a_VLF Phase between ABP and FV 
at VLF 
Phase_a_LF Phase between ABP and FV at LF 
Phase_c_VLF Phase between CPP and FV 
at VLF 
Phase_c_LF Phase between CPP and FV at LF 
Gain_a_VLF Gain between ABP and FV 
at VLF 
Gain_a_LF Gain between ABP and FV at LF 
Gain_c_VLF Gain between CPP and FV at 
VLF 
Gain_c_LF Gain between CPP and FV at LF 
Coh_a_VLF Coherence between ABP and 
FV at VLF 
Coh_a_LF Coherence between ABP and FV at LF 
Coh_c_LF Coherence between CPP and 
FV at LF 
Coh_c_VLF Coherence between CPP and FV at VLF 
 
Mean flow index (Mx) was calculated as a moving Pearson’s correlation coefficient using 5 min long windows of 10 
s averages of CPP and FV. The results were averaged for each recording, labelled here as Mxc. In addition, the 
calculations were repeated using ABP as input, instead of CPP, labelled here as Mxa. 
Statistical analysis 
Statistical analysis of variables was performed using the IBM SPSS Statistics (version 19) software. Results are 
presented as a mean value ± SD. t-tests were used to analyse differences in autoregulatory indices between baseline 
and plateau. The Pearson correlation coefficient between these parameters was calculated, recorded as r. Results 
were considered significant at p < 0.05. 
8.1.3 Results 
The average values of ABP, ICP and FV for all 24 patients can be found in Table 8.2. During the plateau, mean ICP 
increased from 21.7 ± 8.3 mmHg to 43.8 ± 12.7 (mean ± SD, p < 0.05) accompanied by a decrease in FV (p < 0.05) 
and CPP (p < 0.05). However, mean ABP did not show a very significant difference between baseline and plateau。 
An example of the behaviour of ABP, ICP, CPP and FV is presented in Figure 8.2. 
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Figure 8.2 An example of a plateau wave, ABP: arterial blood pressure; ICP: intracranial blood pressure; FVX: flow 
velocity . 
Table 8.2 Mean values of ABP, ICP, CPP and FV at baseline and plateau 
 ABP 
(mmHg) 
ICP 
(mmHg) 
CPP 
(mmHg) 
FV (cm/s) Mxa Mxc ARIa ARIc 
Baseline 94.2 ± 12.8 21.7 ± 8.3 72.5 ± 4.5 56.5 ± 31.4 0.21 ± 
0.34 
0.12 ± 
0.40 
3.39 ± 
1.58 
4.02 ± 
2.46 
Plateau 93.8 ± 11.5 49.9 ± 
15.3 
43.8 ± 
12.7 
48.6 ± 27.7 0.28 ± 
0.42 
0.47 ± 
0.47 
2.18 ± 
1.99 
2.45 ± 
2.21 
Mxa: mean flow index (Mx) between ABP and FV; Mxc: Mx between CPP and FV; ARIa: ARI between ABP and 
FV; ARIc: ARI between CPP and FV. Format: mean value ± SD. 
Following the rise in ICP, the ARI decreased significantly in both ARIa (p = 0.013) and ARIc (p = 0.014) indicating 
deterioration of CA during the plateau phase (Figure 8.3A and Figure 8.3B, Table 8.3). The index Mxc increased 
significantly from 0.12 ± 0.40 at the baseline to 0.47 ± 0.47 at the plateau (p = 0.004), again showing deterioration 
of autoregulation. However, we could not find a significant difference between baseline and plateau when using 
Mxa (Figure 8.3C, p = 0.472). 
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Figure 8.3 Autoregulation indices (ARIa and ARIc) and mean flow indices (Mxa and Mxc) during baseline and 
plateau. Error bars: SE.  
Table 8.3 Mean values of CA parameters during baseline 
ICP 
Stage 
 Phase_a 
(degree) 
Phase_c 
(degree) 
Gain_a Gain_c Coh_a Coh_c 
VLF LF VLF LF VLF LF VLF LF VLF LF VLF LF 
Baseline Mean value –3.64 3.38 –46.6 –31.4 0.95 2.10 0.79 1.81 0.35 0.35 0.46 0.41 
SD 44.7 27.2 57.2 48.2 0.60 2.17 0.47 1.17 0.11 0.11 0.13 0.12 
Plateau Mean value –1.12 11.33 –15.3 –15.1 0.69 1.20 1.30 2.27 0.44 0.39 0.50 0.43 
SD 26.76 15.35 37.85 34.25 0.54 0.87 1.42 2.22 0.12 0.14 0.16 0.12 
Phase_a: phase between ABP and FV; Phase_c: phase between CPP and FV ; Gain_a: gain between ABP and FV; 
Gain_c: gain between CPP and FV; VLF: 0–0.05 Hz; LF: 0.05–0.15 Hz. 
 
Only Phase_c in the VLF range (0–0.05 Hz) showed a significant difference between baseline and plateau (p = 0.02). 
Neither Phase_a nor Gain_a was associated with an increased ICP at the plateau (Figure 8.4, p > 0.05). For Coh_a 
and Coh_c, there was a significant increase in Coh_a_VLF from 0.35 ± 0.11 at the baseline to 0.44 ± 0.12 at the 
plateau (p = 0.004). No significant differences were found in other coherence values (p > 0.05). 
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Figure 8.4 Mean value of phase and gain and coherence of transfer function at baseline and plateau. Gain_a_VLF: 
TF gain between ABP and FV at 0~0.05 HZ; Gain_a_LF: TF gain between ABP and FV at 0.05~0.15 HZ; 
Gain_c_VLF: TF gain between CPP and FV at 0~0.05 HZ; Gain_c_LF: TF gain between CPP and FV at 0.05~0.15 
HZ. 
 
8.1.4 Discussion 
During plateau waves, ICP increases due to vasodilation followed by an increase in blood volume. After the vessel 
dilates to its maximum size, the vascular resistance and the compliance of large cerebral arteries reach their extreme 
levels [266], [271]–[273]. The CBF autoregulation ability will be weakened accordingly because the vessels lose 
their pressure reactivity. This degradation in CA was depicted in the ARI being significantly decreased at the top of 
the ICP plateau and in the Mx being significantly increased. This finding suggests a possible negative relationship 
between Mx and ARI. Changes in Mxc are more pronounced from baseline to plateau than changes in Mxa. This 
finding has also been observed in previous studies [21], [120], [266]. On the other hand, ARI proved to be sensitive 
to changes in autoregulation induced by the plateau waves, although less significantly than Mxc in our material, 
irrespective of whether ABP or CPP was used as input. This is perhaps because the model that ARI is based on 
explicitly uses ABP as input. If CPP is used as input instead, this is likely to introduce errors in the estimation of 
ARI. On the other hand, neglecting ICP waves by using ABP as the input, is likely to introduce errors in assessment 
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of autoregulation, particularly when a high amplitude of ICP slow waves is expected, as seen during plateau waves. 
This might explain why both ARIa and ARIc demonstrated similar sensitivity to changes in autoregulation induced 
by plateau waves, which was lower than Mxc. 
The increase of coherence between ABP and FV at the ICP plateau implies a more direct transmission from input to 
output, suggesting a loss of autoregulation. However, the TF did not behave consistently. Theoretically, if we 
consider CA as a high-pass filter, the better autoregulation is, the bigger time delay from input to output is and the 
smaller the gain is. In this study, neither phase nor gain demonstrated a significant difference between baseline and 
plateau. In some cases, the TF phase even increased during the plateau. This finding may reflect the non-linear 
effects of the CA system. 
8.1.5 Conclusion 
This study confirms that both ARI (ABP- or CPP-based) and mean FV index Mx (CPP-based) could be used reliably 
as indicators of deteriorating CA. On the other hand, the TF-derived parameters, phase, gain and coherence, showed 
rather inconsistent behaviour in our group of patients and thus their use in TBI patients with plateau waves is 
perhaps not advisable.  
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8.2 Wavelet method for CA assessment in TBI patients with refractory ICP 
8.2.1 Introduction 
Intracranial hypertension is commonly encountered in TBI patients, intracranial haemorrhage and ischaemia. 
Refractory-raised ICP, which leads to a reduction of cerebral perfusion, is associated with poor prognosis, and is 
potentially life threatening if not immediately corrected [274]. Few specific treatment options for intracranial 
hypertension have been subjected to randomized trials and it challenges the critical care team [234]. Defined as the 
difference between mean ABP and ICP, CPP can be reduced by an increase in ICP, a decrease in blood pressure or a 
combination of both factors. Through the normal CA, the brain is able to maintain a constant CBF within a normal 
autoregulatory range of CPP via vasodilation or vasoconstriction. However, after brain injury, the ability of the brain 
to autoregulate may be absent or impaired, thus resulting in similar responses of CBF following changes in CPP 
[276]. Therefore, it is important to find a good way to assess the interrelation and influence between ABP, ICP and 
FV, which provides information about the functionality of CA. 
A major limitation of the classical spectral analysis is the steady-state assumption. It requires, at some level, 
disregarding the dynamic, complex and noisy characteristics of the continuous physiological adjustments required to 
maintain stable cerebral perfusion [188]
 
.Thus, time–frequency methods have been introduced to detect the dynamic 
behaviour of ABP and ICP [277], [278]. The WT method, which has been widely applied in geophysical and 
economic fields, is found to be particularly useful for analysing noisy, intermittent and non-stationary signals [151]. 
It is a method of decomposing a signal into a time–scale plane through the convolution of the signal with a wavelet 
function [175]. One advantage of wavelet analysis is the ability to perform local analysis and reveal signal features 
with desired temporal–frequency resolution in different frequencies, higher temporal resolution for higher frequency 
and higher scale (inverse frequency) resolution for lower frequency [175], [176]. 
The aim of this study is to apply the wavelet method to TBI patients with refractory ICP and compare it with 
pressure reactivity index (PRx) and the TFA method. 
8.2.2 Materials and methods 
Recordings of 12 patients (3 females) aged between 16 and 43 years with refractory high ICP admitted to 
Addenbrooke’s Hospital between the years of 2003 and 2012 were studied. Patients were selected from a larger 
database of previously presented cases [238] containing both baseline and high ICP (higher than 45 mmHg). The 
study had local research ethics approval and all subjects gave informed consent. 
Continuous ABP was measured with an arterial line zero calibrated at the level of the right atrium (Baxter 
Healthcare Corp, USA). Continuous ICP was monitored in the frontal lobe with a strain gauge transducer (Codman, 
Codman and Shurtleff Inc., Raynham, MA, USA) implanted intraparenchymally. Signals from the bedside monitors, 
including ABP and ICP were sampled at 30–200 Hz and recorded by software ICM+® (Cambridge Enterprise Ltd, 
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Cambridge, UK, http://www.neurosurg.cam.ac.uk/icmplus) or, before 2001, using waveform recorder WREC for 
DOS (W. Zabolotny, Warsaw University of Technology). Artefacts introduced by tracheal suctioning, arterial line 
flushing or transducer malfunction were removed. Data were recorded and analysed anonymously as part of a 
standard audit approved by the Neurocritical Care Users Group Committee. 
Methodologies 
Wavelet analysis. WTP between ABP and ICP in the frequency range 0.0067 Hz to 0.05 Hz was calculated through 
complex wavelet transform, as described in the Appendix. A Morlet mother wave was applied with the central 
frequency set at 1 Hz. A 500-second window was used to calculate WTP, and updated every 10 seconds. Monte 
Carlo simulations approach was applied to evaluate the distribution of estimated WTC values corresponding to two 
uncorrelated signals. 10000 simulations were conducted and the 95% confidence WTC threshold was used to reject 
corresponding phase values that were deemed unreliable. Individual WTP values with WTC higher than the 
threshold were kept, while the points with WTC lower than the threshold were ignored. The cosine of WTP was 
calculated afterwards, labelled the wavelet (transform) pressure reactivity index (wPRx), which on the one hand can 
limit the wPRx range between –1 and +1, making wPRx directly comparable with PRx; in addition, the result of this 
operation also helps address the problem of phase wrapping. 
Pressure Reactivity Index: The mean pressure reactivity index (PRx) was calculated as the time correlation 
coefficient between 10 s averages of ABP and mean ICP, using a 300 s data window. Positive PRx indicates a 
passive relationship between ABP and ICP, while PRx close to 0 or negative implies good autoregulation. 
TF transform: TF phase and gain between the real ABP and ICP were calculated through the method described in 
Section 3.1.2. The analysis was focused on the frequency range 0.0067 to 0.05 Hz. Generated FV and ABP were 
ﬁrst normalized (mean subtracted and divided by the SD), and then divided into four data segments of 120-second 
duration (amounting to 50% segment overlap) and transformed with the FFT algorithm (Welch method) [141], 
[144]–[147]. TF phase and gain between artificial CBFV and ABP were calculated using the method described in 
Section 3.1.2. All the calculations were performed through a 300-second moving window and updated every 10 
seconds. 
The average values of these CA parameters were calculated for two ICP states: ICP baseline (ICP < 25 mmHg) and 
ICP plateau (with high ICP > 45 mmHg). 
Precision analysis 
A comparison between the precision of the PRx, wPRx and TF was conducted using the method described in 
Brady’s research [205]. The precision was calculated as the median absolute deviation divided by the range of 
possible values (RPV). For PRx and wPRx, the RPV is –1 to +1; and for TFP, the RPV is 0–180o due to the absolute 
function applied to the phase calculation; for TF gain, in this analysis, the RPV is 4. 
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Statistical analysis 
SPSS software (version 21, IBM, Armonk, NY, USA) was used for statistical analysis. A curve-fitting method 
(linear regression) was used to describe cross-relationships between PRx and WTP. Pearson’s correlation coefficient 
(r) was used to examine the linearity of the relationship. Results were considered significant at p < 0.05. An 
independent-samples t-test was used to analyse differences in autoregulatory indices in different CA groups 
according to LLA or ICP state. 
A ROC test was also done for CA groups, rendering an area under the ROC curve for each metric. 
8.2.3 Results 
Impaired CA during refractory ICP  
Figure 8.5 demonstrates an example of signals and CA parameters for a TBI patient with refractory ICP. From 
baseline to high ICP, the CA deteriorated, as shown by increased wPRx and PRx . 
 
Figure 8.5 An example of a traumatic brain injury patient with refractory intracranial pressure. 
Relationship between CA parameters and their precision   
The relationship between one hour average of wPRx and PRx is shown in Figure 8.6. There is a significant positive 
relationship between wPRx and PRx (r = 0.848, p < 0.001, Figure 8.6A). The average precision for PRx, wPRx, TF 
phase and TF gain was 0.13 ± 0.07 (Mean ± SD), 0.08 ± 0.05, 0.11 ± 0.04 and 0.08 ± 0.05. The difference between 
wPRx and PRx was significant (p = 0.038, Figure 8.6B). 
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Figure 8.6 (A) Relationship between wPRx and PRx. (B) The precision of  the four CA parameters: PRx, wPRx, TF 
phase and TF gain. Each dot represents one hour average of wPRx and PRx.  
The ability of CA parameters in distinguishing refractory ICP 
Figure 8.7 demonstrates that both PRx and wPRx can distinguish baseline and plateau ICP, while AUC of PRx 
equalled 0.882 and AUC of wPRx was 0.843. Either TF phase or TF gain can distinguish different ICP states (p > 
0.05). 
 
Figure 8.7 Average value of different CA parameters in two ICP states: baseline and plateau. ICP: intracranial 
pressure; CA: cerebral autoregulation; TF: transfer function; PRx: pressure reactivity index; wPRx: wavelet pressure 
reactivity index. Average value of all patients during baseline and plateau.  
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8.2.4 Discussion 
Refractory ICP can always happen after brain trauma, which is very dangerous and needs immediate clinical action. 
CA is a potentially important parameter to use to monitor the brain state of the patients. In this study, the average 
ICP was increased from 24 ± 8 mmHg to 64 ± 22 mmHg, and the CA significantly deteriorated; this also matched 
the result from a previous study on the ICP plateau [279]. 
In this study, there is a significant linear relationship between wPRx and PRx, which again validates the calculation 
of CA through the wavelet method. Although both wPRx and PRx can distinguish different ICP states, wPRx 
showed a more stable result than PRx. This might be for two reasons: 1. The wavelet mainly focused on a specific 
frequency range, and is able to eliminate noises in unrelated bands, while PRx analysed the data across the whole 
frequency range. 2. The application of WTC can exclude the data points with an unreliable relationship between 
ABP and ICP, making the assessment more robust. TF behaved poorly in distinguishing different ICP states. 
8.2.5 Conclusion 
This section proved that even in sudden emergent cases of TBI, such as refractory ICP, both wPRx and PRx can be 
used to assess CA as a reliable tool, and both parameters can distinguish refractory ICP, with wPRx performing 
more stably. The TF did poorly in this situation. 
8.3 Conclusion 
This chapter applied different CA assessment methods to other clinical cases, ICP plateau and refractory ICP. The 
result showed that CA deteriorated during high ICP, and PRx, wPRx can distinguish ICP baseline and high ICP 
significantly. 
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CHAPTER 9 CONCLUSIONS AND FUTURE DIRECTIONS 
In conclusion, it can be stated that all hypotheses listed in Chapter 1 were positively verified. 
In detail: 
1. This study examined the relationship between different commonly used methods for CA assessment, such as Mx, 
TF, ARI through a group of simulated data based on Tiecks’ model and a cohort of TBI patients. The result showed 
strong relationship between ARI and Mx, as well as ARI and TF phase. It proved the interchangeability of these 
indices from theoretical and practical point of view. It also demonstrated that Mx and ARI were generally related 
with patients’ outcome. Different input (ABP or CPP) will have influences on the CA indices.  
2. A new autoregulation index (wPRx) based on time-frequency analysis, wavelet transform, was introduced and 
validated in two groups of experimental hypotension piglets’ data. The wPRx was compared with a well-established 
parameter, PRx, and the result showed a strongly positive, approximately linear, relationship between wPRx and 
PRx. Afterwards, the wPRx was applied in 515 TBI patients, where similar strong relationship between wPRx and 
PRx was demonstrated, with wPRx showing more stable result.  
3. The final aim of this project was to improve the estimation of CPPopt using the CA parameters for clinical 
guidance. A multi-window and weighting approach to estimate CPPopt for TBI patients was introduced and its 
performance scrutinised in a cohort of TBI patients. The results showed that the new proposed approach hugely 
improved the yield rate, from 55% to higher than 90% of the whole monitoring period offering significantly more 
stable behaviour, and all of that without worsening the relationship with outcome, The method, which can easily be 
programmed in an automated tool at the bedside, has the potential to make the technique of pressure autoregulation-
steered management widely applicable in most ICUs. 
4. In addition, this study also tested the performances of CA parameters in cerebral autoregulation during 
intracranial hypertension. The result showed deteriorated CA at high ICP, such as ICP plateau and refractory ICP.  
Future continuation of the work presented here should include further investigation of the wavelet PRx index in 
order to unleash the full potential of the time-frequency localised ‘PRx’.  And without a doubt more work should be 
put into fine-tuning the algorithm of optimal CPP calculation.  In particular the future work, could be broadly 
divided into several aspects: 
1. The wavelet method in different clinical scenarios 
An understanding of the physiology, pathophysiology, monitoring, and treatment of cerebral autoregulation is key in 
the evolution of clinical management of brain injury patients. This study validated a new time-frequency method, 
wavelet method (wPRx) for CA assessment, in traumatic brain injury. The result showed a great potential for its 
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application at bedside. However, more validations need to be done to extend this methodology into different 
modalities and different brain pathologies, such as tumour, stroke, brain haemorrhage and encephalitis. At the same 
time, various inputshave to be tried, because ICP is not a routine monitoring procedure for some of these brain 
injuries. 
2. The time trends of dynamic cerebral autoregulation  
Dynamic cerebral autoregulation is probably altered in acute brain injury, however, the temporal course of dynamic 
cerebral autoregulation and its correlation with clinical factors and outcomes are poorly understood [253]. In this 
study, the CA parameters were averaged across the whole monitoring time. For the future study, more efforts should 
focus on the time change (e.g. day-to-day change) and investigate how the trend will influence patient outcome. 
3. Further exploration of the multi-window system 
Based on Depreitere’s method, the new multi-window algorithm for CPPopt calculation used in this study has 
already increased yield significantly, but there is still room for improvement. The comparison between different 
weighting strategies did not show big differences suggests that more investigations about weighting parameters need 
to be done. The weight factors of window length, ‘fit error’ and curves shape were fixed values in this study (0.5, 1, 
0.1 respectively), that could be optimised to strike a balance between yield, reliability and variability of the measure 
in the future. Moreover, whether a combination of 36 windows is necessary, and the influence of the criterion of 
enforcing y axis needs to be studied. For CPPopt calculation using PRx or wPRx, we applied the same set of 
weighting factors which could be optimized. Investigations can be conducted with one parameter being changed and 
keeping others fixed, to find the most important factor.    
4.  A randomized clinical trial 
The current retrospective studies already showed good patient outcome is related with small difference between CPP 
and CPPopt, which makes a randomized clinical trial assessing the effect of CPPopt in the management of TBI 
patient necessary. The multi-window algorithm introduced in Chapter 7 made CPPopt available during almost the 
whole monitoring period which makes the clinical application of CPPopt possible. The next step could be gently 
apply the CA parameters into clinical management. The patients can be divided into two groups as suggested in 
CONGITATE project, one was controlled group with CPP managed according to Brain Trauma Foundation 
guideline, between 60 and 70 mmHg (CPPopt information is recorded but hidden for the treating clinicians.); the 
other was experimental group, with CPP is targeted at CPPopt, and while no CPPopt is demonstrated, then CPP is 
managed according to Brain Trauma Foundation guidelines. The trial might contribute to the future individualize 
optimal CPP management guidelines for TBI and potentially improve patient outcome. 
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5. wPRx threshold for bad cerebral autoregulation 
This study already showed advantage of wPRx as a more stable parameter to assess CA. There is a strong 
relationship between wPRx and PRx, and previous studies proved that PRx of 0.3 as a threshold of patients’ bad or 
impaired CA, and PRx below 0 indicating good CA. In this study, we found wPRx can distinguish patient outcome 
more obviously, however, a certain threshold has not been spotted yet. Future study should try to find the threshold 
to make the method more practical and clinically useful.  
6. Multi-window method applied to other patients 
Besides CPPopt assessment inTBI, researchers also applied similar algorithm to different patients, such as infants. 
In a population of preterm infants, Costa et al used tissue oxygenation heart rate reactivity index (TOHRx), which is 
the correlation coefficient between slow waves of heart rate (HR) and tissue oxygenation index (TOI) measured 
with NIRS, to calculate optimal ABP value (ABPopt) [280]. The result showed infants who had an ABP lower than 
optimal ABP by at least 4 mm Hg had greater mortality rate. In their study, the determination of individual ABPopt 
was possible in 81.5% infants. The multi-window algorithm, introduced in this study could be a potential tool to 
improve the yield of ABPopt.    
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